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Thesis summary 
Summary 
Campylobacter concisus is a human oral cavity bacterium, which has been linked to oral 
cavity infections such as gingivitis and periodontitis for the last twenty years. C. concisus has 
also been isolated from non-oral sources since 1989 and was considered as a potential 
aetiological agent of enteritis in children since 1994. Some patient subgroups, mainly 
children under 24 months of age, the elderly, and immunocompromised patients are known to 
be most susceptible to C. concisus enteric infections. However, C. concisus was isolated from 
saliva and stool of healthy individuals and was recently detected in the synovial fluid of 
patients with Campylobacter-associated reactive arthritis. Yet, little is known about this 
bacterium regarding its mode of transmission, reservoir, and its true potential as a pathogen, 
due to the lack of any established typing procedure and other virulence related studies. 
C. concisus clinical strains isolated from children suffering from gastroenteritis at the Royal 
Children's Hospital (Melbourne), were grouped and characterized in this study using 
molecular methods to clarify the identity of these isolates and to detect any possible virulence 
factors that could be related to the pathogenicity of this bacterium. The clinical isolates were 
grouped into two molecular groups (genomospecies) using PCR amplification of the 23S 
rDNA of C. concisus with the majority of the isolates (>70%) belonging to genomospecies A. 
However, the protein profiles for these isolates were divergent even within the same 
molecular group, but they were different from the protein profiles of other closely related 
Campylobacter spp. isolates, which indicate the complex nature of this species. 
Both secreted and cell-bound hemolytic activities were detected in C. concisus clinical 
isolates by different hemolysis assays using mammalian and non-mammalian erythrocytes. 
Variable levels of hemolysis were detected for all tested strains on different types of blood. 
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Thesis summary 
The species specificity of red blood cell hemolysis and the difference in the hemolytic activity 
levels have been previously reported for Campylobacter spp.' and other pathogenic bacteria. 
The fraction containing the membrane-bound hemolytic activity found in C. concisus clinical 
isolates was extracted and characterised using different physical and chemical tests. This 
hemolysin(s) is a stable calcium-dependent and iron regulated protein with phospholipase A2 
enzymatic activity that prefers phosphatidylcholine as a substrate when compared to other 
lipid components of mammalian cells. Similar cell-associated hemolytic activities produced 
by C. coli and C. jejuni strains were previously related to pathogenicity in these bacteria. The 
phospholipase A hemolytic extract of C. concisus caused stable damaging effects on eRO 
tissue culture cell lines. Vacuolation and cytolytic effects were noticed on eRO cells after 18 
hours of incubation with C. concisus diluted and concentrated hemolytic extracts respectively. 
Remolysins and hemolytic phospholipases of several pathogens such as Serratia marcescens, 
Haemophilus ducreyi and in Legionella spp. have been reported to cause a damaging effect on 
human epithelial cells. Moreover, the phospholipases AI, A2 and e of H. pylori were linked 
to the degradation of the phospholipid components of the mucosal barrier and phospholipase 
A of H. pylori is thought to have a role in colonisation. Therefore, further studies are required 
to determine whether this hemolysin isolated from C. concisus produces a vacuolation effect 
on human epithelial cells similar to that produced by VacA toxin of Helicobacter pylori or 
VcVac from Vibrio cholerae. 
The sequencing and analysis of the C. concisus pldA gene in this study indicated that the 
nucleotide sequence of this gene in clinical isolates of C. concisus resembles the pldA gene 
sequence encoding outer-membrane phospholipase A in other pathogenic campylobacters 
such as C. coli and C. jejuni. The pldA gene of C. concisus encodes for a 35 kDa protein with 
97% similarity to the 35 kDa phospholipase A protein found in C. coli. When the nucleotide 
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Thesis summary 
sequences of the flanking regions of the pldA gene were analysed in this study, they revealed 
that the pldA gene in C. concisus is located upstream of the' ceuB and ceuC genes, similar to 
the position of the pldA gene in the C. coli and the C. jejuni genome. Therefore, the presence 
of this gene in C. concisus clinical isolates indicates the possible pathogenic role for this gene 
and its encoded PLA protein in gastroenteritis cases caused by C. concisus. However further 
sequencing studies are needed to analyse both the ceuB and ceuC genes in different C. 
concisus strains belonging to both genomospecies and also from different geographic origins 
to detect any similarity between these genes and other pathogenic campylobacters. C. 
concisus clinical strains from different clinical sources should be screened for the presence of 
other virulence-related genes such as those encoding for cytotoxins, lipopolysaccharides 
(LPS) and flagellin to clarify the pathogenic role of this opportunistic pathogen. 
It is recommended that C. concisus gastroenteritis cases in children under the age of primary 
dentition should be further investigated and highlighted leading to more awareness in the 
community. The detection of possible virulence factors in C. concisus gastroenteritis-related 
strains in this study, in addition to the recent findings for its possible relation to other 
infections such as in Campylobacter-associated reactive arthritis indicates the importance of 
this opportunistic pathogen in patients with low or impaired immunity such as young children, 
the elderly and immunocompromised patients. 
3 
Chapter one 
General introduction 
1.1. Etiology of enteric diseases in children 
Enteric disease is the second most common cause for emergency admission of children in 
most hospitals and it is second only to respiratory infection as a cause of death in children 
under one year of age worldwide. Estimated incidence rates in developing countries range 
from 3.5 to 7.0 episodes per child per year during the first 2 years of life and from 2 to 5 
episodes per child per year for the first 5 years (Black, 1993). Attack rates in children less 
than 5 years old in developed countries range from 1.0 to 2.5 episodes of diarrhea per child 
per year, with 0.1 to 0.4 episodes per child per year resulting in attendance at a general-
practice clinic and 0.001 to 0.003 episodes resulting in hospitalisation. In developing 
countries diarrhoea is considered as a major cause of morbidity and mortality in children (Jin 
et al., 1996). The WHO estimates that throughout the world five million children die of 
infective diarrhoea annually. Repeated episodes of infectious diarrhoea have a major impact 
on developing malnutrition and predispose children to further infections (Chandra, 1983). 
Pediatric diarrhea is a costly disease in terms of direct (and indirect) monetary costs to each 
community, and it is a cause of emotional trauma for the child and the parents (Caprioli et al., 
1996). 
1.2. Campylobacter spp. as a cause of gastroenteritis 
Campylobacter infections are one of the most common causes of gastroenteritis worldwide 
and have been recognised as a cause of diarrhoea in humans for almost three decades (Butzler 
et al., 1973). Food is considered as a primary source for campyIobacter infections, 
particularly poultry, which can be an important reservoir of C. jejuni, C. coli, C. lari (AlIos, 
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2002; Ashbolt et al., 2002). The clinical manifestations of campylobacter infection depend on 
many variables including the infecting strain, the expression of virulence factors, and the 
host's immune status. C. jejuni and C. coli are most frequently reported causes of 
gastroenteritis and are established pathogens resulting in common symptoms of bloody 
diarrhoea together with dyspepsia and mild fever (Taylor and Hiratsuka, 1990). C. jejuni 
bacterial cells colonise the lower gastrointestinal tract within 2-3 days after ingestion of 
contaminated food or water, inducing symptoms ranging from mild discomfort to a 5-7 days 
of a characteristic often bloody diarrhoea. Although infection with C. jejuni is often self-
limiting and resolves in less than two weeks, septicemia may follow intestinal colonisation in 
severe cases. Ulceration of the gastric epithelia by C. jejuni is associated with abdominal 
pain, haemorrhage, along with releasing blood, lymphocytes, and mucus into the stool, as 
reviewed by Konkel et al. (2000). 
In developed countries, infection with Campylobacter jejuni occurs more frequently than do 
infections caused by Salmonella species, Shigella species, or Escherichia coli 0157:H7. The 
incidence of Campylobacter jejuni infections peaks during infancy and again during early 
adulthood, and campylobacteriosis is mostly acquired by the consumption and handling of 
poultry (AlIos, 2002). While C. jejuni is considered as a major cause of sporadic bacterial 
enteritis in the United States and other developed countries, the incidence of campylobacter 
infections in developing countries such as Mexico and Thailand is not known but it may be 
orders of magnitude higher than that in the USA (Nachamkin, 1995). 
In Australia, a study conducted by the Commonwealth Department of Health and Family 
Services, Canberra, found that Campylobacter spp. and non-typhoidal Salmonella spp. were 
the most commonly reported pathogens in food-borne disease in Australia between 1980 and 
1995 (Crerar et aI., 1996). During the year 2001, 15,815 cases of campylobacteriosis were 
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reported by the OzFoodNet group, in 7 sites covering 68% of Australia's population (Ashbolt 
et al., 2002). A water-borne outbreak in North Queensland" Australia was also found to be 
caused by Campylobacter spp., which was introduced into water tanks by contamination with 
the faeces of wild animals (Merrett et al., 1999). Baker et al. (1999), suggested that cats and 
dogs as house-hold pets are a potential reservoir for human enteric infections with 
Campylobacter species. 
Atypical campylobacters such as C. concisus, have also been associated with gastroenteritis, 
however the prevalence of these campylobacters appears to be significantly under-reported 
due to inappropriate isolation and identification methods (Lastovica et al., 2000; Aabenhus et 
al., 2002b; Maher et al., 2003). 
1.2.1. Campylobacter spp. as a cause of gastroenteritis in children 
Campylobacter spp. are one of the most common causes of community acquired bacterial 
diarrhoea in children both in Australia and throughout the world. The prevalence of 
campylobacter-caused enteritis in children under five years of age is 1-10% in developed 
countries and 10-25% in developing countries. Therefore this bacterial pathogen is a major 
diarrhoeal agent leading to childhood malnutrition throughout the world (Tomkins and 
Watson, 1989). 
Campylobacter infection has one of the highest rates of all the notifiable diseases in Australia, 
with a peak in children aged 0-35 months (Tenkate and Stafford, 2001). The same study 
proposed that children aged less than 3 years are at risk of Campylobacter infection if residing 
in a house hold which has puppies or chickens as pets. In a 13-year survey of 4,637 children 
from 0-14 years of age, admitted to the infectious-disease ward for treatment of gastroenteritis 
at the Royal Children's Hospital (RCH), Melbourne, Australia, between April 1980 and 
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March 1993, Campylobacter jejuni was second to Salmonella spp. (3.4% and 5.8% 
respectively) among bacterial pathogens involved, however in 43.5% of gastroenteritis cases 
studied no enteric pathogen was detected by standard methodology (Barnes et ai., 1998). 
Campylobacter spp. other than C. jejuni and C. coli were detected by alterations to 
methodology for Campylobacter isolation, in a study conducted on children with diarrhoea, at 
the Royal Children's Hospital, between 1993-1995. By using phenotypic tests, 56% of the 
unusual campylobacters were identified as C. concisus, 8% C. upsaliencis, 5% C. sputorum, 
2.5% for each species of C. lari, and C. jejuni subsp. doylei (Russell, 1995). Therefore 
campylobacteria other than C. jejuni and C. coli that are generally undetected by standard 
microbiological techniques should also be considered as etiologic agents for gastroenteritis in 
humans, such as C. concisus which appears to be an important opportunistic pathogen that can 
cause gastroenteritis in very young children (Lastovica et al., 2000). 
1.3. The genus Campylobacter 
The genus Campylobacter, named in 1963 by Sebald and Veron, (previously known as 
Vibrio) has been assigned into the family Campylobacteraceae, which consists of the genera 
Campylobacter, Arcobacter and Sulfurospirillum. Campylobacters were considered to be 
veterinary pathogens until the 1970s when they were found in the stools of human patients 
with acute enterocolitis (KetJey, 1995). Genus Campylobacter presently consists of 16 
species of which 12 have been isolated from humans, and six subspecies including C. jejuni 
subsp. jejuni, C. jejuni subsp. doylei, C. hyoinestinaiis subsp. hyointestinalis, C. hyoinestinalis 
subsp. lawsonii, C. fetus subsp. fetus and C. fetus subsp. venerealis (Gorkiewicz et al., 2003). 
However, Campylobacter hyoilei, isolated from lesions of porcine proliferative enteritis, was 
later identified as a strain of C. coli (On, 2001). It was also suggested that these strains may 
represent a pathogenic variant of C. coli based on the identification of a specific genetic 
marker and on the observation of some metabolic differences (Dep et al., 1999) 
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The type species C. fetus (formerly known as Vibrio fetus) was the first to be described in the 
early 20th century as a common cause of fetal and reproductive tract infections and abortion in 
farm animals. In general campylobacters are found in the reproductive organs, intestinal tract 
and oral cavity of humans and animals as commensals or as pathogens (Garcia et aI., 1983; 
Vandamme, 2000). 
Phylogenetic trees drawn from alignments of 16S rDNA sequences of Campylobacter spp. 
were all found to contain three distinct species groups (Laws on et al., 1998; Gorkiewicz et al., 
2003). The first group contains C. hominis, C. gracilis, C. sputorum, C. curvus, C. rectus, C. 
showae and C. concisus. All are organisms associated with niches in the periodontal cavities 
of humans and animals. The second group consists of C. fetus, c. hyointestinalis and C. 
mucosalis, which are associated with disease in farm animals although the first two have also 
been occasionally implicated in human disease. The third group consists of C. jejuni, C. coli, 
C. la ri, C. helveticus, and C. upsaliensis, all known to cause gastroenteritis in humans except 
C. helveticus (Lawson et al., 1999). Lately C. lanienae has also been introduced into this 
third group (Gorkiewicz et aI., 2003). 
Campylobacter cells are mostly motile, slender, spirally curved rods with a size range of 0.5-
0.8 !lm by 0.2-5.0 !lm. They may form coccoid bodies under certain environmental 
conditions and in old cultures, which are considered as viable but non-culturable degenerative 
forms of the organism (Ketley, 1995). These bacterial cells grow in a microaerophilic 
atmosphere and several species require anaerobic conditions or require fumarate with formate 
or hydrogen for optimal growth under micro aerobic conditions such as C. concisus. 
Campylobacter spp. do not ferment carbohydrates or hydrolyse gelatin, casein and tyrosin. 
Oxidase activity is present in all species except C. gracilis but there is no lipase or lecithinase 
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activity in most campylobacters, and the G + C content of their DNA ranges from 29 - 47 
mol%. 
1.3.1. CLO groups and other new Campylobacter spp. 
In the early 1980s the availability of adequate isolation procedures led to the isolation of 
many Campylobacter-like organisms from a variety of human, animal and environmental 
sources when gradually new species were proposed. However, the poor biochemical activity 
and lack of clear-cut differential characteristics led to the wide application of naming many 
groups as Campylobacter-like organisms (CLOs). Some of these CLO groups were later 
classified as novel species such as C. concisus for CLOs isolated from the human oral cavity 
and C. sputorum subsp. mucosa lis isolated from pigs with intestinal adenomatosis, both in 
1981. The species C. nitrofigilis was proposed for a group of CLOs isolated from the 
rhizosphere of a salt marsh plant. In 1983, C. hyointestinalis was proposed for a second group 
of CLOs isolated from pigs with intestinal adenomatosis and C. laridis was proposed for 
thermophilic campylobacters isolated from faeces of gulls (Vandamme, 2000). 
1.3.2. Hydrogen-requiring campylobacters 
The H2-requiring Campylobacter species appear to be closely related phylogenetically 
(Lawson et al., 2001; On, 2001). C. concisus, C. showae, C. rectus, C. curvus, C. gracilis, C. 
sputorum and C. hominis all belong to the first distinct group of the Campylobacter species 
phylogenic tree (Figure 1.1). The first six species are of the gingival flora of the human oral 
cavity and occur mostly in periodontal pockets of diseased gums, although C. sputorum has 
been also found in the enteric and reproductive tracts of various reproductive animals (On, 
2001). Yet C. hominis, which was initially found to be uncultivable, using standard methods, 
has been found only in human lower intestine (Lawson et al., 1998). 
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C. mucosa lis is the only H2-requiring Campylobacter species that belongs to the second 
distinct species group of the Campylobacter species phylogenic tree (Lawson et aI., 1998). C. 
mucosalis strains have been isolated from pigs with proliferative enteritis and from the 
porcine oral cavity (Vandamme, 2000). However, this species is not related to human 
infections, as gastroenteritis cases supposedly caused by this organism were later identified as 
C. concisus infections (Figura et aI., 1993; Lastovica et aI., 1994; On, 1994). 
Occasionally, some isolates of C. hyointestinalis, C. jejuni subsp. doylei, C. upsaliensis, and 
C. lari require an H2-enriched microaerophilic atmosphere for growth, however they can be 
differentiated from the above mentioned six species by differences in simple phenotypic tests 
such as their positive catalase test and the lack of arylsulfatase activity, while all Hz-requiring 
species are negative for catalase test except for C. showae, and are positive for the 
arylsulfatase activity except C. mucosa lis (Lastovica and Skirrow, 2000). 
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Figure (1.1). Phylogenetic tree of the 16S rDNA sequences of Campylobacter species, 
determined by neighbour-joining analysis, by Lawson et al. (2001). 
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1.3.3. Campyiobacter spp. as a part of oral cavity microbiota 
At least seven Campylobacter species have been identified from different subgingival sites 
with C. rectus identified as a periodontal pathogen. Campylobacter spp. other than C. rectus 
and C. gracilis have rarely been detected in periodontal samples which could be related to 
their presence below the detection limit of microbiological assays and to incomplete 
genotypic and phenotypic strain characterization (Tanner et al., 1998). Other Campylobacter 
species or taxa that have been isolated from oral sites include C. concisus, C. curvus, C. 
showae, C. showae-like, C. sputorum and Campylobacter X. A study by Macuch and Tanner, 
(2000) suggests that C. concisus, C. showae, C. curvus and Campylobacter X colonize the 
oral cavity more frequently than might be expected for transient species and may represent 
opportunistic pathogens under certain medical conditions. 
1.4. Campyiobacter concisus 
Tanner et al. (1981) first described C. concisus (Latin concisus meaning concise) as small 
asaccharolytic, non-pigmenting gram-negative rods isolated from gingival crevices of persons 
with gingivitis and periodontitis. In 1984 Holdman et al. renamed a group of organisms that 
derive energy by reduction of fumarate or nitrate with formate or hydrogen as Campylobacter 
concisus, which were previously thought to be human isolates of "Vibrio succinogenes". C. 
concisus cells were reported within a group called "anaerobic vibrios" to be small, Gram-
negative, asaccharolytic rods, which grow in broth media supplemented with formate and 
fumarate (Tanner et al., 1985), motile with one or two polar flagella and to have an optimal 
chemotactic response to formate in a concentration reported to be present in dental plaque 
(Paster and Gibbons, 1986). SDS-PAGE protein profiles were first used to highlight species 
differences between C. concisus and other small asaccharolytic, nonpigmenting Gram-
negative rods of the human oral cavity by Tanner in 1986. C. concisus has no known animal 
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hosts until present, suggesting that C. concisus is highly adapted to the human gastrointestinal 
tract (Engberg et aI., 2005) 
The first isolation of C. concisus from a non-oral clinical specimen was first reported by 
Johnson et al. (1985) in a 53 years old patient with diabetes mellitus from a foot ulcer wound, 
the isolation was later confirmed by Johnson and Finegold (1987). Subsequent studies 
identified these organisms in stool and blood samples of children and adults with and without 
diarrhea (Vandamme et al., 1989). Whole-cell protein electrophoresis and DNA-DNA 
hybridization revealed that C. concisus is a heterogeneous species with many protein 
electrophoretic and genotypic subgroups. However, definitive identification of this species is 
difficult because of its phenotypic diversity (Vandamme et al., 1989). At present, C. concisus 
is known to comprise at least two genomospecies, which are phenotypically indistinguishable, 
but genetically divergent by DNA-DNA hybridization (Vandamme et al., 1989) and AFLP 
analysis (On and Harrington, 2000). Little is known about C. concisus regarding its mode of 
transmission, reservoir and its true potential as a pathogen due to the lack of any established 
typing procedure (Matsheka et aI., 2002) and other virulence related studies. Recently, C. 
concisus was detected in the synovial fluid of patients with Campylobacter-associated reactive 
arthritis (Cox et al., 2003). The researchers used reverse transcription PCR amplification of 
specific 16S rRNA sequences on synovial fluids from arthritis patients, which revealed the 
presence of transcriptionally active skin and gut commensals including two different C. 
concisus strains. Interestingly, no sequences were detected for C. jejuni or C. coli, which are 
the pathogens thought to be responsible for the reactive arthritis cases (Cox et al., 2002). This 
is the first time that C. concisus is reported to be found in synovial fluids of arthritis patients. 
However the role of this organism in the pathogenesis of postinfectious arthritis needs further 
investigation. 
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1.4.1. The possible role of C. concisus in gingivitis' and periodontitis 
Periodontal diseases are best considered as the outcome of an imbalance in the host-parasite 
interaction. Yet the severity and extent of the disease depends upon the interaction between 
the pathogenic bacterial challenge and host responses (Kamma et al., 1999). 
C. concisus has been linked to oral cavity infections since the early 1980's (Tanner et al., 
1981; Haffajee et al., 1984; Ebersole et al., 1985), however its pathogenic role in gingivitis 
and periodontitis could not be established. Literature studies have associated this bacterium 
with gingivitis sites (Moore et al., 1987), periodontitis sites (Kamma et al., 1994) and healthy 
sites (Tanner et al., 1998; Macuch & Tanner, 2000). Recent studies have also linked C. 
concisus to oral cavity infections. Socransky et al. (1998), found that C. concisus is one of 
the bacterial species that forms the forth complex of the sUbgingival plaque in human oral 
cavity infections. 
Research studies on periodontitis, conducted by Kamma et al., between 1994 and 2001, found 
that C. concisus occurred more frequently in bleeding than non-bleeding sites among 
microbiota of rapidly progressive periodontitis (Kamma et aI., 1994). Moreover in gingival 
overgrowth as a side effect associated with the administration of nifedipine, C. concisus was 
among bacterial species more frequently isolated from the more enlarged lesions (Kamma et 
al., 1998). In cases with early onset of periodontitis C. concisus was identified as a possible 
periodontal pathogen which was found in significantly higher numbers and more frequently in 
smokers than non-smokers (Kamma et al., 1999). In a study to investigate the composition of 
subgingival microbiota in children with primary dentition aged 4-5 years, C. concisus was 
present in low numbers in children with deciduous teeth and was isolated in greater numbers 
in the molars than incisors (Kamma et al., 2000a), while in children with mixed dentition 
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aged 7-8 years, C. concisus was found more frequently in permanent than deciduous teeth 
(Kamma et al., 2000b). In both studies C. concisus was associated with bleeding sites where 
it was more frequently isolated (Kamma et al., 2000 a and b). A later study by the same team 
to investigate the association of early onset periodontitis microbiota with aspartate 
aminotransferase (AST) activity found a high level of agreement between the presence of 
putative periodontal pathogens including C. concisus, and positive AST scores at periodontal 
sites that clinically were considered to be disease active (Kamma et al., 2001). 
1.4.2. C. concisus as an etiologic agent for gastroenteritis 
The correlation between C. concisus and enteritis was first reported by Vandamme et al. 
(1989). The researchers used immunotyping and numerical analysis of gel electrophoretic 
protein profiles to identify the EF group 22 Campylobacter strains isolated from 
gastroenteritis cases between 1980 and 1987. DNA:DNA hybridizations demonstrated that all 
EF group 22 strains were Campylobacter concisus, showing a considerable degree of genomic 
heterogeneity with DNA binding values of at least 42% with the type strain (Vandamme et 
al., 1989). In a study conducted in Siena, Italy, on stool samples from children with diarrhoea 
between 1989 and 1990, two cases of misidentified C. mucosa lis were reported by Figura et 
al. (1993). Both children were 12 and 18 months old male patients. Those two isolates were 
later classified as C. concisus by using numerical analysis of phenotypic tests combined with 
visual comparison of SDS-PAGE protein profiles of whole cells (On, 1994) and by high 
stringency DNA-DNA hybridization studies (Lastovica et ai., 1994). In a following study by 
the Italian team those two isolates were examined for their virulence characteristics on cell 
cultures, one C. concisus strain was reported to induce intracytoplasmic vacuole formation on 
Intestine 407 cells similar to that caused by cytotoxic Helicobacter pylori while cell-free 
culture supernatants of both isolates induced a cytotonic-like effect as an elongation of CHO 
cells (Musmanno et al., 1998). 
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A serological study on the immune response in patients with enteritis using ELISA and 
Western blot analysis, indicated that a specific serum antibody response to C. concisus was 
found in patients with culture-positive C. concisus (Zhi et al., 1996). However children 
tended to have lower specific antibody levels than adults in both healthy controls and patients, 
and therefore, Lastovica et al. (2000), proposed that C. concisus appears to be an important 
opportunistic pathogen in very young children, and should be considered as an etiologic agent 
for gastroenteritis (campylobacteriosis) in humans. 
1.4.2.1. Isolation of Campyiobacter concisus from gastroenteritis cases in 
Australian children 
The isolation and identification of C. concisus in Australia was reported from children with 
gastroenteritis admitted to the Royal Children's Hospital (RCH) in Melbourne, between June, 
1993 and June 1995 (Russell, 1995). Campylobacter like organisms (CLOs) were first 
isolated after modifying the protocol for detection and isolation of Campylobacter species. 
The modifications involved using a 0.65!-tm cellulose acetate membrane filter and incubation 
with a gas combination of 79% (v/v) nitrogen, and 7% (v/v) for each of carbon dioxide, 
oxygen and hydrogen (Russell, 1995). 
As the alteration to the methodology led to the isolation of CLOs, which were not known as 
pathogenic campylobacters, those hydrogen-requiring campylobacters were identified using 
phenotypic characterisation tests such as indoxyl acetate hydrolysis, DNA hydrolysis, 
hippurate hydrolysis, nitrate reduction, antibiotic susceptibility, H2S production on Kligler 
iron agar and growth on MacConkey medium (Russell, 1995). Among the 39 characterised 
CLO strains, 56% were identified as C. concisus, 8% C. upsaliensis, 5% C. sputorum, 2.5% 
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for each of C. lari, C. mucosalis and C. jejuni subsp. doyZei, however 23% of the isolated 
CampyLobacter strains could not be identified (Russell, 1995). 
The study indicated that 86% of the patients with the hydrogen requiring campylobacters were 
24 months or younger. Case histories of children from whom C. concisus strains were 
isolated, including clinical signs and symptoms associated with the infection were all recorded 
and followed up. Gastrointestinal symptoms including diarrhoea, vomiting, fever, and 
abdominal pain were recorded. All cases with C. concisus strains were for children between 
2-30 months of age with the majority being under 2 years old (18/19). This age distribution is 
also similar to the published worldwide data for C. jejuni and C. coli infections (Russell, 
1995). Furthermore, a potential seasonal distribution for C. concisus infections was recorded 
as occurring from July to January when over 85% of clinical strains were isolated at the Royal 
Children's Hospital. This is different from the seasonal distribution of C. jejuni which peaks 
from late summer to autumn (RusseU, 1995). 
Adhesion and invasion assays performed by Russell & Ward (1998) on four of the 22 C. 
concisus isolates showed that three strains were potentially associative strains and had a 
percentage adhesion: invasion ratio of 5.27%, 1.08% and 1.56%, whereas the fourth strain had 
no associative potential with a ratio of 0.17%. This was compared to a ratio of 3.82% for C. 
jejuni RCH 1 strain isolated from a blood culture, and a ratio of 12.38% for C. coli type strain 
NCTC 11366 (Russell & Ward, 1998). However adhesion assays in the same study showed 
that all four C. concisus strains had higher adhesion ratio (12.1 %,0.57%,0.32%,0.36%) than 
the control strains, C. jejuni RCH 1 (0.18%) and C. coli NCTC 11366 (0.21 %). This can be 
explained by the fact that C. concisus is a member of the indigenous oral microbiota and a 
suspected periodontal pathogen (Socransky et al., 1998; Kamma et al., 2000a), which require 
adhesion to the mucous membrane in the oropharynx or on the teeth to colonise for long 
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periods and become resident flora of the oral cavity (Beachey, 1981; Van Houte, 1982). On 
the other hand, adhesion to the mucosa is not a strict requirement for colonisation of the 
intestine by indigenous bacteria which possess proper enzymes to digest the nutrients 
continuously provided by the host (Van der Waaij, 1992). 
1.4.2.2. Prevalence of C. concisus in gastroenteritis 
The routine method used in many clinical microbiological laboratories for isolation of 
Campylobacter spp. from stools generally does not permit the growth of species other than C. 
jejuni and C. coli, which are known as common causes of human gastroenteritis. Therefore, 
other fastidious hydrogen-requiring campylobacters are poorly recovered by those frequently 
used culture techniques (Engberg et al., 2000). Since 1990, the isolation of C. concisus from 
stool samples of patients with diarrhoea at the Red Cross Children's Hospital, Cape Town, 
South Mrica, was possible for the very first time by applying a new method of isolation called 
"Cape Town protocol" (Table 1.1) (Le Roux and Lastovica, 1998). This technique, which is a 
modification in the stool filtration method of Megraud and Elharrif (1985), was the first to 
combine both membrane filtration on an antibiotic-free blood agar medium and incubation in 
a hydrogen-enhanced micro aerobic atmosphere. Therefore, between 1990 and 2000, this 
group reported a C. concisus isolation rate of 23.55% in pediatric patients with diarrhoea, the 
second highest rate after C. jejuni, which had an isolation rate of 28.29% among other 
Campylobacter spp. as indicated in table 1.1 (Lastovica et al., 2000). 
Unusual campylobacters were found to represent 20% of all campylobacters isolated by the 
filtration technique in a study conducted on children with enteritis in Siena, Italy between 
1989 and 1990. The isolation percentage in this study was found to be 6.9% for C. jejuni 
subsp. jejuni, 2% for C. coli, and 0.7% for each of C. concisus, C. upsaliensis and C. jejuni 
subsp. doylei (Musmanno et al., 1998). 
18 
C. concisus was also isolated from enteritis cases in both children and adults in a 17 months 
study conducted in Brussels, Belgium by Zhi et al. from January 1990 until August 1991. 
The researchers reported the isolation of C. concisus from patients with enteritis with an 
isolation rate of 2.4% in children and 1.5% in adults among the total number of patients with 
enteritis (Zhi et al., 1996). However C. concisus was found only in children and not in adults 
in a study conducted in Sweden on patients with diarrhoea by Lindblom et al. (1995). The 
study found that among total Campylobacter spp. isolated, the isolation rate of C. concisus in 
children was only 6% compared to a C. jejuni rate of 40% in the children's group and of 77% 
in the adults' group (Lindblom et aI., 1995). 
Van Etterijck et al. (1996) conducted a 7 months study between September 1991 and March 
1992 on children with and without diarrhea in Brussels, Belgium. Using biochemical and 
phenotypic tests with SDS-PAGE of whole cells, C. concisus was detected in 23 stool 
samples of 174 children with enteritis giving an isolation percentage of 13.2%. By 
comparison, C. concisus was isolated from 86 of 958 children with no symptoms of enteritis 
giving an isolation percentage of 9% in the control group. Using the Chi square test, the study 
found that the difference in isolation rate between children with and without diarrhoea was 
statistically not significant (Van Etterijck et al., 1996). However, contradicting results were 
reported later by Lawson et al. (1998), by using peR primers to amplify the 16S rRNA gene 
sequence of Campylobacter spp. in saliva and stool samples of 20 healthy humans. C. 
concisus species-specific amplicons were produced from 19 of 20 saliva samples (95%) and 
only 3 faecal samples (15%), while genus specific amplicons were produced from 19 of 20 
saliva samples and from 18 of 20 faecal samples, highlighting the predominant location of this 
bacterium in the oral cavity. 
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In a study to investigate the prevalence of campylobacters in human clinical samples and in 
samples from healthy individuals, C. concisus was isolated from a large number of diarrheal 
cases, particularly those at the extremes of age, (Engberg et al., 2000). Using the filtration 
technique for isolation C. jejuni and C. coli accounted for 78 isolates of the 144 
Campylobacter spp. strains isolated, while 52 isolates of C. concisus, originating from 39 
clinical cases of gastrointestinal disorders, were identified among campylobacter isolates. In 
the control group C. concisus was recovered from only 3 of 107 healthy individuals and 5 sick 
individuals with a suspected enteric pathogen. 
The study indicated that most of the 15 cases with C. concisus in the 1-9 years group were 
less than 2 years of age, while 10 C. concisus cases were > 60 years of age, therefore 
suggesting C. concisus to be considered as an opportunistic pathogen in patients with a 
compromised or immature immune system (Engberg et al., 2000). Lastovica et al. (2000) 
suggested that the difference in the isolation rate, between different studies, could be 
influenced by geographical factors, sources and routes of transmission, as well as numbers of 
fecal samples tested and differences in study population regarding age group and health 
condition. 
A recent study on the prevalence of C. concisus in diarrhoea of immunocompromised patients 
in Copenhagen, Denmark between June 1997 and December 1998, by Aabenhus et al. 
(2002b), assigned C. concisus isolates into two groups by means of protein profiling, with the 
predominant group 2 to be found in 85% of patients (83/98). However, twenty-six patients of 
this group had a concomitant infection with an established pathogen. This study found that C. 
concisus was the most prevalent Campylobacter spp. isolated, being responsible for 49% 
(110/224) of all campylobacter isolates. Moreover, the isolation rate was highest in late 
summer with a smaller peak in spring (Aabenhus et al., 2002b). Seasonal variations in 
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gastroenteritis cases caused by C. concisus in children, was found to have similar peak 
patterns in spring and summer, in a previous study conducted at the Royal Children's 
Hospital, Australia (Russell, 1995). 
To investigate the optimal method for the detection of Campylobacter spp. from stool 
samples, Kulkarni et al. (2002), compared selective culture with membrane filtration and with 
PCR methods. In 343 stool samples tested 18 were classified as C. jejuni and C. coli and 5 
strains belonged to other Campylobacter spp. including one C. concisus strain, which was 
detectable by membrane filtration, selective culture and then by PCR. Comparing this study 
with two previous studies, the optimal method for the detection of campylobacters from stool 
samples in the diagnostic laboratory involves the use of selective culture only. However, C. 
concisus is generally sensitive to cefoperazone and does not usually grow on CCDA medium 
(Kulkarni et al., 2002), therefore the stool filtration method combined with selective culture 
(Engberg et al., 2000) or growth on an antibiotic free medium (Lastovica et al., 2000) was 
suggested as the most efficient method for the isolation of C. concisus from stool of enteritis 
patients. However, in a recent study to compare the efficiency of different methods used for, 
detection of Campylobacter spp. in stool samples, Maher et al. (2003) found that molecular 
assays are rapid methods for the detection and identification of Campylobacter species in 
fecal specimens. In this study, 320 specimens of feces from patients with symptoms of acute 
gastroenteritis were cultured for Campylobacter spp. by direct plating on modified charcoal 
cefoperazone deoxycholate agar and by enrichment in modified Preston broth, with or without 
blood. Moreover, a 16S/23S PCR/DNA probe membrane-based calorimetric detection assay 
was evaluated on a subset of the feces, including 18 culture-positive and 109 culture-negative 
specimens. The 16S/23S PCR/DNA probe assay detected campylobacter DNA in 17 of 18 
(94% sensitivity) culture-positive specimens and in 41 (38%) culture-negative specimens. 
The presence of campylobacter DNA in 35 of 41 culture-negative specimens was confirmed 
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by the 16S peR/DNA probe assay. DNA sequence analysis of 16S/23S peR products and 
16S peR products amplified from a selection of these specimens confirmed the presence of 
Campylobacter jejuni, C. concisus, C. curvus, and C. gracilis DNA in these specimens. The 
finding of Campylobacter spp. DNA in a large number of specimens of feces from patients 
with no other identified cause of diarrhea may suggest that Campylobacter spp. other than C. 
jejuni and C. coli may account for a proportion of cases of acute gastroenteritis in which no 
etiological agent is currently identified. These studies suggest that the role of C. concisus in 
cases of gastroenteritis, especially in young children and in the elderly, needs further 
investigation (Aabenhus et al., 2002b; Maher et al., 2003). 
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Specimens 
Species and subspecies 
No. positive % Positive 
C. jejuni subsp. jejuni, biotype 1 1,166 28.29 
C. concisus 971 23.55 
C. upsaliensis 948 23.00 
C. jejuni subsp. doylei 378 9.17 
H. fennelliae 260 6.31 
C. coli 119 2.87 
C. jejuni subsp. jejuni, biotype 2 115 2.79 
C. hyointestinalis 53 1.29 
H. cinaedi 42 1.01 
CLO/HLO 35 0.85 
Arcobacter butzleri 16 0.39 
C. fetus subsp. Fetus 7 0.17 
"H. rappini" 4 0.10 
C. lari 2 0.05 
C. curvus 2 0.05 
C. rectus 2 0.05 
C. sputorum biovar sputorum 2 0.05 
Total 4,122 100.00 
Table 1.1. Distribution of Campylobacter and related species isolated from 19,535 diarrheic 
stools of pediatric patients at the Red Cross Children's Hospital, Cape Town, South Africa, 
from 1 October 1990 to 29 February 2000, by Lastovica et al., 2000. 
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1.4.3. Identification of C. concisus strains 
The understanding of the epidemiology of C. concisus has been hampered by the lack of a 
suitable genotypic identification tool. Since C. concisus is fastidious and has low biochemical 
activities, its identification is problematic by using the conventional phenotypic techniques 
(Lastovica et al., 1994). Although phenotypic differentiation between C. concisus and 
members of the Wolinella genus is difficult, silver stained SDS-PAGE protein profiles of 
sonicated cells were used since 1986 as a reliable method in the identification of C. concisus 
isolates and Wolinella species as microflora of the human oral cavity (Tanner, 1986). Both 
DNA G:C content and serologic techniques can also be used to make this distinction (Johnson 
& Finegold, 1987). 
In 1989 Vandamme et al. used SDS-PAGE protein profiles, immunotyping and DNA:DNA 
hybridization, to identify the EF group 22 C. concisus strains isolated from patients with 
gastroenteritis. The EF group 22 strains had a DNA binding value of at least 42% with the C. 
concisus type strain showing a degree of genomic heterogeneity. This study indicated that C. 
mucosa lis is more closely related to C. concisus than any other Campylobacter spp. However 
the immunological, biochemical, and rRNA-cistron similarities between the two species did 
not extend to the DNA: DNA similarity level (Vandamme, et al., 1989). 
Other biochemical tests used in the early 1990s to differentiate between members of 
Campylobacter spp. have been less promising, such as pyrazinamidase activity test. C. 
concisus strains were reported to have a weak positive result for pyrazinamidase activity 
compared to thermophilic campylobacters which give strong positive results and to C. 
mucosalis which is negative for this test (Burnens & Nicolet, 1993). The arylsulfatase test has 
I 
been used to differentiate C. concisus which is positive for this test from C. mucosa lis and C. 
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upsaliensis, as both are negative for arylsulfatase activity (Burnens & Nicolet, 1993; 
Lastovica et al., 1994). 
Sensitivity to cephalothin and nalidixic acid, the growth of cultures at 25Co and 42Co , and 
colony colour, are of little use in differentiation between C. concisus and C. mucosa lis, and so 
a numerical analysis of 64 phenotypic characters has been used by On (1994), to differentiate 
strains from both species. Furthermore, a diagnosis based only on biochemical reactions and 
susceptibility testing misidentified a C. concisus strain, isolated in almost pure culture from 
stool of a young male with a chronic lymphatic leukaemia, as C. mucosalis. The isolation was 
later identified as C. concisus by conducting a 16S rRNA sequencing (Anderson et al., 1996). 
In 1995 Bastyns et al. developed a C. concisus-specific PCR assay, based on a target 
sequence which comprises the most variable areas of 23S rDNA. However Engberg et al. 
(2000) reported consistently obtaining a PCR product of 308 bp for the amplified gene 
fragment from type strains of C. showae and Wolinella succinogenes in preliminary set up 
experiments. Matsheka et al. (2001) suggested that this method did not identify C. concisus 
consistently, probably because of the genotypic heterogeneity within the species while they 
reported developing a more reliable and rapid PCR assay for molecular identification of C. 
concisus. Using primers annealing to the extremities of a 1.6kb DNA fragment isolated from 
a C. concisus genomic library, a single product of the expected size was obtained from all C. 
concisus strains tested including known reference strains. This assay was specific for C. 
concisus and PCR products were not obtained from any other Campylobacter spp. (Matsheka 
et al., 2001). Recently, Gorkiewicz et al. (2003) suggested that partial 16S rRNA gene 
sequencing is an effective and rapid procedure for the specific identification of 
Campylobacter spp. including C. concisus. 
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1.4.4. Typing of C. concisus strains 
As only limited genotyping studies have been carried out on C. concisus and as no typing 
procedure for epidemiological investigations of the species is established, little is known 
about C. concisus with regard to its mode of transmission, reservoir and its true potential as a 
pathogen (Matsheka et al., 2002). Randomly amplified polymorphic DNA analysis (RAPD) 
was used to compare C. concisus strains isolated from children with and without diarrhoea 
(Van Etterijck et al., 1996). These children attend the same day care center, during 
overlapping period of time, and 35 of 37 children were found to harbour different C. concisus 
strains as was demonstrated by arbitrary primer peR DNA finger printing. Therefore, 
suggesting the lack of any epidemiological relationship and the absence of a pathogenic role 
for C. concisus in gastroenteritis (Van Etterijck et al., 1996). However, the cytotoxic effect 
shown by one of C. concisus strains in the study of Musmanno et al. (1998), suggests that 
some C. concisus strains may carry virulence factors although further studies are required to 
identify the possible pathogenic mechanisms of this microorganism. 
C. concisus is known to comprise at least two genomospecies, which are phenotypically 
indistinguishable but genetically divergent as indicated by DNA-DNA hybridization and 
AFLP analyses (Vandamme et al., 1989; On and Harrington, 2000). More recently, 
macrorestriction profiling was used by Matsheka et al. (2002), to investigate the genetic 
diversity of C. concisus and assisting molecular typing studies. Pulsed field gel 
electrophoresis (PFGE) typing was suggested to be a useful adjunctive method helping to 
resolve key taxonomic issues for this species. In this study 51 distinct patterns were obtained 
from 53 C. concisus strains isolated from cases of diarrhoea in children suggesting this 
species to be a taxonomic continuum comprised of several genomospecies (Matsheka et al., 
2002). 
26 
j ~ 
Based on their reaction with plant lectins, 45 clinical isolates and type strains of C. concisus 
were grouped into 13 lectin reaction patterns by Aabenhus' et al. (2002a). All lectin types 
were both stable and reproducible but no consistent correlation between lectin reaction pattern 
and patient clinical categories was observed (Aabenhus et al., 2002a), indicating further 
studies are required to advance information on this species as well as identifying the role of C. 
concisus in gastroenteritis in different age groups. 
1.5. Virulence factors in Campylobacter spp. 
Upon entry into the host, campylobacters have to overcome the innate immune system by first 
avoiding removal by peristalsis, then they must adhere, multiply, colonise, and resist host 
defense mechanisms. For successful colonisation, C. jejuni penetrates the physical mucus 
barrier, binds to, and then invades the cell lining in the small intestine by direct contact of the 
pathogen with the host cells via outer membrane proteins with high avidity for host cell 
receptors. Some bacteria may translocate the epithelia and move into the lamnia propria. 
Identifying potential virulence determinants in Campylobacter spp., specially in C. jejuni, has 
been hampered by many difficulties including the lack of a suitable animal model. A number 
of mechanisms, including host cell invasion, toxin production, and apoptosis are responsible 
for the pathological changes that result in the clinical symptoms observed in patients, mostly 
diarrhoea. Moreover there may be some degree of overlap between these virulence 
determinants and mechanisms used by the pathogen to avoid stress outside the host (Ketley, 
1995; Leach, 1997; Konkel et al., 2000). 
Virulence factors studied in Campylobacter spp. include the flagella, adhesins, S-layer protein 
microcapsules, cellular invasion, toxins, phospholipase A, iron-scavenging systems, and 
resistance to oxidation damage. The best characterised virulence determinant in C. jejuni is 
the flagellum, which is needed for adhesion and for colonisation in a range of animals. After 
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colonisation of the mucous membrane and adhesion to intestinal cell surfaces, campylobacters 
perturb the normal absorptive capacity of the intestine by damaging epithelial cell function 
either by cell invasion or the production of toxins, or both (Ketley, 1995). 
1.5.1. Importance of detecting virulence factors in C. concisus 
The pathogenic role for C. concisus remains unclear, although it has been isolated from 
patients with periodontitis (Kamma et al., 1994; Kamma et al., 2001), from gastroenteritis 
cases in children (Vandamme et al., 1989; On 1994; Russell, 1995; Lastovica et al., 2000) and 
immunocompromised patients (Aabenhus et al., 2002b). Yet, the occasional isolation of C. 
concisus together with other enteric pathogens from patients with enteritis (Engberg et al., 
2000) and the detection of this organism in many healthy individuals (Van Etterijick et al., 
1996) does not support the etiologic role of C. concisus in patients with enteritis. However, 
recent studies have suggested that C. concisus is an important opportunistic pathogen in 
patients with compromised or immature immune systems (Engberg et al., 2000; Aabenhus et 
al., 2002b). 
Furthermore, C. concisus is considered a heterogeneous group being phenotypically and 
genotypically diverse (Vandamme et al., 1989; On, 1994). Two phenotypic groups of C. 
concisus were defined, using SDS-PAGE analysis of whole cell proteins, in both 
immunocompetent and immunocompromised, with one group being most common (85%) in 
patients with diarrhoea (Aabenhus et al., 2002b). Moreover, this species was suggested to be 
a taxonomic continuum comprised of several genomospecies after applying pulsed field gel 
electrophoresis-based macro restriction profiling on strains of oral and faecal origin (Matsheka 
et al., 2002). 
28 
j m 
Only two studies on the potential pathogenicity of this species have been conducted on 
isolates from children with gastroenteritis. Adhesion and invasion assays performed on four 
C. concisus isolates showed that three strains were potentially associative strains causing 
disruption to the human Hep 2 cell line (Russell et al., 1998). The second study was 
conducted on two C. concisus isolates, which were originally misidentified as C. mucosalis 
(Figura et al., 1993). One isolate was found to induce intracytoplasmic vacuole formation in 
Intestine 407 cells similar to that caused by H. pylori, while both isolates induced a cytotonic-
like effect as an elongation of Chinese hamster ovary (CHO) cells, which did not change after 
prolonged incubation (Musmanno et aI., 1998). 
The lack of well-documented methods that can effectively discriminate C. conClSUS 
genomospecies (Aabenhus et aI., 2002b) as well as the lack of extensive studies for virulence 
factors has hindered the findings on whether C. concisus strains colonising the oral cavity 
represent a single genomospecies that is also recovered from cases of diarrhoea or if a 
particular genomospecies is responsible for gastroenteritis. Therefore studying virulence 
factors in different groups (genomospecies) of C. concisus will assist to establish the 
pathogenesis of this species and to define its role in human enteric and oral diseases. 
1.5.2. Toxins as virulence factors in enteropathogens 
As reviewed by Wassenaar, (1997), proteinaceous toxins have been considered as important 
factors for the pathogenesis of Campylobacter spp. and other enteric bacteria. They can be 
classified into two classes depending on their primary mode of action: 
3; enterotoxins, defined as secreted proteins that can bind to a cellular receptor, enter the cell, 
and elevate intracellular cyclic AMP levels, such as the cytotonic toxin (CT) in Vibrio cholera 
and the closely related heat labile toxin (LT) in E. coli. 
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b; cytotoxins, defined as proteins that kill target cells by either acting intracellularly or by 
forming pores in the cells. Cytotoxins with intracellular activity usually bind to the cell and 
are processed before reaching the cell cytoplasm. They act by different mechanisms of 
toxicity, but most predominantly by inhibition of cellular protein synthesis such as Shigella 
dysenteriae toxin and the related E. coli shiga-like toxin (Stx), or by inhibition of actin 
filament formation such as Clostridium difficile toxins A and B. The second mechanism for 
cytotoxin action is pore formation in target membranes such as cytolysins, which can often be 
detected by their lytic action on erythrocytes, therefore they are called hemolysins. 
Toxin formation in bacteria frequently involves a number of genes, which encode the toxin 
polypeptide as well as proteins for toxin activation and secretion. Regulation of toxin 
production is usually coupled with that of the synthesis of a number of other virulence factors. 
As reviewed by Stanley et al. (1998), the Gram-negative hemolysins (cytolysins) are usually 
synthesized as precursor proteins, then covalently modified to yield an active hemolysin, 
secreted via specific export systems, which differ for various types of hemolysins. 
1.6. Membrane-damaging toxins (Cytolysins) 
Membrane-damaging toxins are toxic molecules, which destroy or derange known 
constituents of biological membranes leading to membrane dysfunction and jor physical 
disruption. They can be classified into different groups according to their mode of action, 
such as pore forming toxins, thiol-activated cytolysins, and phospholipases. 
1.6.1. Pore forming toxins 
As reviewed by Braun and Focareta, (1991), these toxins are spontaneously inserted into 
eukaryotic membranes, and form pores of defined size. The majority of medically relevant 
pathogens produce pore-forming proteins (Bhakdi et al., 1994). Protein pore forming toxins 
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such as proteolytic enzymes occur frequently in Gram positive and Gram negative bacteria. 
These toxins either kill other bacteria or eukaryotic cells (but some seem to act on both). 
Many of these toxins have been designated hemolysins because of their lytic action on red 
blood cells. However it is now recognized that their biological significance derives from their 
action on nucleated cells and platelets (Bhakdi et ai., 1996; Wassenaar, 1997). The toxins 
exert harmful local effects by destroying tissue cells and also immune cells involved in first 
line defense. Furthermore, pore-forming toxins provoke a wide spectrum of secondary 
reactions on target cells that in turn elicit short- and long-range effects in the host, thus 
contributing to the pathogenesis of bacterial infections (Bhakdi et ai., 1994). 
The secretion of heterologous proteins via the hemolysin secretion system has mainly been 
studied using immunological and vaccine research. As E. coli a-hemolysin (HlyA) is a very 
weak antigen for B cells and T cells, hemolysin-fusion proteins were successfully used to 
produce polyclonal and monoclonal antibodies and to detect protective antigens of different 
pathogenic bacteria. However the most important application of the hemolysin secretion 
system is the presentation of heterologous antigens in attenuated Gram-negative bacterial live 
vaccines, as reviewed by Gentschev et al. (2002). E. coli HlyA and other bacterial pore-
forming proteins such as Streptolysin 0 and S-layer proteins have been engineered and used 
by biomedical researchers in the area of drug delivery for patients with certain genetic 
disorders, such as phenylketonuria and to deliver hormones such as in people with insulin-
dependent diabetes as reviewed by Bayley (1997). 
1.6.1.1. RTX pore-forming Cytolysins 
Toxins belonging to a close family of membrane-damaging toxins, called the RTX (repeats in 
toxin) family, are considered as an important virulence factor in a large number of Gram 
negative bacteria, which include E. coli a-hemolysin (HlyA), enterohemorrhagic 0157 E. coli 
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hemolysin, the leukotoxin of Pasteurella haemolytica, the hemolysins and leukotoxins of 
Actinobacillus spp., the bifunctional adenylate cyc1ase-hemolysin of Bordetella pertusis, and 
the hemolysins of Proteus vulgaris, Morganella morganii, and Moraxella bovis (Braun & 
Focareta, 1991; Stanley et al., 1998). The RtxA-like protein in Legionella pneumophila has 
been shown to be involved in entry into macrophages and the rtxA gene is not required for 
pore-formation-mediated bacterial egress (Alli et al., 2000; Molmeret et ai., 2002). 
1.6.1.2. E. coli a-hemolysin (Hly A) 
E. coli u-hemolysin (HlyA) is the best-characterized RTX protein secreted by type I secretion 
system (Figure 1.2). It is mainly produced by E. coli strains causing extra-intestinal 
infections, such as those of the urinary tract (UPEC). It is considered as an important 
virulence factor owing to its cytolytic and cytotoxic activity against a wide range of 
mammalian cell types such as erythrocytes, granulocytes, monocytes, and endothelial cells 
(Salmond & Reeves, 1993; Stanley et ai., 1998; Gentschev et ai., 2002). Moreover, u-
hemolysin (HlyA) appears to be a major virulence factor in E. coli strains that were generally 
regarded as avirulent commensals but later found to be associated with enteric disease 
especially among young children (DHEC) (Elliot et al., 1998). Based on the RITARD model 
of diarrhoea (reversible intestinal tie adult rabbit diarrhoea), the researchers found that all 
DHEC strains are virulent, and therefore, suggesting that u-hemolysin is a virulence factor 
and demonstrated that this hemolysin could not be significantly distinguished from UPEC 
hemolysin on the basis of the restriction map, DNA hybridisation, protein size, or antibody 
reactivity (Elliot et al., 1998). 
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Figure 1.2. Secretion of E. coli hemolysin (HlyA) from the bacterial cell through type I 
secretion system, from Salmond & Reeves (1993). 
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1.6.1.3. Role of calcium ion in E. coli (HlyA) hemolysin activity 
The importance of Ca2+ in the interaction of Hly A with erythrocytes was investigated by 
Boehrn et al. (1990). These researchers found that the binding of full-length, active 
hemolysin to erythrocytes was calcium dependent and suggested that the binding of 
hemolysin to cells requires an interaction between the calcium binding domain of multiple 
acidic glycine-rich repeats and the modification produced by the HlyC protein (Boehm et al., 
1990). Recent studies on the intracellular maturation of hemolysin by fatty acylation has 
indicated that Ca2+ induces a major change in toxin conformation extending over more than 
200 amino acids, that includes an increased surface hydrophobicity, leading to irreversible 
insertion of the toxin in the membrane. Therefore, for lytic activity to occur, HlyA must 
contain bound Ca2+ prior to interacting with membranes (Koronakis and Hughes, 1996; 
Stanley et al., 1996; and Bakas et al., 1998). Urea (up to 8 M) was found to inhibit calcium 
binding and hemolytic activity of the HlyA protein by altering its secondary and tertiary 
structures, and reducing its tendency to self-aggregation (Soloaga et aI., 1998; Schindel et al., 
2001). 
1.6.1.4. Effect of pore-forming toxins on eukaryotic cells 
Most bacterial cytolysins act primarily by killing host mammalian cells and their cytocidal 
action is the main factor underlying their significance in the context of microbial 
pathogenesis. Furthermore, secondary reactions mounted by cells under toxin attack are 
diverse and often provoke profound, long-range effects in the infected host organism (Bhakdi 
et al., 1994). Different cells species can display highly varying susceptibilities towards the 
action of different pore-forming toxins, whereby the underlying mechanisms remain 
unclarified (Bhakdi et aI., 1996). 
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E. coli hemolysin targets mammalian cells of normal tissue, notably endothelial cells, renal 
epithelial cells, and the immune system, particularly granulocytes and monocytes (Welch, 
1991). At high concentrations, HlyA causes target cell lysis by generating cation-selective 
pores with voltage and pH dependence in whole cells, planar lipid membranes and liposomes 
(Benz et al., 1989), but at lower levels its pseudo-chemokine activity initiates G-protein-
dependent reactions, thus stimulating the respiratory burst and the secretion of vesicular 
constitutes (Coote, 1996). 
1.6.2. Thiol-activated cytolysins 
Thiol-activated (SH-activated) cytolysins are called oxygen-labile hemolysins because of their 
loss of activity upon exposure to oxygen, which can be restored by the addition of sulfhydryl 
compounds. These proteins are irreversibly inhibited by low concentrations of cholesterol, 
which seems to be an important constituent of cytolysin-sensitive biomembranes (Braun and 
Focareta, 1991). The SH-activated toxins have been identified and studied in Gram-positive 
bacteria such as the listeriolysin 0 of Listeria monocytogenes, pneumolysin of Streptococcus 
pneumoniae, streptolysin 0 of S. pyogenes, cereolysin of Bacillus cereus, tetanolysin of 
Clostridium tetani and perfringolysin (theta toxin) of C. perfringens (Stephen and Pietrowski, 
1981). These toxins have common functional properties such as being lethal and cardiotoxic, 
cross-reactive by hyperimmune sera, lyse a wide range of species of mammalian erythrocytes, 
lose activity when incubated with erythrocyte ghosts, as well as exhibiting similar pH and 
temperature optima for cytolytic activity suggesting that they may share similar structures 
(Stephen and Pietrowski, 1981; Braun and Focareta, 1991). 
1.6.3. Toxin production by Campylobacter spp. 
Although tissue invasion and inflammatory changes could be solely responsible for the 
clinical picture resulting from a campylobacter infection, toxin production could also 
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contribute to the disease process. C. jejuni disease symptoms which often include a transient 
watery diarrhea that progresses to a more bloody diarrhea, 'are consistent with the idea that 
toxin(s) play a role in this disease, however, the role of toxin(s) production by Campylobacter 
spp. in the mechanism of pathogenesis is not well understood (Ketley, 1995). Watery 
diarrhoea would be consistent with enterotoxin involvement, while more invasive diarrhoea 
with blood and inflammatory cells would be consistent with the action of cytotoxins (Leach, 
1997; Wassenaar, 1997; and Pickett, 2000). Since the clinical picture for Campylobacter 
disease may include watery diarrhea, many investigators suggested that some C. jejuni strains 
produce a cholera-like (CT-like) enterotoxin with antigenic relatedness to cholera toxin CT, (a 
major Vibrio cholerae virulence factor which is responsible for massive fluid loss in patients). 
However, it remains controversial whether Campylobacter spp. produce CT-like toxin and 
what the role of this enterotoxin is in pathogenesis, since the existence of such an enterotoxin 
has not been proven yet despite the immunological cross reactivity in vitro and in vivo. 
Moreover, no homology, at the DNA level for cholera-like enterotoxin genes, was found in C. 
jejuni genome (Wassenaar, 1997; and Pickett, 2000), 
Wassenaar (1997) proposed the existence of six different cytotoxin groups in Campylobacter 
spp. on the basis of a weighed comparison of the data: (i) a 70-kDa cytotoxin active on Hela, 
CHO, and other cells but inactive on Vero cells; (ii) a cytotoxin active on Vero and Hela cells; 
(iii) a cytolethal distending toxin (CDT) which produces a response in different cell culture 
lines that appears distinct from enterotoxin activity. This response was first reported by 
Johnson and Lior in 1988 as CLDT, subsequently, further studies reported the isolation and 
characterisation of the cdt genes from C. jejuni (Pickett et aI., 1996); (iv) a shiga-like toxin in 
some C. jejuni and C. coli strains that could be neutralized by Stx antitoxin which was raised 
against the E. coli stx gene product, however, attempts to find genes with homology to the 
shiga-like toxin genes in C. jejuni was not successful (Pickett, 2000); (v) a hepatotoxin; and 
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(vi) hemolytic cytotoxins and cytolysins. Both cell-associated and secreted hemolytic 
activities have been reported to be produced by Campylobacter spp. (Wassenaar, 1997; 
pickett, 2000). Therefore, further studies are required to determine all virulence factors in 
Campylobacter species. 
1.6.4. Hemolysin production by Campylobacter spp. 
Earlier studies suggested Campylobacter spp. as non-hemolytic, however it has been reported 
that some C. coli and C. jejuni strains produce hemolytic activity that could be related to 
pathogenicity. However, conflicting results obtained from different studies have shown that 
several factors affect hemolytic activity. Arimi et al. (1990) reported that 92.3% of C. jejuni 
strains and 21.7% of C. coli strains tested positive for hemolytic activity on sheep blood agar 
plates after incubation at 42 Co for 4 days under microaerophilic conditions. However, 
organisms on plates incubated at 37 Co were nonhemolytic, as were C. lari and C. fetus 
strains. The authors also found that certain media and atmosphere conditions were better 
suited for the detection of hemolytic activity, which was better observed on aging cultures 
suggesting that it could be an intracellular component that is released when bacteria apoptose 
and lyse (Arimi et al., 1990). Two years later, Pickett et al. (1992) used the contact 
hemolysin to detect hemolytic activity from several C. jejuni strains that did not appear 
hemolytic when plated on blood agar media. The level of hemolysis by C. jejuni detected was 
similar to that reported for Shigella flexneri using the same assay by Sansonetti et al. (1986). 
Hemolysin production was reported to be strain dependent with some strains producing little 
or no hemolysin, however, the research concluded that hemolytic activity in C. jejuni did not 
appear to be iron-regulated (Pickett et al., 1992). 
Both heat-labile and heat-stable hemolytic activities were reported in culture filtrates of C. 
jejuni isolates from Scotland and Bangladesh (Hossain et al., 1993). The protein 
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hemolysin(s) showed a spectrum of activity against erythrocytes from different animals. The 
researchers suggested a two-step mechanism of action for the hemolysin: (1) a temperature-
independent binding reaction, and (2) a temperature-dependent lytic stage. Moreover a multi-
hit lytic system was thought to be involved (i.e. more than one hemolysin molecule is required 
to lyse a single erythrocyte), since a decrease in hemolysis was observed when higher 
concentrations of erythrocyte suspension were used. In contradiction to previous results by 
Pickett et al. (1992), it was concluded in this study that although the heat-labile and heat-
stable hemolysins produced by C. jejuni were not identical to those described in other 
organisms, they might be involved in iron acquisition in vivo (Hossain et al., 1993). 
Moreover, a pH-dependent, a-hemolytic-like activity from C. jejuni, was reported by Misawa 
et al. (1995) when the pH of the blood agar medium ranged from 6.0 to 6.5, but hemolytic 
zones disappeared when pH was lower than 5.7 or higher than 7.2. The researchers concluded 
that lowering the medium pH by incubation in a gas mixture with high concentration of CO2 
resulted in better detection of this activity. Furthermore, a j3-hemolytic-like activity appeared 
only beneath the bacterial growth after prolonged incubation, and the hemolytic activity was 
not influenced by the species of the blood (Misawa et al., 1995). 
Tay et al. (1995) reported wider, clear hemolytic zones in 56% of C. jejuni clinical isolates 
from Malaysia, within 24 hours of incubation under aerobic conditions with the use of agarose 
as the solid base in blood agar plates. Moreover, they reported a quantitative identification of 
cell-associated, hemolytic activity in 94% of C. jejuni isolates in a low titer, ranging from 1-
64, by using the microplate technique, which was adopted by Dominques-Rodriguez et al. 
(1986) for detecting hemolytic activity in Listeria monocytogenes. They suggested that this 
cell-associated hemolytic activity could be a potential virulence factor contributing to 
Campylobacter gastroenteritis (Tay et al., 1995). However, calcium-dependent, cell-
associated hemolytic activity in C. coli, was found to be lysophospholipase and phospholipase 
38 
1 "' { 
A activity in a study for molecular characterisation of the gene (pldA) encoding phospholipase 
A in C. coli (Grant et al., 1997). This therefore indicated that cell associated hemolytic 
activity in Campylobacter spp. could be mostly related to phospholipase A activity. 
1'herefore, most observations regarding hemolytic activity in Campylobacter spp. described 
cell-associated or contact hemolysis (Wassennar, 1997). 
Cloning a hemolysin gene from C. jejuni, in an expression library in E. coli was attempted by 
Park and Richardson (1995). However, all clones expressing hemolytic activity on blood agar 
cultures contained the same gene on their insert that coded for a 36 kDa typical lipoprotein, 
with homology to the periplasmic-binding-protein dependent system for ferric siderophores, 
and not a true hemolysin. No hemolytic activity was detected in culture filtrates or in total 
cell lysates, therefore suggesting that the protein might be the siderophore-binding protein 
component of an iron acquisition system of C. jejuni. Therefore, further studies are required 
on hemolysins of Campylobacter spp. in situ rather than in E. coli clones. 
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1.7. Phospholipases 
1.7.1. Function 
Phospholipases constitute a diverse (heterogenous) subgroup of lipolytic enzymes that share 
the ability to hydrolyse one or more ester-linkage in phospholipids with phosphodiesterase as 
well as acyl hydrolase activity. As reviewed by Waite (1996), although all phospholipases 
target phospholipids as substrates, they are diverse in the site of action on the phospholipid 
molecule, their function and mode of action, and their regulation. The diversity of function 
suggests that phospholipases are critical to life since the continual remodelling of cellular 
membranes requires the action of one or more phospholipases. Moreover, they also function 
in such diverse roles from the digestion of nutrients to the formation of bioactive molecules. 
There are indications that some phospholipases may carry out a biological function 
independent of their catalytic activity by binding to a regulatory membrane receptor. Most, of 
the studied phospholipases are soluble proteins, suggesting that their interaction with cellular 
membranes is a regulatory mechanism to prevent membrane degradation. Yet, in most 
pathogens invasion of host cells entails penetration and damage of the outer cell envelope. 
This transmigration process is mediated, by either physical or enzymatic means or a 
combination of the two. Phospholipids and proteins represent the major chemical constituents 
of the host cell envelope. Therefore, enzymes capable of hydrolysing these chemical classes, 
such as phospholipases, are likely to be involved in the membrane disruption processes that 
occur during host cell invasion. Therefore, a wide variety of bacteria have evolved enzymes 
capable of hydrolyzing phospholipids, which are key components of all eukaryotic bilayer 
membranes (Waite, 1996). 
1.7.2. Classification 
The classification of phospholipases is based on their site of attack on the phospholipid. 
Thus, qualifying letters, such as A, B, C, and D, are used to differentiate among the 
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phospholipases and to indicate the specific bond targeted in the phospholipid molecule. 
Phospholipases A are acyl hydrolases classified according td their hydrolysis of the acyl ester 
bond. Phospholipase Al (PLAI ) hydrolyses the fatty acyl ester bond at the sn-l position of the 
glycerol moiety, while phospholipase A2 (PLA2) removes the fatty acid at the sn-2 position of 
this molecule (Figure 1.3. a). The action of PLAI and PLA2 results in the accumulation of 
free fatty acids and 2-acyl lysophospholipid or I-acyl lysophospholipid, respectively. The 
fatty acid, which is still linked to the lysophospholipid is, in turn, cleaved by other enzymes 
termed lysophospholipases (Figure 1.3. b). Some phospholipases hydrolyse both acyl groups 
and are termed phospholipases B, they also have high lysophospholipase activity (Waite, 
1996). 
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respectively; B, PLB; C, PLC; D, PLD. (b) Lyso-PL and Lyso-PL transacylase, (Ghannoum, 
2000) 
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1.7.3. Phospholipase Al (PLAI ) 
The phospholipases Al comprise a large group of 1-acyl hydrolases, some of which also 
degrade neutrallipids (lipases). It has been reported that PLA1 plays important roles in both 
phospholipidosis, a pathological condition in which phospholipids accumulate in lysosomes, 
and as virulence factors for bacterial and fungal pathogenesis (Schmeil et aI., 1998). In 
addition to its physiological roles, PLA1 is of particular interest for industrial applications as it 
yields 2-acyl-Iysophospholipids, which are excellent emulsifiers suitable for use in fields such 
as food technology, cosmetics and pharmaceutical industries (Song and Rhee, 2000). 
1.7.3.1. Bacterial phospholipase Al 
Two phospholipases Al have been purified from E. coli based on their differential sensitivity 
to treatment with detergents. A detergent-resistant enzyme, of the outer membrane 
(OMPLA), with broad substrate specificity hydrolyzing all phospholipids and many neutral 
glycerides (Rock et aI., 1996). This enzyme is unusually resistant to inactivation by heat and 
ionic detergents and requires calcium for maximal activity. The second enzyme is a 
detergent-sensitive PLA1 found as a soluble fraction on the cytoplasmic membrane. This 
cytoplasmic PLA1 with a high degree of specificity for phosphatidylglycerol, can be 
inactivated by heat and by ionic detergents. This enzyme also acts as a transacylase and 
requires calcium for activity (Rock et al., 1996). 
A gene encoding for a secreted phospholipase Al activity linked to lecithin-dependent 
hemolysis, was identified in the human pathogen Yersinia enterocolitica (Schmeil et al., 
1998). This yplA gene product has 74% identity and 85% similarity to the PLA found in 
Serratia liquefaciens (Givskov et al., 1988). Moreover, phospholipase Al activity in Y 
enterocolitica plays a role in bacterial pathogenesis and in the inflammatory process observed 
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in humans and mIce, by promoting colonization and increasing the pathological changes 
resulting from the host inflammatory response (Schmeil et al., 1998). 
Secreted (extracellular) PLAI activity from Serratia sp. strain MK1 isolated from Korean soil 
was purified and characterized by Kim and Rhee (1996). The cloning and characterisation of 
the pldA1 gene encoding for a phospholipase with a predicted molecular weight of 33.4 kDa 
revealed a significant similarity (around 70%) to phospholipase Al from Serratia liquefaciens 
and Yersinia enterocolitica (Givskov et al., 1988; Schmeil et al., 1998). Furthermore, 
improving the conditions for a large scale production of a soluble and active enzyme from 
Serratia sp. MK1 strain in E. coli, which was further improved by evolutionary molecular 
engineering to increase the thermostability of the produced enzyme, has broadened the 
possibility of the application of this phospholipase Al in various phospholipid-related 
industries (Song et al., 1999; Song and Rhee, 2000). 
1. 7.4. Phospholipase A z 
The phospholipases A2 (PLA2) were the first of the phospholipases to be recognised for over 
more than a century, such as the pancreatic phospholipase which was known to degrade 
phoshatidylcholine since 1878, and later at the turn of the century, cobra venom was shown to 
have hemolytic activity directed toward the membranes of erythrocytes by Keyes in 1902 
(Waite, 1996). The family of eukaryotic PLA2 enzymes is diverse and has been shown to 
function in digestion of lipids, microbial degradation, inflammation, cell signalling, and 
membrane remodelling. PLA2 proteins are of great interest to the pharmaceutical industry 
since they are responsible for the release of the fatty acid, arachidonic acid, from membranes, 
and the subsequent conversion of this fatty acid to leukoterins and prostaglandins is part of the 
inflammatory response (Farber et al., 1999). 
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Eukaryotic Phospholipases A2 (PLA2; EC 3.1.1.4) can be classified broadly into two 
categories, secreted and cytosolic types as well as on the basis of their Ca2+ -dependence 
(Table 1.2). Recently, a proposal for classification has been made after many types of PLA2 
were found in each category. According to this classification, secreted PLA2s are grouped 
into classes, I, II, Ill, V, IX, X, XI, and XII, while cytosolic PLA2s were represented by 
classes IV, VI, VII, and VIII (Matoba et al., 2000). 
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Source 
Group I 
(A) Cobras and kraits 
(B) Porcine/human pancreas 
GroupII 
(A) Rattle snakes and vipers; human 
synovial/platelets 
(B) Gaboon viper 
GroupIII 
Bee/lizard 
Group IV 
Rat kidney; macrophage cell lines/platelets 
Group? 
(A) Canine/human myocardium 
(B) P388D1 
(C) Rat liver/macrophages 
(D) Blood (platelet activation factor acetyl 
hydrolase) 
Lotation Size 
(kDa) 
Secreted 13-15 
Secreted 13-15 
Secreted 16-18 
Cytosolic 85 
Cytosolic 40 
Cytosolic 80 
Lysosomal ? 
60 
Table 1.2. Mammalian phospholipase A2 groups, from (Waite, 1996). 
mM 
mM 
mM 
J.iM 
None 
None 
None 
None 
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1.7.4.1. Secreted phospholipases A2 in microorganisms 
Secreted PLA2 activity has been described in bacteria,' fungi, protozoa (Waite, 1996; 
Ghannoum, 2000; Matoba et al., 2002). This activity is Ca2+ -dependent and related to 
pathogenesis in most microorganisms. The crystal structure and the tertiary structure of the 
secreted phospholipase A2 (EC 3.1.1.4) from Streptomyces violaceoruber A-2688 were 
determined by NMR and X-ray analyses (Matoba et al., 2002; Matoba and Sugiyama, 2003). 
In this study, the X-ray diffraction data of this PLA2 indicated that although the tertiary 
structure of the microbial PLA2 is strikingly different from that of the bovine pancreatic 
phospholipase, the internal motion, which is associated with the Ca2+ -binding, phospholipid-
binding, and allosteric interfacial activation is commonly observed in both. 
Two phospholipase A activities secreted by several Legionella spp. were considered as 
possible powerful agents of Legionellae in causing lung disease due to destruction of lung 
surfactant and epithelial cells (Flieger et aI., 2000). Legionella pneumophila secretes, via its 
type II secretion system, phospholipase A activities that are distinguished by their specificity 
for certain phospholipids. However, the timing of phospholipase A and lysophospholipase A 
(LP LA) secretion in L. pneumophila differed compared to other species. PLA activity was 
secreted prior to LPLA activity in L. pneumophila, which may lead to an accumulation of the 
cytotoxic agent (Flieger et aI., 2001). Recently, the Legionella plaA gene encoding a 309-
amino-acid protein (PlaA), that cleaves fatty acids from lysophospholipids was identified and 
characterized by Flieger et al. (2002). Overexpression of plaA completely protected L. 
pneumophila from the toxic effects of lysophosphatidy1choline, suggesting a role for PlaA in 
bacterial detoxification of lysophospholipids. 
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1.7.5. Phospholipases C (PLC) 
1. 7 .5.1. Bacterial PLCs 
As reviewed by Titball (1998), phospholipases C are the best characterised group since 1941, 
when the first bacterial toxin shown to be an enzyme was the a toxin of Clostridium 
perfringins which was found to have phospholipase C activity. Although the enzyme has a 
broad specificity, its preferred substrate is phosphatidylcholine. The PLCs from Bacillus 
cereus are the most studied PLCs. Three distinct enzymes have been purified from the culture 
media of this bacteria, including phosphatidylinositol-specific and PC-preferring enzymes 
(similar to PLC from C. perfringens), as well as sphingomyelinase (Waite, 1987). L. 
monoeytogenes secretes a number of extracellular enzymes including the two phospholipases: 
PLC-A, encoded by pleA, which is an inositol-specific PLC and PLC-B, encoded by pleB, 
which is a broadly active PLC with the ability to hydrolyse most cellular phospholipids. The 
two enzymes have a synergistic effect on the ability of the organism to invade host tissues, 
hence, both phospholipases play overlapping roles in the pathogenesis of L. monoeytogenes 
(Smith et aI., 1995). 
Two distinct PLCs are produced by Pseudomonas aeruginosa: PLC-N (nonhemolytic) and 
PLC-H (hemolytic). The genes (pleN and pIeS) encoding these enzymes have been cloned 
(Songer, 1997). Although the expression and secretion of both enzymes are phosphate 
regulated, each enzyme has distinct substrate specificity, with PLC-H hydrolyzing 
sphingomyelin in addition to phosphatidylcholine (PC), while PLC-N is active in 
phosphatidylserine and PC degradation. The difference in substrate specificity has a bearing 
on the efficiency with which these enzymes degrade eukaryotic membranes. Ostroff et al. 
(1990) proposed that the two enzymes could work sequentially and synergistically to lyse host 
cells. PLC-H initiates membrane lysis by hydrolysing PC and sphingomyelin (the major 
constituents of the membrane outer leaflet), and this is followed by the action of PLC-N, 
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which cleaves phosphatidylserine (the major constituent of the membrane inner leaflet). 
Furthermore, substrate specificity studies have shown that PLC-H preferentially cleaves 
phospholipids containing quaternary ammonium groups, such as phosphatidylcholine, which 
are found primarily in eukaryotic membranes and lung surfactants, however it has minimal 
activity toward phospholipids found III the prokaryotic membrane, such as 
phosphatidylethanolamine (Berka and Vasil, 1982). This selective ability may explain why 
the invading organism can lyse the host cells without damaging its own membrane as 
indicated in figure (1.4). 
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Figure 1.4: The asymmetric distribution of lipids across the plane of the cell membrane of 
human erythrocyte and Bacillus megaterium. Modified from Lipid assembly into cell 
membranes by D. R. Voelker, (1996). PC, phosphatidylcholine, PE, 
phosphatidylethanolamine, PG, phosphatidylglycerol, PS, phosphatidylserine and SM, 
sphingomyelin. 
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1.7.6. Phospholipase D 
Three major clusters of various species were identified in a phylogenetic tree for PLDs, as 
reviewed by Ghannoum (2000). The first cluster is composed of mammalian PLD1 and plant, 
nematode, and Streptomyces PLDs. The second cluster was composed of mammalian PLD2, 
and the third cluster was composed of fungal PLDs. 
1.7.6.1. Bacterial Phospholipase D 
Some bacterial PLDs are known to be toxins and can lead to severe cellular damage such as 
PLD in Corynebacterium pseudotuberculosis, which is considered as a virulence determinant 
increasing the persistence and spread of the bacteria within the host extracellular. 
Furthermore, phospholipase D possibly plays a role in the pathogenicity of similar Gram-
positive bacteria such as Corynebacterium ulcerans and Arcanobacterium haemolyticum. The 
genes encoding the PLD in C. pseudotuberculosis and A. haemolyticum have been cloned and 
sequenced. Targeted mutagenesis ofPLD in C. pseudotuberculosis reduced the ability of this 
bacterium to establish a primary infection or cause chronic abscess formation in regional 
lymph nodes (Ghannoum, 2000). 
1.8. Outer membrane phospholipase A (OMPLA) in Gram-negative 
bacteria 
1.8.1. Molecular and biochemical characteristics of the enzyme 
Outer-membrane phospholipase A (OMPLA; EC 3.1.1.32) is one of few enzymes present in 
the outer membrane of Gram-negative becteria. Phospholipase A and lysophospholipase 
activities were first reported in E. coli in 1971 and the membrane-bound phospholipase A 
activity was isolated and purified later in the same year (Scandella and Kornberg, 1971; Doi 
et al., 1972). OMPLA of Escherichia coli, the most studied protein among this group of 
phospholipases, is a 31-kDa protein encoded by the structural pldA gene, the amino acid 
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sequence is composed of 269 amino acids residues preceded by a 20 amino acid signal 
sequence which targets the protein across the inner membrane: The gene is under the control 
of a constitutive promoter, resulting in the presence of 500 copies of the 31 kDa enzyme in 
the outer membrane of normally growing cells (de Geus et al., 1983; Homma et al., 1984). 
This enzyme is strictly calcium dependent and displays broad substrate specificity. It 
hydrolyses the acyl ester bonds in phospholipids with phospholipase Al and A2, activities, and 
- also harbours I-acyl and 2-acyl lysophospholipase activity, as well as mono- and 
diacylglyceride lipase activities (Horrevoets et al., 1989). 
Brok et al. (1994) compared the predicted primary structures of the pldA gene in Salmonella 
typhimurium, Klebsiella pneumoniae, and Proteus vulgaris with that of the E. coli pldA gene. 
Sequence analysis of pldA genes revealed a high degree of homology, with 79% of the amino 
acid residues being identical in all four proteins. The pldA genes were cloned in E. coli and 
were expressed by enzymatically active gene products. Furthermore, it was indicated that this 
protein is well conserved among Enterobacteriaceae, including pathogenic species and in 
other Gram-negative bacteria. 
Merck et al. (1997) used genetic approaches to propose a model for the topology of OMPLA 
in Salmonella typhimurium based on the prediction of turns and loops and calculations of 
hydrophobicity and hydrophobic moment. In this model, OMPLA transverses the outer 
membrane 14 times as antiparallel amphipathic ~Jstrands, thereby exposing hydrophilic loops 
to the cell surface, while the ~Jstrands are connected by short turns on the periplasmic side. 
Screening of databases of whole genome sequencing projects revealed the presence of 
proteins with homology to OMPLA in Helicobacter pylori, Campylobacter jejuni, Yersinia 
pestis, Neisseria meningitidis, and N. gonorrhoeae. Comparison of OMPLA amino acid 
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sequences in Gram-negative bacteria also revealed that 30 amino acid residues are completely 
conserved, indicating an important physiological role of this enzyme in Gram-negative 
bacteria (Brok et al., 1998). 
1.8.2. Activation and functions of OMPLA 
Although OMPLA of Gram-negative bacteria is an integral membrane protein that is 
embedded in its own substrate in the cell envelope, no enzymatic activity can be detected in 
normally growing cells. Genetic regulation cannot explain the absence of enzymatic activity 
because OMPLA is constitutively expressed, and the expressed protein is correctly 
transported to and inserted into the outer membrane which is composed of phospholipids in 
the inner leaflet and of lipopolysaccharides (LPS) in the outer leaflet. As uncontrolled 
breakdown of the outer membrane would have lethal consequences for the cell, in vivo, 
OMPLA is present in the outer membrane as a monomeric protein in a dormant state. Hence, 
enzymatic activity can only be induced after severe perturbation of the cell envelope integrity 
that occurs during various processes such as phage-induced lysis, temperature shock, and 
colicin secretion (Figure 1.5). Membrane-perturbing peptides, such as polymyxin B, melittin, 
or cardiotoxin can also activate the enzyme (Dekker, 2000; Snijder and Dijkstra, 2000). 
Brok et al. (1994), indicated that the pldA gene could be deleted from the E. coli chromosome 
without changing the phenotype except for the lack of enzymatic activity, suggesting that 
OMPLA is not required for the bacterial cell under laboratory conditions but it might be 
essential for growth in the natural environment. However, the constitutive expression of 
OMPLA, even in E. coli strains that do not possess bacteriocin (colicin) encoding plasmids, 
Suggests that there must be additional physiological roles for the phospholipase. One 
speculative function of OMPLA is related to organic solvent tolerance in the bacterium, 
hence, the role of OMPLA in this process still needs to be clarified (Snijder and Dijkstra, 
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2000). Recently, Kingma and Egmond, (2002a), suggested a function for OMPLA as a 
hOusekeeping enzyme, indicating that the inhibition of OMPLA by its substrate provides the 
means to prevent this enzymatic activity from being lethal to the cell once activated. 
1.8.3. Structural analysis of OMPLA protein molecule 
The 12-f3-stranded architecture of OMPLA resembles the folds of other f3-barrel outer 
membrane proteins (OMPs) that have 8-22 strands (Brock et aI., 1994). The crystal structure 
of the monomeric and the inhibited dimeric enzymes were determined by Snijder, et al., 
(1999), which revealed that OMPLA monomers are folded into a 12-stranded antiparallel 13-
barrel with a convex side and a flat side with approximate dimensions of 20 X 30 X 45 A 03 
(Figure 1.6). As reviewed by Dekker (2000), the f3-strands are connected by long 
extracellular loops and short periplasmic turns. The interior of the f3-barrel is hydrophilic 
with extensive hydrogen bonding networks and electrostatic interactions, resulting in a very 
stable structure. The f3-barrel has a hydrophobic outer surface with which the protein is 
embedded in the outer membrane. The active site of the enzyme is located at the 
hydrophilic/hydrophobic boundary (apolar-polar boundary) of the outer leaflet of the outer 
membrane (Dekker, 2000). 
Serine (Ser) 144 and histidine (His) 142 have been identified as essential residues in the active 
site by chemical modification and by site-directed mutagenesis, in an arrangement resembling 
the corresponding residues of a serine hydrolase catalytic triad. However instead of an 
aspartic acid (Asp) or Glutamic acid (Glu) that is normally present in the triad of serine 
hydrolases, a neutral asparagine (Asn 156) was found in OMPLA (Kingma et al., 2000). 
As reviewed by Snijder and Dijkstra, (2000), dimeric and monomeric OMPLA hardly exhibit 
structural differences, as OMPLA dimers are formed by the association of two enzyme 
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wonomers interacting via the flat barrel side. Dimerisation creates two extended clefts along 
the subunit interface, which run down from the two active sites. Thus, although a monomer 
contains a catalytic triad, the monomeric enzyme form lacks catalytic activity due to absence 
of substrate binding pockets, which are only formed in the dimeric complex. The architecture 
of the catalytic site and substrate binding clefts allow a broad range of substrates to bind, 
therefore, substrates with either one or two acyl chains of various lengths can be productively 
bound (Snijder and Dijkstral, 2000). 
1.8.4. Dimerisation as an essential step for OMPLA activity 
Snijder et al. (1999) indicated that as phospholipids normally are only present in the inner 
leaflet of the outer membrane, where OMPLA is in the inactive monomeric form, but as 
activation concurs with the perturbation of the bacterial membrane, the researchers suggested 
that the relief of lipid asymmetry and the presentation of substrate to the outer leaflet induces 
activation by promoting dimerisation and calcium binding (Figure 1.5). 
Kingma and Egmond (2002b) constructed a well-defined covalent OMPLA dimer to study the 
importance of dimerisation for activity regulation both in a detergent system, and after 
reconstitution in a phospholipid bilayer. This study revealed that a proper OMPLA dimer 
displays high affinity for calcium as OMPLA variants with an impaired dimeric interface also 
lacked high affinity calcium binding. Furthermore, a covalent linkage failed to restore high 
affinity calcium binding in these variants, demonstrating that a proper dimer interface is 
essential for optimal catalysis 
Recently, the structure of the detergent in crystals of outer membrane phospholipase A 
(OMPLA) has been determined by Matoba and Sugiyama (2003). Further research indicated 
that the enzyme's active site is positioned just outside the hydrophobic detergent zone, 
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therefore, is in a proper location to catalyse the hydrolysis of phospholipids in a natural 
membrane (Snijder et al., 2003). Moreover, Baaden et al. (2003) studied the possible 
differences in conformational dynamics that may be related to enzyme activation. They 
jndicated that dimeric OMPLA is less flexible than monomeric OMPLA, especially around 
the active site, and also proposed that the increased stability of the active site in dimeric 
OMPLA is a consequence of the local ordering of water around the nearby calcium ion. 
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OMPT,A rlimer 
Figure (1.5). Model for the activation of OMPLA, modified from N. Dekker, (2000). Under 
normal conditions (top), OMPLA is present as a monomer in the asymmetric outer membrane. 
Upon activation of the enzyme (bottom), dimerisation is triggered by the relief of outer 
membrane asymmetry, therefore presenting substrate to the active site of OMPLA, and by the 
concurrent induction of non-bilayer lipid structures. (AS) is the active site of the enzyme. 
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Figure (1.6). 3-D structure for outer membrane phospholipase A (OMPLA) molecule of 
Escherichia coli. From Snijder et al. (1999). 
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1.8.5. Role of calcium in activation of OMPLA 
OMPLA has two calcium-binding sites per monomer, one high affinity, calcium binding site 
(Kd 36 J!M) and a second binding site with a 10 fold lower affinity (Kd 358 J!M) (Ubarretxena-
Belandia et al., 1998). As dimerisation occurs at low calcium concentration, Snijder and 
Dijkstra (2000) suggested that the first calcium ion plays a role in dimer stabilisation. 
However, in the normal habitat of E. coli, the calcium level exceeds the determined binding 
affinities for calcium to OMPLA therefore, it is unlikely that the requirement for the cofactor 
calcium is involved in the regulation of its activity (Dekker, 2000). One calcium-binding site 
of the OMPLA monomer is located approximately 10 A 0 away from the active site and is 
bound between loops L3 and lA (L3lA site). Mter dimerisation a second calcium-binding 
site (catalytic site or interfacial site) at the dimer interface is present. The calcium ion is 
ligated by the side chain of Ser 152 and by one main chain carbonyl oxygen atom from each 
monomer (Snijder and Dijkstral, 2000; Dekker, 2000). 
In crystallographic studies, Snijder et al. (2001), revealed that the L3lA site was identified 
only in the structure of monomeric OMPLA, whereas the interfacial site (catalytic site) was 
only found in the dimeric enzyme, with no calcium binding observed at the L3IA site. 
Therefore, suggesting that L3L4 calcium ion could serve as a sink for calcium ions, and that it 
might complex with the LPS matrix, thus maintaining the barrier function of the outer 
membrane. The researchers also indicated that key elements of this model (calcium-binding 
and activation) are conserved in Gram-negative bacteria, suggesting that the architecture of all 
OMPLA enzymes is most likely the same, and that their activity is calcium and dimerisation-
dependent. Several of the conserved residues are close in sequence, and form a complete and 
highly specific consensus sequence motif, (YTQ-Xn-G-X2-H-X-SNG), which proves to be 
much more specific than a motif based on the active-site residues alone (Figure 1.7) (Snijder 
et al., 2001). 
59 
In a following study, Kingma et al. (2002), investigated the biochemical relevance of both 
calcium-binding sites using site-directed mutagenesis. They concluded that the interfacial 
calcium site is essential for both catalysis and calcium-dependent dimerisation, whereas the 
L3iA site is redundant in vitro. It was indicated that their results are in accordance with 
sequence homology noted for several OMPLAs (Snijder et al., 2001), revealing absolute 
conservation of Ser 152, whereas both Asp 149 and Asp 184 are not conserved in H. pylori, 
Bordetella pertussis, and Neisseria species (only Asp 149) (Figure 1.7). Moreover, indicating 
that although OMPLA in H. pylori lacks the L3L4 calcium site, activity still depends on the 
cofactor calcium (Kingma et al., 2002). Furthermore, the lack of the L3L4 calcium site may 
be related to differences in outer membrane composition compared to that of E. coli. In 
Neisseria, phospholipid molecules are present in the outer leaflet of the membrane, while the 
outer membrane of H. pylori may contain substantial amounts of lyso-phospholipids. 
Alternatively, those OMPLAs, which are least similar to the E. coli OMPLA, may still have 
an L3L4 site that is obscured by sequence differences and insertions (Snijder et al., 2001). 
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Figure (1.7). Sequence alignment of E. coli OMPLA and 15 homologous enzymes from 
other Gram-negative bacteria. By Snijder et al. (2001). 
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1.9. Phospholipases as virulence factors in pathogenic microorganisms 
Phospholipase activity has been linked to pathogenesis in bacteria and recent studies indicated 
that many bacterial outer membrane or secreted phospholipases are hemolytic and could be 
responsible for tissue damage during infection (Songer, 1997), such as the secreted PLAI 
activity of the human pathogen Yersinia enterocolitica (Schmeil et al., 1998), and the two 
secreted PLA activities in Legionella spp. (Flieger et aI., 2000). Moreover, phospholipases 
AI, A2 and C activities in Helicobacter pylori were linked to the degradation of the 
phospholipid components of the mucosal barrier (Nilius and Malfertheiner, 1996). 
Extracellular PLA2 activity in Rickettsia rickettsii and Rickettsia prowazekii is suggested to 
mediate host cell lysis. Ojcius et al. (1995) found that this hemolytic PLA2 activity requires 
divalent cations (Ca2+, or Mg2+), and is enhanced by an acidic pH. Moreover, the researchers 
proved that this membranolytic activity is of pathogen rather than erythrocyte or host cell 
origin, and suggested that it could contribute to microbial escape from early phagosomal 
compartments during invasion. Furthermore, phospholipase A is known to facilitate host cell 
penetration by the two protozoan species Toxoplasma gondii and Entamoeba histolytica. 
Indirect evidence implicates a calcium dependent-PLA2 produced during host cell invasion by 
T. gondii was obtained by Saffer and Schwartzman (1991), who showed that incorporation of 
exogenous PLA2 from snake venom increases host cell penetration by T. gondii. The parasite 
E. histolytica has two PLA enzymes: a calcium-dependent protein which is associated with the 
plasma membrane and is most active at an alkaline pH, and a calcium-independent enzyme 
that is localised predominantly in soluble subcellular fractions of E. histolytica and IS 
optimally active at acidic pH. Therefore, amoebic cytolytic activity and virulence, is 
associated with the calcium-dependent PLA (Ravdin et al., 1998). 
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l'hospholipase C is considered as a virulence factor in a number of pathogenic bacteria such 
as a toxin of Clostridium perfringens (Waite, 1987). The nbn-hemolytic PLC-N and the 
hemolytic PLC-H of Pseudomonas aeruginosa, and the two extracellular phospholipases 
PLC-A and PLC-B of Listeria monocytogenes were reported to have a synergistic and 
selective effect on the ability of the organism to invade host tissues, therefore, those 
phospholipases were found to play overlapping roles in the pathogenesis of both 
microorganisms (Ostroff et al., 1990; Songer, 1997; Titball, 1998). Furthermore 
phospholipase D in C01ynebacterium pseudotuberculosis, was found to play a role in 
pathogenicity and spread of the bacteria within the host (Ghannoum, 2000). 
The use of microbial phospholipases as vaccines in protection against diseases has been 
investigated. Clostridial alpha-toxin (PLC) was reported by Kameyama et al. (1975) to 
induce protection against C. pelfringens-mediated gas gangrene. Williamson and Titball 
(1993) were able to protect sheep against experimentally induced Clostridium novyi and C. 
perfringens gas gangrene by using a toxoid mixture from C. pelfringens-c. septicum-C. novyi 
as a vaccine. Hodgson et al (1992) constructed a PLD-negative strain (called Toxminus), 
which was incapable of inducing caseous lymphadenitis, and used it to vaccinate sheep 
instead of using PLD to develop a vaccine against C. pseudotuberculosis. Sheep vaccination 
and challenge trials with this mutant showed that it elicited strong humoral and cell-mediated 
immune response and protected the animals from wild-type challenge (Hodgson et aI1992). 
PLA, PLB, PLC and PLD activities have been reported to be possible virulence factors in 
pathogenic fungi (Ghannoum, 2000). The virulence of two Candida albicans isolates, CA30 
and CA87, was compared in an infant-mouse model to obtain further evidence of the 
Contribution of phospholipases to candidal pathogenicity. Strain CA87 failed to cross the 
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bowel wall of the infant mouse after oral-intragastric challenge and did not cause 
disseminated infection, while strain CA30 was able to cross the bowel wall and to disseminate 
hematogenously. The only apparent difference in expression of virulence factors between the 
twO strains was in the superior ability of CA30 to produce phospholipase enzyme, suggesting 
that phospholipase is involved in the invasion process of C. albicans (Ibrahim et al., 1995). 
64 
1 n 
1.10. Phospholipase A (PLA) as a virulence determinant in Gram-negative 
bacteria 
1.10.1. Campylobacter spp. 
Grant et al. (1997) identified a pldA gene upstream of an operon encoding an enterochelin 
transport system in Campylobacter coli. The pldA gene product is a 35 kDa protein with 
significant similarity to the Escherichia coli OMPLA, and is considered to be a major 
hemolytic factor in C. coli. This pldA gene was cloned in E. coli and the recombinant gene 
product was purified. The pure protein displayed calcium-dependent lysophospholipase and 
phospholipase activities in vitro, indicating similar expression and recognition of this gene 
product by E. coli. Furthermore, a constructed pldA mutant in C. coli showed a reduced 
hemolytic activity compared to the wild type strain, indicating a role for phospholipase A in 
the lysis of erythrocytes and suggesting a possible role for phospholipase A in virulence of 
Campylobacter species. A pldA gene sequence was also reported for Campylobacter jejuni, 
encoding a putative phospholipase A protein with significant similarity to phospholipase A in 
C. coli (Brock et al., 1998). More recently, the genome sequence of the food-borne pathogen 
C. jejuni (NCTC 11168) by Parkhill et al. (2000) revealed the presence of a pldA gene 
sequence (Cj 1351) upstream of theceuB and ceuC genes, similar to the position of the pldA 
gene in the C. coli genome. 
Ziprin et al. (2001), found that C. jejuni strains containing mutations in the ciaB and pldA 
genes are extremely poor colonisers, and were avirulent as a result of their impaired ability to 
colonise the chicken cecum. These strains could not establish themselves in the caeca even 
after massive doses were given both orally and intraperitoneally. The ability of the mutant 
strains to serve as viable bacterial vaccines against cecal colonisation by C. jejuni was also 
investigated. However, although the mutants proved avirulent, inoculation with these strains 
did not induce biologically significant resistance against subsequent challenge with the 
65 
{ 
parental strain, in contrast to the H. pylori PldA mutant, which was unable to colonise mice 
but it did induce a significant immune response (Dorrell et al., 1999; Ziprin et al., 2001). 
1.10.2. Helicobacter pylori 
Phospholipase A has been lately implicated as a virulence factor in pathogenic bacteria. H. 
pylori is known to possess several different phospholipase activities such as PLAlo PLA2, and 
PLC, which are linked to the degradation of the phospholipid components of the mucosal 
barrier. The gastric mucus contains abundant surface-active phospholipids, which provides 
the gastric mucosa with unusually high hydrophobic properties, with most prominent 
constituents of phosphatidylcholine (PC 34%-45%) and phosphatidylethanolamine (PE 18%-
32%). Therefore, PH-activated PLA2 is suggested to act as an initial mucosal barrier breaker 
and is considered to have a pivotal role in the pathogenesis of peptic ulcer (Berstad et al., 
2002). In addition to direct disruption of the mucosal barrier, phospholipases are also able to 
liberate leukotrienes and other eicosanoids, converted from arachidonic acid, which could also 
affect membrane permeability and mucous discharge (Nilius and Malfertheiner, 1996). 
Moreover, it has been indicated that the gastric juice of H. pylori-infected individuals contains 
significantly higher PLA2 and lyso-PC concentrations than that of healthy individuals. 
However, it has not been established yet whether this observed increased activity originates 
predominantly from the bacterium or from the inflammatory cells of the host (Berstad et al., 
2002). 
The H. pylori 26695 and 199 genome sequences revealed the presence of an open reading 
frame (HP0499) encoding a putative protein of around 42.5 kDa with homology (54.1% 
Similarity) to E. coli OMPLA and encoding an active phospholipase with lecithinase, PLA2, 
and hemolytic activities (Dorrell et al., 1999). The researchers constructed an isogenic pldA 
mutant in H. pylori, which showed a marked reduction in phospholipase A2 and hemolytic 
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activities and was unable to colonise mice at 2 and 8 weeks as compared with the wild type 
strain. Although the ability of the mutant to adhere to human gastric adenocarcinoma cells 
was unaffected, it did induce a significant immune response, which indicated a role for 
phospholipase A in colonisation of the gastric mucosa and possible tissue damage after 
colonization (Dorrell et al., 1999). Moreover, in a recent study, Zhang et al. (2002), 
confirmed that mutations in genes coding for the urease (ureB) and phospholipase (pldA) 
enzymes did not affect adherence of the bacteria to gastric epithelial cells. 
Bukholm et al. (1997) reported that H. pylori can spontaneously and reversibly change its 
membrane lipid composition, under slightly acidic conditions, from the "normal" L-variant, 
with less than 2% lysophospholipids to the "lyso" S-variant, with over 50% lysophospholipids 
in the membrane. The "lyso" variant is more hemolytic with enhanced affinity for epithelial 
cells and increased release of urease and VacA toxin. Furthermore, the deletion of the pldA 
gene in the S-variant, restored the normal phenotype, suggesting that the L- to S- transition 
might be due to the activation of OMPLA. In a following study, Tannaes et al. (2001) 
showed that the change in membrane lipid composition is due to phase variation in the pldA 
gene. A change in the C-tract length of this gene results in reversible frame shifts, translation 
of a full-length or truncated pldA, and the production of active or inactive OMPLA. Growth 
at low pH resulted in a selection of the best-adapted (S) phenotype with an almost complete 
conversion of normal L-variant (C7, OMPLA "off') to the lyso S-variant (C8, OMPLA "on"). 
The observed difference in colony morphology could not be explained by an LPS variation, 
therefore it was concluded that the pldA gene might contribute to survival of H. pylori at low 
pH. It was also demonstrated that the active OMPLA genotype in fresh isolates of H. pylori 
from patients referred to gastroscopy for dyspepsia (Tannaes et al., 2001). 
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In a recent study to determine the degree of variation in the pldA gene of H. pylori from 
different geographic locations, the phospholipase A gene (pldA) was found to be a highly 
conserved feature of the H. pylori genome irrespective of geographical origin (Xerry and 
Dwen, 2001). The study also investigated links between pldA genotype and clinical disease 
severity, as well as with variation in cagA status and vacA genotypes. It was concluded that 
pldA appears to be a conserved feature of the H. pylori genome with isolates of the same 
PCR-RFLP genotype having a widespread geographical distribution. As there was no 
evidence for strain-specific associations between pldA RFLP or sequence type and 
gastroduodenal presentation, comparisons with other putative pathogenicity markers 
indirectly support a role for phospholipase A activity in colonisation and persistence rather 
than in chronicity of infection (Xerry and Owen, 2001). 
1.10.3. Yersinia spp. 
The pldA gene in Y. pseudotuberculosis encodes a phospholipase, which is active towards 
both phosphatidylcholine and sphingomyelin, which are the major phospholipid components 
of the outer leaflet of eukaryotic cell membranes. The determined 1,468-bp sequence, 
including the pldA gene with flanking regions, was found to be 100% identical to the 
corresponding sequence of Y. pestis the causative agent of human plaque (Karlyshev et al., 
2001). Moreover, the researchers indicated that a PldA mutant strain of Y. pseudotuberculosis 
exhibited reduced phospholipase activity compared to the wild type strain and confirmed in 
vivo attenuation of the mutant, therefore suggesting that PldA is an essential virulence factor 
in the murine yersiniosis model of infection (Karlyshev et al., 2001). 
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1.11. Aims of this study 
• Phenotypical and biochemical examination of Campylobacter concisus strains 
isolated from gastroenteritis cases in children at the Royal Children's Hospital 
(RCH), Melbourne. 
• Protein profile analysis of whole cell lysates and outer-membrane proteins, and 
phenotypical grouping of Campylobacter concisus RCH strains, to investigate 
the relatedness and heterogeneity of these isolates. 
• Molecular typing (Genotyping) and identification of Campylobacter concisus 
strains using PCR amplification methods. 
• Identifying possible virulence factors in Campylobacter concisus isolates, such 
as hemolysins and other membrane damaging toxins. 
• Extraction and characterisation of membrane-bound hemolytic activity in 
Campylobacter concisus. 
• Sequencing and cloning of phospholipase A (PldA) gene III Campylobacter 
concisus. 
• Detecting possible genes related to hemolytic activity III RCH isolates by 
screening a C. concisus genomic library in E. coli. 
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Chapter Two 
General Materials and Methods 
2.1 General Procedures 
All chemicals and reagents used were of analytical laboratory reagent grade. Glassware was 
washed in Pyroneg detergent (Diverey Pty Ltd, Melbourne, Australia), rinsed twice in tap 
water, and then in deionised water before use. All solutions were prepared in deionised water 
delivered from a Millipore Milli-Q®-water system (Liquipure, Melbourne, Australia). All 
media, reagents, pipette tips, and Eppindorf tubes were sterilised by autoclaving at standard 
conditions (121°C for 15 min) , and glassware was achieved by autoclaving at standard 
conditions, 121°C (15 lbs/sqr.in.) unless stated otherwise. All solutions were dispensed using 
either a Gilson P-200 Pipetman Micropipette (John Morris Scientific, Melbourne Australia) 
for volumes of 20-200 !ll, Gilson P-1000 Pipetman for volumes of 200-1000 !ll, Gilson P5000 
Pipetman for volumes of 1000-5000 !ll, or a Finpipette (pathtech, Australia) for volumes 
ranging from 0.5-20 !ll, 20-40 !ll and a Finpipette for volumes from 2 !ll to 10 !ll. 
2.2. General Materials and Equipment 
2.2.1. General Materials 
Reagent Supplier 
Acetic acid, glacial BDH Chemicals, Australia 
Acetone BDH Chemicals, Australia 
Acrylamide, 40% (W/V) solution BDH Chemicals, Australia. 
Agar (Bacteriological Agar No. 1) Oxoid Australia Pty. Limited Agarose 
Agarose (DNA grade) Progen Industries, Australia 
Albumin, bovine serum Sigma-Aldrich Pty., Ltd., USA 
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Alkaline phosphatase (calf intestinal) 
Ammonium acetate 
Ammonium chloride 
Ammonium hydroxide 
Ammonium persulfate 
Ammonium sulphate 
Ampicillin 
Bacteriological tryptone 
BALB/cmice 
Bis-acry lamide (N ,N' -methy lene-bis-acry lamide) 
Brain-Heart infusion broth 
Bromo-phenol blue 
Brucella Broth 
Calcium chloride (dihydrate, AR) 
Centricon Microconcentrator Starter Kit 
Centrifuge tubes: 
(i) 1.5 ml Eppendorf centrifuge tubes 
(ii) 10 ml centrifuge tubes 
(iii) 50 ml centrifuge tubes 
Cephalothin powder 
Chloroform 
Cholesterol 
4-Choloro-1-napthol 
Citric acid (hydrate) 
Columbia agar base 
Coomassie brilliant blue R-250 
z ~ ~ 
Boehringer Mannheim, Germany 
Ajax Chemicals Ltd, Australia 
BDH Chemicals, Australia 
BDH Chemicals, Australia 
Bio-Rad Laboratories, USA 
Ajax chemicals, Astralia 
CSL, Melbourne, Australia 
Oxoid Australia Pty. Limited 
Monash animal services, Australia 
BDH Chemicals, Australia 
Oxoid Australia Pty. Limited 
BDH Chemicals, Australia 
Oxoid, Australia 
BDH Chemicals, Australia 
Amicon, USA 
Sarstedt, Germany 
Greiner Labortechnik, Germany 
Greiner Labortechnik, German 
ICN Pharmaceuticals, Australia 
Ajax Chemicals Ltd, Australia 
ICN Pharmaceuticals, Australia 
Sigma-Aldrich Pty., Ltd., USA 
BDH Chemicals, Australia 
Oxoid Australia Pty.Limited 
Bio-Rad Laboratories, USA 
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Copper sulphate 
Cover slips 
Cryovials (1.8 ml) 
Deoxynuc1eoside triphosphates (dNTPs) 
Dextrose (D-glucose, AR) 
Dimethy lformamide 
Dimethylsulphoxide (DMSO) 
DNA Ligase (T4) 
DNase I (bovine pancreas, grade I) 
DNA Polymerase: 
AmpliTaq 
Dulbecco's Modified Eagle's Medium (DMEM) 
Ethanol 
Ethidium bromide 
EDDA (Ethylene diamine-N,N' -di acetic acid) 
EDTA (Ethylene diamine tetra acetic acid) 
EGTA 
Ajax Chemicals Ltd, Australia 
Mediglass, Australia 
Nalgene Company, USA 
Boehringer Mannheim, Germany 
Ajax Chemicals Ltd, Australia 
BDH Chemicals, Australia 
BDH Chemicals, Australia 
Boehringer Mannheim, Germany 
Boehringer Mannheim, Germany 
Perkin Elmer, USA 
Trace Biosciences, Australia 
BDH Chemicals, Australia 
Boehringer Mannheim, Germany 
ICN Pharmaceuticals, Australia 
BDH Chemicals, Australia 
ICN Pharmaceuticals, Australia 
(Ethylene glócolJbisJE~JaminoJÉthól ether)-N,N,N' ,N'-tetra acetic acid) 
Ferrous chloride (tetrahydrate) 
Film: 
(i) Polaroid 665 
ICN Pharmaceuticals, Australia 
Polaroid, USA 
(Black and white, positive-negative instant film) 
Filters: 
(ii) Polaroid 667 Polaroid, USA 
(Black and white, positive-negative instant film) 
Syringe Filters (O.22!lm, 0.45!lm) 
Ultrafiltration-unit filters (XM, YM) 
Gelman Sciences, USA 
Amicon, USA 
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Folin-Ciocalteau reagent 
Gene Clean Kit 
Gentamicin sulfate 
GIGAPRIME DNA labelling kit 
L-Glutamine 
Glycerol 
Glycine 
Goat anti-mouse IgG 
(HRP conjugated antibodies) 
HEPES buffer (1 M) 
Ajax Chemicals Ltd, Australia 
Bio101, Australia 
Sigma-Aldrich Pty., Ltd, USA 
Bresatec LTD, Australia 
Cytosystems Pty Ltd, Australia 
BDH Chemicals, Australia 
BDH Chemicals, Australia 
Bio-Rad Laboratories, USA 
Cytosystems Pty Ltd, Australia 
(N-2-hydroxyethyl piperazine-N-2-ethane sulfonic acid) 
Horse Blood (Defibrinated) 
Hydrochloric acid (32 %) 
Hydrogen peroxide (30 %) 
8-Hydroxyquinoline 
Immersion oil (Gun) 
IPTG EIsopropó1thioJ~JD-galactosidase) 
Isoamyl alcohol 
Isopropanol 
Kanamycin 
Kligler's iron agar 
Lambda DNA 
Low-molecular-weight Calibration Kit 
(for SDS electrophoresis) 
Low-molecular-weight pUC19/Hpa II marker 
(for DNA electrophoresis) 
Lysozyme 
Eqicell Products P/L., Australia 
Ajax Chemicals Ltd, Australia 
BDH Chemicals, Australia 
BDH Chemicals, Australia 
BDH Chemicals, Australia 
Sigma-Aldrich Pty., Ltd, USA 
BDH Chemicals, Australia 
BDH Chemicals, Australia 
CSL, Melbourne, Australia 
Oxoid Australia Pty. Limited 
Pharmacia LKlB, Sweden 
Amersham Pharmacia Biotech. 
Progen Industries Ltd., Australia 
Boehringer Mannheim, Germany 
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MacConkey agar 
Magnesium chloride (Hexahydrate) 
~_MÉrcaptoÉthanol 
Methanol 
Microaerobic gas mixture 
Microscope slides 
Microtitre plate (96 wells, flat bottom; v-bottom) 
Naldixic acid 
Needle (sterile 18G, 19G, 21G) 
Newborn Calf Serum (NCS) 
Nitrocellulose membrane (Hybond-C) 
Nitrophenyl phosphoryl choline (NPPC) 
Nutrient broth No. 2 
Nylon membrane (Hybond-N) 
Paraffin 
Petri dish 
Phenol/chloroform 
Phenylmethylsulfonyl fluoride (PMSF) 
Phosphate buffer saline (PBS) tablets 
Phosphatidyl choline (soy bean lecithin) 
Phosphatidyl ethanol amine (L-a-cephalin) 
c { 
Oxoid Australia Pty. Limited 
BDH Chemicals, Australia 
Bio-Rad Laboratories, USA 
BDH Chemicals, Australia 
Linde Gas, Australia 
LOMB Scientific Co., Australia 
Nunc, Denmark 
ICN Pharmaceuticals, Australia 
Terumo Pty, Ltd., Australia 
Cytosystems Pty Ltd, Australia 
Amersham, USA 
Sigma-Aldrich Pty., Ltd., USA 
Oxoid Australia Pty. Limited 
Amersham, USA 
BDH Chemicals, Australia 
Nunc, Denmark 
BDH Chemicals, Australia 
Sigma chemicals, Co., Australia 
Oxoid limited, England 
Sigma chemicals, Co., Australia 
Sigma chemicals, Co., Australia 
Phosphatidyl-DL-glycerol (egg yolk lecithin) Sigma chemicals, Co., Australia 
Poly ethylene glycol 6000 
Potassium chloride 
Pristane (2,6,10, 14-tetramethy l-pentadecane) 
Pronase 
Boehringer Mannheim, Germany 
BDH Chemicals, Australia 
Sigma-Aldrich Pty., Ltd, USA 
Boehringer Mannheim, Germany 
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protein standards (low MW) 
aIAEX II gel extraction kit 
Remazol brilliant blue-R 
Rifampin 
RNase 
Salmon sperm DNA 
Sarkosy I (N -laury lsarcosine ) 
Secretory phospholipase A2 correlate-enzyme kit 
Sheep Blood (Defibrinated) 
Skim milk 
supplements (SR069E) 
Sodium acetate 
Sodium bicarbonate (7.5 %) 
Sodium chloride 
Sodium citrate (dihydrate) 
Sodium desoxycholate (AR) 
Sodium dodecyl sulfate (SDS) 
dj-Sodium hydrogen orthophosphate (anhydrous) 
Sodium hydroxide (pellets, AR) 
Sphingomyelin (from bovine brain) 
Staurosporine 
Sulphuric acid 
Syringe (1 ml, 5 ml, 10 ml, 20 ml, 50 ml) 
TEMED (N,N,N' ,N' -tetramethylethylenediamine) 
Tetracycline powder 
Tissue culture flask (25 cm2, 75 cm2) 
l\ 
Bio-Rad Laboratories, USA 
QIAGEN, Australia 
Sigma-Aldrich Pty., Ltd, USA 
Sigma-Aldrich Pty., Ltd, USA 
Boehringer Mannheim, Germany 
Boehringer Mannheim, Germany 
Sigma-Aldrich Pty., Ltd., USA 
Assay Designs, Inc. USA 
Eqicell Products P/L., Australia 
Bonlac Foods Limited, Australia Skirrow 
Oxoid Australia Pty. Limited 
BDH Chemicals, Australia 
Cytosystems Pty Ltd, Australia 
BDH Chemicals, Australia 
BDH Chemicals, Australia 
BDH Chemicals, Australia 
BDH Chemicals, Australia 
BDH Chemicals, Australia 
BDH Chemicals, Australia 
Sigma chemicals, Co., Australia 
Sigma chemicals, Co., Australia 
BDH Chemicals, Australia 
Terumo Pty, Ltd., Australia 
Bio-Rad Laboratories, USA 
ICN Pharmaceuticals, Australia 
Nunc, Denmark 
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Tris-base (Tris (hydroxymethyl) amino methane) 
Tris-HCl 
Triton-X-lOO 
Trypsin - EDTA 
Tryptone 
Tween-20 
Urea 
Whatman blotting paper 
Wizard PCR prep. Kit 
X-gal 
(5-bromo-4-chloro-3-indoly 1-13-D-galactoside) 
Xylene cyanol FF 
Yeast extract 
Boehringer Mannheim, Germany 
Boehringer Mannheim, Germany 
Sigma-Aldrich Pty., Ltd, USA 
Trace Biosciences, Australia 
Oxoid, England 
BDH Chemicals, Australia 
BDH Chemicals, Australia 
Whatman, England 
Promega 
Sigma-Aldrich Pty., Ltd, USA 
Bio-Rad Laboratories, USA 
Oxoid, England 
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2.2.2. General Equiplnent 
gquipment 
Anaerobic jars 
Balance: 
(i) Analytical balance 
(ii) Balance (0.1-500 g) 
Camera (135 mm Polaroid MP4 Land Camera) 
Cell counting chamber (Neubauer, double ruled) 
Centrifuge: 
(i) Microcentrifuge (EBA12) 
(ii) Bench top centrifuge (Centaur 2) 
(iii) High-speed centrifuge (L2-21 M/E) 
(iv) Ultra-speed centrifuge (L8-80M) 
DNA Thermocycler (for PCR) 
Electrophoresis Power Supply: 
(i) EPS 500/400 
(ii) EPS 3000xi 
Electrophoresis Units: 
(i) DNA 
(a) Mini gel (GNA-lOO) 
(b) Midi gel (wide mini-sub cell GT) 
(c) Maxi gel (GNA-200) 
(ii) Protein 
(a) Mini Protean II gel system 
(b) Maxi Protean gel system 
GELDOC system 
Supplier 
Oxoid Australia Pty. Limited 
Sartorius GMBH, Germany 
U-Lab, Australia 
Polaroid, USA 
Propper MFG Co., USA 
Zentrifugen, Germany 
Graykon Scientific 
Beckman, USA 
Beckman, USA 
Perkin Elmer, USA 
Pharmacia LKIB, Sweden 
Bio-Rad Laboratories, USA 
Pharmacia LKIB, Sweden 
Bio-rad Laboratories, USA 
Pharmacia LKIB, Sweden 
Bio-Rad Laboratories, USA 
Bio-Rad Laboratories, USA 
Bio-Rad Laboratories, USA 
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Incubators 
(i) Bellsouth 100 still air incubator 
(ii) Tissue culture (5 % CO2) 
Microscopes: 
(i) Light microscope 
(ii) Phase contrast microscope 
pH meter 
Sonicator 
Trans-blot electrophoretic transfer cell 
Transilluminator (Novaline UV) 
Ultrafiltration unit 
Vortex mixer (V ml) 
2.2.3. General Solutions 
( 
Bellsouth, USA 
Forma Scientific, USA 
Olympus Optical Co., Japan 
Nikon Kogaku KK, Japan 
Radiometer, Denmark 
Branson Sonic Power Co., USA 
Bio-Rad Laboratories, USA 
N ovex Australia Pty Ltd 
Amicon, USA 
Ratek Instruments, Australia 
Alsever's solution (for erythrocyte collection). Prepared by dissolving 20.5g D-glucose, 
8.0 g sodium citrate (dihydrate), 4.2g NaCl, and 0.6g citric acid (hydrate), in Milli-Q water 
and made up to 1 litre in a volumetric flask. Filter-sterilised after pH was adjusted between 
6.0- 6.2. 
Ammonium acetate. Made up as 10M ammonium acetate (NH4 Ac) in Milli-Q water. 
Ammonium persulfate. Freshly prepared as 10% (w/v) solution in water. 
Cell lysate buffer. Freshly prepared as O.lM Tris base, 2% (w/v) SDS, 15% (v/v) glycerol, 
and 2mM phenylmethylsulphonyl fluoride (PMSF), pH 6.8. 
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Chloroform. Prepared as 24:1 (v/v) chloroform:isoamyl alcohol. 
Coomassie Brilliant Blue Stain. Prepared as 0.05% (w/v) Coomassie brilliant blue R-250 in 
40% (v/v) methanol, 10% (v/v) glacial acetic acid and 50%(v/v) distilled water. 
De-staining solution (for SDS-PAGE gels). Prepared as 40% (v/v) methanol and 10% (v/v) glacial 
acetic acid in Milli-Q water. 
EDTA solutions. Prepared as 1mM, 100mM, and O.SM EDTA in distilled water. 
Ethidium bromide (EtBr). Prepared as lOmg/ml (w/v) EtBr solution in Milli-Q water. 
O.lM IPTG stock solution. Prepared by dissolving 1.2 g of isopropyl ~JaJ
thiogalactopyranoside in SOml of sterile water. 
6X loading buffer (for DNA gels). Prepared as 0.2S% (w/v) bromophenol blue, 0.2S% (w/v) 
xyelene cyanol FF and 40% (w/v) sucrose in Milli-Q water (Sambrook et al., 1989). 
Phosphate buffered saline (PBS). Prepared by dissolving one PBS tablet in 100 ml Milli-Q 
water. The buffer was sterilised by autoclaving at 109°C for 30 min. 
Potassium acetate solution. Prepared as 3M potassium acetate (KAc), in distilled water, pH 
was adjusted to 4.8. 
Resolving gel buffer. Prepared as 1.SM Tris-HCI in distilled water, pH was adjusted to 8.8. 
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RNase (DNase free). Prepared as 20 mg/ml bovine pancreatic ribonuclease in sterile Milli-Q 
water, then heat treated at 100°C for 10 min. Aliquots of 100 !--LI each were kept frozen at -
20°e. 
lOx Running buffer (electrophoresis buffer for SDS-PAGE). Prepared by dissolving 
0.25M Tris-HCI (PH 8.8), 1.92M glycine and 1 % (w/v) SDS, in distilled water. 
Sample Buffer (for protein gels). Prepared as 10% (v/v) glycerol, 0.02% (w/v) 
bromophenol blue, 0.125M Tris-HCI, pH 6.8 and 5% (v/v) ~JmÉrcaptoÉthanol in distilled 
water. 
SarkosyJ detergent (for outer membrane proteins). Prepared as 1.88% Sarkosyl (N-
laurylsarcosine) in 12.5mM Tris-HCI, pH 7.4. 
Stacking gel buffer. Prepared as 0.5M Tris-HCI in distilled water, pH was adjusted to 6.8. 
Substrate solution (for western blots). Freshly prepared by dissolving 30 mg of 4 chloro-1-
napthol in 10 ml methanol. The solution was protected from light and used immediately after 
it was mixed with 20 mM Tris-HCI (PH7.4) and 20 !--L1 of H20 2. 
Sucrose buffer. Prepared by dissolving 25% (w/v) sucrose in 50 mM Tris, pH 8.3. The 
buffer was filter sterilised or autoclaved at 109°C for 30 min. 
50x TAE buffer (electrophoresis buffer for DNA gels). Prepared by mixing 24.2% (w/v) 
Tris-base, 5.17% (v/v) glacial acetic acid and 1.86% (w/v) EDTA, then made up to 1 I in 
deionised water. 
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TE buffer. Prepared as 10 mM Tris base, 1 mM EDTA, pH'S.O in Milli-Q water. 
Transfer buffer (for western blots). Prepared as 10 mM Tris base, 50 mM glycine, and 
20% (v/v) methanol in Milli-Q water. 
Tris-Saline-Tween (TST). Prepared as 10 mM Tris-base (PH 7.4), NaCI (0.9% w/v) and 
Tween 20 (0.05 % v/v) in Milli-Q water. 
Western Blots Blocking Solution. Prepared as 5% (w/v) skim milk in TST buffer. 
X-Gal Stock Solution (20mg/ml). Prepared by dissolving 100 mg of 5-bromo-4-chloro-3-
indolyl-j3-D-galactoside (X-Gal) in 5 ml of N,N '-dimethylformamide. The solution was 
stored in the dark at -20°C. 
2.3. General Microbiological Methodology 
2.3.1. General antibiotics for culture media 
Ampicillin: 100mg/ml stock solution was prepared in sterile distilled water, stored at -20°C 
and used in 50""g/ml, 100""g/ml, and 200 ""giml final concentrations. 
Cephalothin: 100mg/ml stock solution was prepared in sterile distilled water, stored at -20 
°C and used in a final concentration of 30""g/ml. 
Kanamycin: 100mg/ml stock solution was prepared in sterile distilled water, stored at -20°C 
and used at a final concentration of 50 !-!g/ml. 
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Naldixic acid: Final concentrations of 20f,lg/ml, and of 30f,lg/ml were obtained by dissolving 
O.02mg or 0.03mg of the antibiotic in 1000ml of agar medium before autoclaving. 
Skirrow antibiotic supplements (SR069E): Ready to use vial supplements as an antibiotic 
compound of vancomycine, trimethoprim lactate and polymyxin B, was incorporated into 
growth medium when needed. 
Tetracyline: 10mg/ml stock made up (dissolved) in 100% ethanol and used at a final 
concentration of 20 f,lg/ml. 
2.3.2. Bacteriological media 
All media were prepared according to the manufactures directions unless noted in the text. 
Blood agar (BA): Columbia agar base 3.9 % (w/v) dissolved in deionised water, autoclaved 
at standard conditions and cooled to 50°C -55°C before adding 10% (v/v) of defibrinated 
horse blood. Similarly sheep, chicken, and rabbit blood agar media were prepared and used 
for hemolysis assays. Campylobacter selective supplement (SR069E) was added to BA to 
prepare Skirrow media when needed. 
Brucella Broth (BB): Brucella broth powder (2 % w/v) was dissolved in deionised water and 
autoclaved at standard conditions. 1-2% yeast extract was added to enhance growth of C. 
concisus. 
Egg yolk agar (lecithinase medium): Columbia agar base with (10% v/v) egg yolk was 
prepared by separating the egg yolk from the white under aseptic techniques. The yolk was 
then mixed with an equal volume of phosphate buffer saline and centrifuged at 5000 xg for 10 
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minutes. The supernatant was collected and then 50 ml of this supernatant were added to 450 
ml of sterile Columbia agar before it was poured in Petri dishes. 
Luria Bertani Agar (LA): Tryptone (1 % w/v), yeast extract (0.5% w/v), NaCI (0.5 % w/v) 
and bacteriological agar (0.6 % w/v) were dissolved in deionised water and autoc1aved at 
standard conditions. 
Luria Bertani Broth (LB): Tryptone (1 % w/v) , yeast extract (0.5% w/v) and NaCI (0.5 % 
w/v) were dissolved in deionised water, dispensed into aliquots and autoc1aved at standard 
conditions. 
Nutrient Agar (NA): Columbia agar base was dissolved in deionised water (3.9 % w/v) , 
autoc1aved at standard conditions. 
Nutrient Broth: Nutrient broth No. 2 mix (1.3 % w/w) was dissolved in deionised water, 
dispensed into aliquots, and autoc1aved at standard conditions. 
SOC Broth: Tryptone (2 % w/v) , yeast extract (1 % w/v) , sodium chloride (10 mM), 
potassium chloride (2.5 mM), magnesium chloride (10 mM), magnesium sulphate (10 mM) 
were dissolved in water and autoc1aved at standard conditions. Fresh filtered glucose (20 mM) 
was added prior to use. 
Tryptone milk (Storage Media): Prepared by dissolving 10 % (w/v) skim milk and 1% 
(w/v) tryptone in 10 mM Tris-HCl (PH 7.5). The medium was autoc1aved at 109°C for 30 
min. 
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x-gal Plates: X-gal plates were prepared by spreading 40 flL of X-gal (20 mg/ml) and 4 fllof 
IPTG (0.1M) onto LB agar plates and dried before use. The'plates were stored in the dark at 
4°C. 
2.3.3. Bacterial strains and plasmids 
Campylobacter concisus strains used in this study were isolated from children suffering from 
gastroenteritis at The Royal Children's Hospital, Melbourne. Clinical history for all C. 
concisus isolates used in the study including two reference strains are listed in (Table 2.1). 
Campylobacter strains other than C concisus strains used in this study are listed in (Table 
2.2). 
2.3.4. Bacterial culture conditions 
Campylobacter concisus and C. mucosalis strains were grown on horse blood agar (HBA) for 
48-96 h at 3rC under microaerophilic conditions, in a gas mixture consisting of 6% O2, 8% 
CO2, 6% H2 and 80% balance of nitrogen in anaerobic jars without anaerobic catalyst. C. 
jejuni and C. coli strains were grown on HBA plates with Skirrow supplement (SR069E) in an 
atmosphere of 5% O2, 10% CO2 and 85% N2 for 48 h at 3rc. For liquid cultures all 
Campylobacter strains were grown in Brucella broth, supplemented with 2% yeast extract and 
incubated in jars with the same gas mixture as for plate cultures, at 3rC for 36-72 h. 
Escherichia coli strains were grown on nutrient agar (NA) for 18 hat 3rc. They were then 
inoculated into nutrient broth or and grown for a further 18 h at 3rC, shaking at 100 rpm on 
an orbital shaker. E. coli clones were cultured on Luria Bertani Agar (LA) with appropriate 
antibiotics while liquid cultures were grown into (LB) Broth (with appropriate antibiotic as 
needed), under the same previous conditions. 
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Table 2.1 Campylobacter concisus strains used in this study' 
strain no. Source and clinical history Strain designation and Reference 
-ATCC 51561 Faeces, 24Y, female CCUG 20034, Sw, Vandamme, et al., 1989 
ATCC 51562 Faeces, 7M, male, D CCUG 20700, UK, Vandamme, et al., 1989 
RCH3 Faeces, 1Y, male, D& V, 3 d 94/20398.2, RCH, Au, Russell, 1995 
RCH4 Faeces, 1 Y, female, D& V, 5 d 95/53.6, RCH, Au, Russell, 1995 
RCH5 5M, female, D, 5 d 94/21492.8, RCH, Au, Russell, 1995 
RCH6 Faeces, 2Y, male, D, 3 d 95/16586.6, RCH, Au, Russell, 1995 
RCH7 Faeces, 16M, male, D& V, 7 d 94/20814.5, RCH, Au, Russell, 1995 
RCH8 Faeces, 5M, female, D& V, 2 d 93/19775.9, RCH, Au, Russell, 1995 
RCH9 Faeces, 2Y, male, D& fever, 7 d 95/11037.8, RCH, Au, Russell, 1995 
RCHlO Faeces, 3M, male, D, 6 d 95/727.2, RCH, Au, Russell, 1995 
RCH11 Faeces, 2Y, male, D, 4 d 94/18314.3, RCH, Au, Russell, 1995 
RCH12 Faeces, 30M, male, D, 20 d 95/1331.6, RCH, Au, Russell, 1995 
RCH13 Faeces, 1 Y, male, D, 2 d 93/27278.4, RCH, Au, Russell, 1995 
RCH14 Faeces, 2Y, female, D*, 5 d 94/81237.1, RCH, Au, Russell, 1995 
RCH15 Faeces, 5M, female, D& V, 9 d 94/20537.9, RCH, Au, Russell, 1995 
RCH16 Faeces, 7M, male, D& V, 2 d 94/81103.3, RCH, Au, Russell, 1995 
RCH17 Faeces, BM, male, D, 3 d 94/80728.3, RCH, Au, Russell, 1995 
RCH18 Faeces, 2M, female, D& V, 7 cl 93/27855.3, RCH, Au, Russell, 1995 
RCH19 Faeces, 2Y, female, D& V, 5 d 94/14367.1, RCH, Au, Russell, 1995 
RCH20 Faeces, 10M, female, D&V, 14 d 94/6464.2, RCH, Au, Russell, 1995 
RCH21 Faeces, 16M, male, D, 2 d 94/26505.8, RCH, Au, Russell, 1995 
Y; years and M; months of age; d; days of symptoms, D; diarrhoea, V; vomiting, 
*: more than one pathogen was detected; Country of isolation: Sw; Sweden, UK; United 
Kingdom, Au; Australia 
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Table. 2.2 Other Campylobacter strains used in the study 
Campylobacter Strain, and Classification Source and Reference 
Origin 
351, (Chicken isolate) C. coli RMIT, N. Stern, * 
81116, (Human gastroenteritis) C. jejuni RMIT, Palmer et aI., 1983 
ATCC 43264, (Pig intestine) C. mucosalis USA, Vandamme, et aI., 1989 
CSIRO 15, (Sheep isolate) C. coli RMIT, Korolik et aI., 1995, 
Cj 108, C. jejuni RMIT, Korolik et al., 1995 
Cj 007 C. jejuni RMIT, Korolik et al., 1995 
FF3, (Human faeces) C. jejuni RMIT, Korolik et al., 1995 
NCTC 11366, (Human faeces) C. coli RCH, Russel et al., 1998 
RCH 2, (Human blood) C.jejuni RCH, Russel et al., 1998 
RMIT 0032A (Proliferative C. hyoilei RMIT, Korolik et aI., 1995 
enteritis case in swine) 
*; Personal communication, USA 
RMIT; RMIT University, Melbourne 
RCH; Royal Children's Hospital, Melbourne 
86 
2.3.5. Bacterial strains storage and stock cultures 
Bacterial strains and clones were harvested from lawn cultures with tryptone milk. Aliquots 
of cell suspension were placed into cryovials and stored at -70°C. 
2.3.6. Estimation of bacterial cell concentrations 
Campylobacter culture cell density, was estimated by absorbance readings (AtJoo) at 600nm. 
Absorbance reading was then plotted against a growth curve for Campylobacter spp. and 
confirmed by plate cultures of bacterial dilutions on RBA plates. The suspension fluid 
(without cells) was used as blank for absorbance readings. 
2.4. Hemolytic Activity Methodology 
2.4.1. Blood agar diffusion assay 
Using a sterile cork borer., 5-7 wells were introduced into columbia agar plates supplemented 
with 10% (v/v) blood erythrocytes from different sources. The wells were sealed by melted 
agar before adding O.lml of a bacterial suspension or culture supernatants into each well. 
Relative controls of sterile buffer or liquid medium were used in each plate. Plates were left 
at room temperature for 1-2 hours to dry before they were incubated under microaerophilic 
conditions as described in 2.3.4. 
2.4.2. Erythrocyte suspension preparation 
Defibrinated blood was centrifuged at 900 xg for 5 min to pellet the erythrocytes. Erythrocyte 
pellet was washed three times in sterile phosphate buffer saline and resuspended in PBS as 
1 % or 2% (v/v) erythrocyte suspension. Freshly prepared erythrocyte suspension was 
prepared for each test. 
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2.4.3. Contact hemolysin assay 
Bacterial cell pellet was washed with sterile PBS, bacterial cells were then resuspended in 
PBS to a concentration of lx109 CFU. Equal volumes of the bacterial suspension and of 2% 
(v/v) erythrocyte suspension were mixed in a sterile tube. The mixture was then centrifuged 
at 1000xg for 5 min, to pellet the bacterial cells on top of blood erythrocytes, and the 
supernatant was discarded. The pellet was then incubated at 3 rc under microaerophilic 
conditions for 18 h. A negative control of sterile PBS and blood erythrocytes was also 
incubated under the same conditions. After incubation, the pellet was re suspended in cold 
PBS and centrifuged at 1000xg for 5 min to pellet the non-lysed cells. The optical density 
(OD) of the supernatant was detected on 550 nm. A positive control for complete hemolysis 
was performed, by replacing the same volume of bacterial suspension with distilled water in 
the test. 
2.4.4. Liquid hemolysin assay 
Equal volumes of supernatants or hemolysin extracts were mixed with 2% (v/v) blood 
erythrocytes and incubated aerobically at 3rC for 2-8 hours, then centrifuged at 1000 g for 5 
min to pellet the non-lysed cells, and the OD550 for the supernatants was detected. Negative 
controls of erythrocyte suspension mixed with equal volumes of the proper broth or buffer 
were also incubated as indicated. Positive controls were performed by mixing equal volumes 
of the same concentration of lysed erythrocytes with the proper broth or buffer. 
2.4.5. Microtitre plate hemolysin assay 
Two fold dilutions of bacterial suspensions, supernatants, or hemolysin extracts were prepared 
in a 96-well, v-bottom microtitre plate. Equal volume of 2% erythrocyte suspension was 
added to each well. Positive and negative controls were prepared in each micro titre plate as 
explained for previous method. Plates were then incubated aerobically at 37°C for either 8-
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18 hours for both bacterial suspenSIOns and for culture supernatants or 2-8 hours for 
he1ll0lysin extracts. Mter incubation the rate (titre) of hemdlysis was detected by comparing 
the volume of erythrocyte pellet in the bqttom of each well with negative and positive controls 
performed in the same plate. 
2.5. Tissue Culture Techniques 
2.5.1. Tissue culture media 
2.5.1.1. Dulbecco's Modified Eagle's Medium (DMEM) 
5xDMEM 
Hepes Buffer (1 M) 
Sodium Bicarbonate (7.5 %) 
L-Glutamine (200 nM) 
Milli-Q H20 
100.0 ml 
10.0 ml 
13.5 ml 
4.5 ml 
372.0 ml 
2.5.1.2. DMEM + 10 % Newborn Calf Serum (NCS) 
NCS was added to DMEM to give a final concentration of 10 %. 
2.5.1.3. Phosphate Buffered Saline (pH 7.4) 
One litre of 10x stock solution of PBS was made by mixing the following reagents and made 
up to 1L with Milli-Q water. : 
Sodium Chloride 
Potassium Chloride 
Potassium dihydrogen orthophosphate 
di-Sodium hydrodgen orthophosphate (anhydrous) 
80.0 g 
2.0 g 
2.0 g 
11.5 g 
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2.5.2. Cytotoxin Assay 
Chinese hamster ovary (CHO) cell line (purchased from CSL, Australia) was routinely 
cultured in 25 ml tissue culture flasks containing 10-12 ml of Dulbecco's modification of 
Eagle's medium (DMEM) supplemented with 10% (v/v) newborn calf serum. The cultures 
were incubated at 37°C with 5% CO2 . When used in cytotoxicity assays, confluent cells were 
washed with sterile PBS and harvested from culture flasks by using trypsin-EDTA. The 
pellet was resuspended in 1.0 ml of DMEM without serum. An aliquot of 0.1 ml of 1 x 105 
CHO cells (estimated using a Neubauer counting chamber) was added into each well in a 96 
well culture tray. One hundred !-LI samples of serial two fold dilutions of tested material were 
added to each well and incubated as above. The cells were tested for cytotoxic effect (visible 
rounding or cell damage) at 16, 24, 48 and 72 hours. 
2.5.3. Maintenance and storage of tissue culture cells 
Upon reaching cell confluence, the tissue culture medium was discarded and cells were 
washed once with sterile PBS. Cells were then trypsinised (by adding trypsin-EDTA and 
incubating for 5 min.) and pelleted. For the maintenance of cell lines, the freshly trypsinised 
cells were re suspended in 1ml of DMEM supplemented with 10% (v/v) newborn calf serum. 
Two hundred !-LI of this cell suspension was added to a new 25ml tissue culture flask with new 
growth medium. For long-term storage of cell lines, freshly trypsinised cells were 
resuspended in 0.9ml of DMEM without serum and transferred into a sterile 1.5ml cryotube. 
One hundred microlitres of DMSO was added and mixed well by inversion. The tubes were 
placed in -70°C for 2 h before transferring to liquid nitrogen storage. 
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2.6. Methods for protein analysis 
2.6.1. SDS-PAGE acrylamide gel electrophoresis. 
2.6.1.1. Whole cell lysate preparation 
Bacteria were harvested from fully grown lawn cultures on appropriate medium by flooding 
one agar plate with 1 ml of 10 mM Tris-HCI (PH 7.4). The bacterial suspension was 
centrifuged at 2000xg for 5 min at room temperature (RT) and the bacterial pellet washed by 
resuspending in 1 ml of 10 mM Tris-HCI (PH 7.4) followed by centrifugation as above. The 
cell pellet was lysed with 0.5 ml cell lysate buffer and boiled for 5 min. After cooling, the 
cleared cell lysate was recovered by centrifugation at 10000xg for 1 min at RT. Protein 
concentration was determined (2.6.1.3), and protein samples were stored frozen at -20°e. 
2.6.1.2. Outer membrane protein isolation 
Bacteria were harvested from lawn culture using 1 ml of 10mM Tris-HCI (PH 7.4) per agar 
plate and centrifuged at 2000xg for 5 min at room temperature (RT). The bacterial pellet was 
resuspended in 5-10 ml of lOmM Tris-HCI (PH 8) and was then sonicated on setting 6 for 6 x 
30 sec bursts with cooling on ice between each sonication. The sonicated cells were 
centrifuged at 1000xg for 10 min at 4°C to remove unbroken cells. The resulting supernatant 
was collected and centrifuged at 12000xg for 60 min at 4°C to pellet the total membrane. The 
total membrane pellet was then resuspended with 8 volumes of sarkosyl detergent and 
incubated for 30 min at RT with mild shaking according to the method of Filip et al. (1973). 
The outer membrane proteins (OMP) were then collected by centrifugation at 12000xg for 30 
min at RT. The OMP pellet was resuspended in O.lml sterile distilled water and stored at -20 
QC. The protein concentration of the outer membrane extract was determined as outlined in 
the following section. 
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2.6.1.3. Protein quantification of samples (Estimation of protein 
concentration) 
Protein quantification was performed using a modification of Lowry method as described by 
Markwell et al. (1978). Fifty millilitres of reagent A (2 % sodium carbonate, 0.4 % sodium 
hydroxide, 0.16 % sodium potassium tartrate and 1 % SDS) was mixed with 500 [ll of reagent 
B (4% copper sulphate) to give reagent C. Six hundred microlitres of reagent C was mixed 
with 200 [ll of bacterial cell lysate (or BSA protein standards), and left at room temperature 
for 20 min. Sixty microlitres of Folin's reagent (Folin-Ciocalteu reagent 1:1 water) was then 
added, mixed rapidly and left to stand for 30 min. Two hundred microlitres of the mixture 
was pipetted into a 96-well microtitre tray and the OD600nm was detected and then compared 
to the protein standards. 
2.6.1.4. Low molecular weight protein standards. 
Molecular weights of unknown proteins were determined by electrophoresis of samples 
against known low molecular weight (LMW) markers of sizes 94, 67,43, 30, 20.1, and 14.4 
kDa. The lyophilised protein standards were mixed with 180[l1 of 0.2M Na2HP04 pH9.2 and 
SO[l1 of Remazol Brilliant Blue solution, and incubated at 70°C for 30 min. The contents 
were then mixed with 770[l1 of sample buffer, aliquoted into eppendorf tubes and stored 
frozen at -20 Co. The protein standards were boiled before use and S[ll loaded per SDS-
PAGE gel. 
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2.6.1.5. Protein sample preparation 
Samples were prepared according to the method of Laemmli (1970). Protein samples were 
reduced with 10% (w/v) SDS-sample buffer in a volume ratio of 4 sample:1 SDS:1 buffer. 
Samples were boiled for 5 min and cooled prior to loading onto SDS-PAGE gels using a 1-
100111 micro-syringe. 
2.6.1.6. Preparation of SDS-PAGE gels 
Both mini and maxi protean II gel systems were used to analyse protein samples, and were 
made to 12 % (w/v) acrylamide for the resolving gel and 4% (w/v) acrylamide for the 
stacking gel. The composition of both gels is indicated below: 
Resolving gel for SDS-PAGE (12%) 
Distilled water 3.35ml 
1.5M Tris-HC1, pH 8.8 2.5ml 
10% (w/v) SDS stock 100 111 
Acrylamide/bis (30%stock) 4.0ml 
10 % ammonium persulfate (fresh) 50 ~l 
TEMED 5 ~l 
Stacking Gel for SDS·PAGE (4%) 
Distilled water 6.1 ml 
O.SM Tris-HCl, pH 6.8 2.5 ml 
10% (w/v) SDS stock 100 ~1 
Acrylamide/bis (30%stock) 1.3 ml 
10 % ammonium persulfate (fresh) 50 ~1 
TEMED 10 111 
93 
2.6.1.7. Running SDS-polyacrylamide gels 
The setting used to run the mini systems was 150 V for 1-2 h, while a voltage of 200 V was 
applied for 8-10 h to run maxi gels. For both mini and maxi gels, the electrophoresis was 
stopped when the dye front was about 5-lOmm from the bottom edge of the gel. 
2.6.1.8. Coomassie blue stain for SDS· PAGE and photography of gels 
After the completion of electrophoresis, acrylamide gels were removed from the apparatus 
and placed in a fixing solution of 40% methanol and 10% acetic acid for 30 min. The gels 
were then stained with Coomassie blue stain for 30 min then excess stain was removed by 
placing the gel in destaining solution overnight with several changes of destain solution. 
SDS-PAGE gels were placed on a light box and photographed with a Polaroid MP 4 camera 
using Polaroid 665 film. 
2.6.1.9. Immuno blotting (Western blotting) 
Proteins resolved by SDS-PAGE were transferred electrophoretic ally onto nitrocellulose 
membrane, using a trans-blot apparatus. The voltage applied was set at 70V (170 mA) for 45-
60 min, as described by Towbin et al. (1979). 
2.6.2. Antiserum production 
2.6.2.1. Preparation of C. concisus whole celllysates 
c. concisus cells were cultured as previously described (section 2.3.2) and were harvested and 
washed twice with PBS. The pelleted cells were resuspended in PBS as 106 cellshtl. This C. 
concisus bacterial suspension was prepared freshly for each injection. 
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2.6.2.2. Preparation of antisera in Balb/c mice 
polyclonal C. concisus antisera were produced using 8-week old female Balb/c mice. The 
mice were initially primed by intraperitoneal (ip) injection of 200 fll of pristane using a 1 ml 
syringe and 21-gauge needle to draw lymphocytes to the area. After one week, the mice were 
given the first dose of antigen by injecting 200 fll of C. concisus cell suspension into the 
peritoneum (ip). After 14 days from the first dose, the mice were given a booster (ip) 
injection of 200 fll of C. concisus cell suspension followed by a second and then third (ip) 
booster injections in the following two weeks. Seven days after the last injection the mice 
were injected with 200 fll 2 x 107 Sp/2 myeloma cells and were observed daily for signs of 
abdominal swelling. When appropriate, the ascites fluid containing the antibodies was 
drained from mice using a 21 gauge needle and collected into 10 ml centrifuge tubes. The 
fluid was centrifuged at 1000 xg for 10 min to remove cells and the supernatant was collected 
and stored at -20oe. 
2.6.2.3. Adsorption of anti-C. concisus antibodies to E. coli 
E. coli host cells used in cloning studies with the cloning plasmid vector were grown 
overnight at 3rc on LA. Five millilitres of 10 mM Tris-HCI, pH 7.4 were used to harvest 
one E. coli culture. Bacterial cells were sonicated using 6 x 30 sec bursts to disrupt cell wall. 
One ml of the sonicated suspension was then mixed with ascites fluid in a ratio of 5 
supernatant: 1 antisera. The suspension was placed on an orbital shaker at 4°C for 24-48 h, 
then it was centrifuged at 10000xg for 5 min and the supernatant was stored at -20°e. 
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2.7. Methods for DNA analysis. 
2.7.1. DNA isolation procedures 
2.7.1.1. Small scale plasmid DNA isolation 
Isolation of bacterial plasmid DNA was performed by the method described by Sambrook et 
al. (1989). Five millilitres of LB broth containing appropriate antibiotic was inoculated with 
a single colony of bacteria and grown overnight on a shaker at 3rc. One and a half 
millilitres of the culture was placed in a micro centrifuge tube and centrifuged at 12,000 xg. 
The pellet was resuspended into 100 ",,1 of ice-cold solution I (50 mM glucose, 10 mM EDTA, 
25 mM Tris.Cl pH 8.0, 4 mg/ml lysozyme), and left at room temperature for 5 min followed 
by lysis with 200 ",,1 of solution Il (0.2 N NaOH, 1% SDS). Chromosomal DNA and protein 
were precipitated with 150 ",,1 of ice-cold solution III (potassium acetate, 5M acetate, 3M 
potassium). The sample was vortexed in an inverted position for 10 sec and left on ice for 5 
min. The cell debris was removed by centrifugation at 12000xg for 5 min at room 
temperature, and the supernatant was then transferred to a new tube. An equal volume of 
phenol:chloroform:isoamyl alcohol (25:24:1) was added and the contents mixed vigorously 
by inversion, then centrifuged as above. The aqueous phase was transferred into a new tube, 
and the protein extraction procedure was repeated once more with phenol/chloroform and 
once with chloroform. The double stranded DNA was precipitated with an equal volume of 
isopropanol. The sample was mixed and incubated for 2 min at room temperature then, 
centrifuged as above. The DNA pellet was washed with 1 ml of 70% ethanol and then air-
dried by placing the tube upside down on tissue paper. The DNA pellet was finally 
resuspended in 20 ",,1 of TE or sterile H20. Plasmid samples were stored at -20 QC. 
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2.7.1.2. Isolation of chromOSOlnal DNA 
Bacterial chromosomal DNA was isolated by the method of Sambrook et al. (1989). Three 
millilitres of sucrose buffer (25% sucrose in 50 mM TrisCl pH 8.3) was used to flood one 
agar plate of lawn bacterial culture. Two millilitres of cell suspension was placed into a 10 ml 
centrifuge tube, mixed with 0.5 ml of 0.25M EDTA (PH 8) containing 20 mg/ml of lysozyme 
(freshly prepared), incubated at 3rC for 15 min. This was followed by the addition of 0.5 ml 
of 10% SDS and mixing by inversion to achieve complete lysis. Contaminating proteins were 
then digested by the addition of 150 ,",,1 of pronase (20mg/ml) and incubation at 3rC for 30 
min. The density of the preparation was reduced by the addition of 500 ,",,1 of TE buffer, 
followed by an extraction with an equal volume of phenol and the preparation was shaken for 
1 h. After centrifugation at 2000xg for 10 min, the aqueous phase was collected and the 
extraction procedure was repeated twice with phenol:chloroform:isoamyl alcohol (25:24:1). 
The DNA was then precipitated from the aqueous phase with an equal volume of isopropanol 
and incubated at -20°C for 1 h, or overnight. The DNA was collected by centrifugation at 
12000xg for 10 min. 
The pellet, once dried, was re suspended in 500 ,",,1 of TE buffer and 20 ""I of RNase (10 
mg/ml) was added and incubated at 3rC for 30 min. This was followed by the addition of 
20 ""I pronase (10 mg/ml) and the mixture was again incubated for a further 30 min at 3rC. 
The mixture was then extracted twice with phenol:chloroform (50:50) and once with 
chloroform (24:1 chloroform:isoamyl alcohol). In each case the phases were separated by 
centrifugation at 12000xg for 5 min in a micro centrifuge and the aqueous phase transferred to 
a sterile tube. The purified DNA was precipitated from 400 ,",,1 of the aqueous phase by the 
addition of 80 ""I of 10 M ammonium actetate (1/5 x volume) and 1 ml of ice-cold 100% 
ethanol (2 x volume). After incubation at -20°C for 30 min or overnight, the DNA was 
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collected by centrifugation at 12000xg for 20 min. The purified chromosomal DNA pellet 
was resuspended in 200 - 400 !!l of sterile water and stored frozen at -20°C. 
2.7.1.3. Rapid boiled method for template DNA used in peR 
Bacterial suspension in distilled water containing around 107 CFU was prepared as described 
earlier. One millilitre of this suspension was boiled for 5 min then cooled on ice for 10 min to 
disrupt the cells. Bacterial debris was removed by centrifugation at 10000xg for 5 min. Ten 
micro litres of the DNA containing sup em at ant were used to provide the template DNA for 
PCR reactions. 
2.7.1.4. Purification of DNA from peR amplification 
DNA from PCR amplification was purified using the Wizard PCR prep. kit following the 
manufacturer instructions. The purified DNA was eluted with 40 !!l of H20 and stored at -
2.7.1.5. Purification of DNA fragments from agarose gels 
The desired DNA fragment was cut out of the agarose gel using a clean scalpel and put into a 
microcentrifuge tube. The DNA fragment was extracted from the gel after estimating the 
weight of the agarose gel slice, using the QlAEX II gel extraction kit. Mter the DNA pellet 
was air-dried for 15 min, the DNA was resuspended in 20 !!l of H20 and centrifuged at 
3000xg for 30 sec to remove the QlAEXII particles. The collected DNA was then stored at -
20°C and used within few days. 
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2.7.1.6. Concentrating DNA anlount by ethanol precipitation 
This method was used to decrease the total volume of the extracted DNA to concentrate the 
DNA sample. Two and a half volumes of 100% (v/v) ethanol and a 1/5 volume of 10 M 
ammonium acetate were added to DNA preparation and stored at -70oe for 1 h or -20oe for 
24 h. DNA was then pelleted by centrifugation in an eppendorf microcentrifuge at 12,000 xg 
for 15 min. The pellet was washed with two and a half volumes of 70% (v/v) ethanol 
followed by 2.5 volumes of 100% (v/v) ethanol and was then air-dried. The DNA pellet was 
then resuspended in the appropriate volume of TE buffer or in H20. 
2.7.1.7. Estimation of DNA concentration by ethidium bromide agar plates 
Ethidium bromide agar plates were prepared as 1% (w/v) of DNA grade agarose in 1x TAB 
buffer and boiling the solution using a microwave oven. The agarose was cooled to 500 e and 
R~1 of ethidium bromide solution (10 mg/ml) was added. After mixing, the agar was poured 
into petri dishes and allowed to set in the dark. The agar plates were dried at 400 e for 30 min 
then stored in the dark at room temperature before use. To estimate the concentration of DNA 
in samples, a range of standard DNA concentrations (0.5, 1, 2, 3, 4, 5, 6, 8, 10, 15, and 20 
~g/ml) were prepared by diluting Lambda DNA in TE buffer. Tested DNA samples were 
diluted to 1/10, 1/50, 1/100 in TE buffer. One microlitre of each of the DNA standards and 
samples was spotted onto the ethidium bromide plates and allowed to soak into the agar for 5 
min. The plated were viewed under UV illumination, and the concentration of DNA in each 
sample was then estimated by comparison with the Lambda DNA standards. 
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2.7.2. Agarose gel electrophoresis of isolated DNA 
2.7.2.1. Agarose gel preparation 
Agarose gels for electrophoresis of DNA were prepared using DNA grade agarose dissolved 
in Ix TAB buffer by boiling. The agarose was poured into a casting tray after cooling to 
50°C. The percentage of agarose used was 0.7%, 1 %, and 2% (w/v), as weight of agarose per 
volume of Ix TAB buffer. 
2.7.2.2. Gel electrophoresis 
Prior to electrophoresis, DNA samples were mixed with 6x loading buffer as 5:1 (v/v). 
Pharmacia gel electrophoresis apparatus was used to run mini and maxi gels, while the Bio 
Rad apparatus was used for midi gels. Electrophoresis was usually carried out at 80-100V for 
1.5-3 h for mini and for midi gels, while maxi gels were run at 60V for 8-10 h or 30V 
overnight. 
2.7.2.3. Ethidium bromide staining 
Gels were stained after electrophoresis by placing them in a 1mg/ml ethidium bromide bath 
for approximately 5-10 min. Agarose gels were destained before viewing by washing in 
running tap water. 
2.7.2.4. Visualisation and photography of ethidium bromide stained gels 
DNA on ethidium bromide stained gels was visualised under DV light (312nm) using a 
Novaline DV transilluminator and photographed through a No. 23 Wratten filter with a 
Polaroid MP 4 camera using Polaroid 667 film. Later on visualisation and photography was 
performed by using the GELDOC BioRad system. 
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2.7.3. PCR Amplification 
2.7.3.1. Primer design 
Primers were designed with the aid of the software program Primer Designer (version 2) by 
Scientific & Educational Software. Primers were designed to have a %GC content between 
40-60% with a TmoC in the range of 50-80°C. 
2.7.3.2. PCR amplification conditions 
All PCR reactions were performed using the following reagents: 
Reagent Volume 
DNA template (100 ng/f!L) O.S f!l 
Primer 1 (100 ng/f!L) 0.5 f!l 
Primer 2 (100 ng/f!L) 0.5 f!l 
dNTPs (2.SmM) 2.0 f!l 
lOx reaction buffer 2.S f!l 
AmpliTaq DNA polymerase (S units/f!l) 1.0 f!l 
H2O 17.0 f!l 
Total volume 25.0 f!l 
A negative control containing all previous reagents except DNA template, which was replaced 
with an equal volume of sterile distilled water, was used in all PCR amplifications to ensure 
the PCR mix purity. 
All PCR amplifications were performed using a DNA Thermocycler under the following 
conditions: 
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Number of cycles Temperature Duration' 
----
1 (denaturation) 94°C 3-5 min 
30 (denaturation) 94°C 1 min 
30 (annealing) 50°- 60°C 1 min 
30 (extension) 72°C 30 slkb 
1 (extension) 72°C lOmin 
2.7.3.3. Detection ofPCR amplification products 
peR ampliction products were detected and analysed using agarose gel electrophoresis as 
described in Section 2.7.2.2. 
2.7.3.4. Purification ofPCR products 
PCR products were purified using the Wizard PCR prep. Kit for cloning, and the Bio 101 
GeneClean Kit for sequencing purposes. 
2.7.4. DNA Sequencing 
2.7.4.1. Reagents and cycle parameters for DNA sequencing 
All DNA sequencing was carried out using the ABI PRISM BigDye Terminator Cycle 
Sequencing Ready Reaction Kit according to the manufacturer's instructions using the 
following reagents: 
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Reagent Volume' 
Terminator Ready Reaction Mix 8.0 III 
Template DNA 
Double stranded DNA x III (200-500 ng) 
or 
PCR product x III (30-90 ng) 
Primer (100 ng/Ill) 0.5 III 
Milli-Q H2O x III 
Total volume 20.0 III 
The following cycle parameters were applied using DNA Thermocycler under the following 
conditions: 
Number of cycles Temperature Duration 
25 94°C lOs 
25 50°C 5s 
25 60°C 4min 
2.7.4.2. Purification ofPCR products for sequencing 
Two microlitres of sodium acetate (PH 4.6) and 50 ilL of 95 % ethanol were added to 20 III of 
sequencing reaction, mixed and placed on ice for 10 min and then centrifuged for 30 min at 
12,000 xg in a microcentrifuge. The supernatant was discarded and the pellet was rinsed in 
250 III of 70 % ethanol, vortexed briefly and then centrifuged again for 10 min at 12,000 xg. 
The pellet was air-dried and then read on an ABI Prism 377 DNA sequencer at Monash 
University, Clayton, Victoria. 
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2.7.5. DNA Manipulation 
2.7.5.1. Restriction digests 
All restriction digests were carried out with the following reagents: 
Reagent Volume 
DNA x ~l 
Restriction enzyme 2 ~l (10 units/~l) 
lOx buffer 2 ~l 
BSA 1 ~l (2mg/ml) 
H2O x ~l 
Total volume 20 ~l 
All reactions were carried out at 3rC for at least 1 h. 
2.7.5.2. DNA ligation 
Ligations were performed in the ratio of 1 vector molecule: 3 insert molecules, using the 
following reagents: 
Vector DNA x ~l (20 ng) 
Insert DNA x ~l (60 ng) 
Ligase 1 ~l (1 unit/~l) 
10 Ligation buffer 2 ~l 
Sterile Milli-Q water x ~l 
Total volume 20 ~l 
Ligation reactions were carried out at 16°C for 16 h, then the mixture was used for 
transformation into E. coli competent cells 
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2.7.5.3. Preparation of competent E. coli cells 
2.7.5.3.1. for electroporation 
E. coli cells were grown in 100 ml of LB broth on a shaker at 37°C for 16 h. Ten millilitres of 
this culture was used to inoculate 1 litre of pre-warmed LB broth in a flask and shaken 
vigorously at 3rC for 3 h. The cells were chilled on ice for 15 min and then centrifuged at 
4000 xg for 10 min. The supernatant was completely drained off before the cells were 
resuspended in 1 I of ice-cold Milli-Q water and then centrifuged at 4000 xg for 10 min. This 
step was repeated with 500 ml of ice-cold Milli-Q water. The cell pellet was resuspended in 
20 ml of ice-cold with 10% (v/v) glycerol and centrifuged as before. The cells were 
resuspended in a final volume of 2 ml of ice-cold 10% (v/v) glycerol in Milli-Q water and 
divided into aliquots of 40 !!l each. Aliquots of electro-competent E. coli cells were stored at 
2.7.5.3.2. for natural transformation 
Competent E. coli cells were prepared using a modification of the method described by Cohen 
et al. (1972). All solutions and centrifugation steps in this procedure were performed at 4°C. 
Four isolated colonies of E. coli from an agar plate were inoculated into 10 ml of LB broth 
and incubated on a shaker at 37°C for 16 h. One millilitre of this overnight culture was used 
to inoculate 30 ml of LB broth. The culture was grown to exponential phase by shaking 
vigorously at 37°C for 3 h, then chilled on ice for 30 min. The broth culture was transferred 
into 15 ml centrifuge tubes and cells were collected by centrifugation at 4000 xg for 5 min. 
The supernatant was decanted and the cells were gently resuspended in 5 ml of ice-cold 
MgCh (lOOmM). The cells were re-pelleted at 4000xg for 5 min and resuspended in 5 ml of 
75 mM CaCh per tube and incubated on ice for 30 min, then centrifuged as above. 
105 
J\ 
Competent E. coli cells were resuspended in 1 ml of 75 mM CaCh and divided into aliquots 
of 40 1-11 each. Competent cells were either used immediately or frozen at -70°C for future. 
2.7.5.4. Electro-transformation (Electroporation) 
Frozen electro-competent cells were thawed on ice and mixed with up to 1 /!g of plasmid 
DNA in a volume of 2 1-11 and transferred to an ice-cold electro-cuvette with a 0.2 cm gap. 
The Gene pulser apparatus was set at 25 I-1F, 2.5 kV, with the pulse controller set at 200 
Q. The mixture was pulsed once then 1 ml of SOC medium was immediately added to the 
cells and they were incubated at 3rC for 1 h on a shaker. Fifty to one hundred microlitres of 
transformed culture were plated out onto LB agar containing the appropriate antibiotic or X-
gal plates. 
2.7.5.5. Natural transformation 
For this transformation assay, 200 !-Ll of competent cells prepared as described in 2.7.5.3.2 
were incubated on ice for 30 min with 50 ng of plasmid DNA. The cells were heat shocked in 
a water bath at 41°C for 45-60 sec and were kept on ice for 5 min. 1 ml of SOC broth was 
then added and the tube containing the transformation reaction and incubated on a slow 
shaker at 37°C for 1 h. One hundred millilitres of this culture was gently spread onto an LB 
agar plate containing the appropriate antibiotic and incubated at 3rC overnight. 
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Chapter Three 
Biochemical and Molecular Characterisation of 
Campyiobacter concisus Clinical Strains 
3.1. Introduction 
C. concisus is a fastidious hydrogen-requiring bacterium of the human oral cavity. It is 
known to be associated with gingivitis and periodontitis (Kamma et al., 1994; Kamma et al., 
2001), as well as being a potential aetiological agent of enteritis in children (On, 1994; 
Russell, 1995; Lindblom, 1995). C. concisus enteric infections are known to be most 
common in some patient subgroups, mainly children under 24 months of age and in 
immunocompromised patients. Therefore this micro-organism is considered a potential 
enteric pathogen accounting for a significant proportion of cases for which, no other 
etiological agent has been found (Engberg et al., 2000; Lastovica et al., 2000; and Maher et 
al., 2003). 
C. concisus is Gram negative, slender or slightly curved rods, which is motile by a polar 
flagellum. It is characterised by low biochemical activity, which makes it hard to be 
identified by conventional phenotypic techniques (Matsheka et al., 2001). C. concisus 
clinical isolates, demonstrate considerable genomic heterogeneity by molecular typing 
methods such as DNA-DNA hybridization, PFGE, peR and protein profiling within the 
species. These isolates represent a diverse group with at least two genomospecies, which are 
phenotypically indistinguishable but genetically divergent (Vandamme et al., 1989; Matsheka 
et al., 2002; Bastyns et al., 1995; Aabenhus et ai., 2002b). Therefore, further analysis is 
required to identify and relate the clinical isolates with pathogenesis. 
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In the last decade, the isolation of atypical campylobacters such as C. concisus from stool 
samples of patients with diarrhoea has been enhanced by applying the stool filtration method 
on an antibiotic-free blood agar medium and incubation in a hydrogen-enriched micro-
aerophilic environment (Le Roux and Lastovica, 1998; Lindblom et al., 1995; Russell, 1995). 
Consequently Campylobacter spp. other than C. jejuni and C. coli have been identified more 
frequently from acute gastroenteritis cases (Lastovica et aI, 2000; Aabenhus et al., 2002; 
Maher et al., 2003). 
The aims of the experimental procedures performed in this chapter were to confirm C. 
concisus strains identification through: 
• Phenotypic, biochemical properties and antibiotic resistance profiles. 
11 SDS-PAGE analysis of outer membrane protein profiles. 
• Molecular identification and typing by PCR amplification of 23S rDNA and 
PCR amplification of the 0.5-kb C. concisus species-specific fragment. 
Parts of the results in this chapter were published in (Istivan et aI., 1998) and in (Istivan et al., 
2004). 
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3.2. Materials and Methods 
3.2.1. Bacterial strains 
C. concisus strains used in work reported in this chapter were isolated from children suffering 
from mild to severe bloody diarrhoea at the Royal Children's Hospital between June 1993 and 
June 1995 (1.4.2.1.). The nineteen clinical isolates (RCH 3-RCH 21) were identified 
according to Liors' biotyping scheme (Lior, 1984) and additional biochemical tests including: 
Gram stain, oxidase, catalase, growth conditions, indoxyl acetate hydrolysis, DNase 
production, hippurate hydrolysis, nitrate reduction, susceptibility to cephalothin and nalidixic 
acid, H2S production on Kligler iron agar and growth on MacConkey agar (Russell, 1995). 
Two C. concisus type strains ATCC 51561 and ATCC 51562 were also used in tests included 
in this chapter (Table 2.1), and a C. mucosalis type strain ATCC 43264 was used as a control 
strain (Table 2.2), being a species closely related to C. concisus (On, 1994). The clinical 
histories for C. concisus isolates used in this study have been presented previously in table 
2.1. 
3.2.2. Biochemical characterisation of C. concisus 
Phenotypic tests to characterise C. concisus isolates were performed using a standard 
inoculum of 107 cfu/ml. The nineteen RCH C. concisus isolates and the two reference strains 
ATCC 51561 and ATCC 51562 were tested for oxidase production, catalase production, H2S 
production in Kligler iron agar (KIA), growth on MacConkey agar (MCA), and growth at 
42°C, following standard methods (Isenberg, 1995; Russell, 1995). 
3.2.3. Antibiotic resistance patterns of C. concisus isolates 
Antibiotic susceptibility/resistance of C. concisus isolates to cephalothin and to nalidixic acid 
was determined on HBA agar containing either nalidixic acid or cephalothin in final 
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concentrations of 10, 20, 30 !lg!ml, prepared as described in 2.1.3. Bacterial suspensions (107 
etu/ml) for each C. concisus strain were lawn cultured on the'antibiotic-HBA plates and were 
incubated at 37°C under microaerophilic conditions for 72 hours. The tested strain was 
considered as susceptible when no growth was noticed within 48-72 hours of incubation 
under standard growth conditions as described in 2.3.4, or as resistant if there was clearly 
evident growth on the medium with antibiotic. This test was repeated 4 times for each strain 
to confirm the accuracy of the resistance patterns. C. concisus reference strains ATCC 51561 
and ATCC 51562 were used as controls in each test. 
3.2.4. SDS-PAGE analysis for protein profiles of C. concisus strains 
Whole celllysates of 19 C. concisus isolates (RCH 3-RCH 21), two C. concisus type strains 
ATCC 51561 and ATCC 51562, and C. mucosa lis type strain ATCC 43264 were prepared as 
described in 2.6.1.1. Outer membrane proteins were prepared as described in 2.6.1.2. using 
the method of Filip et al. (1973). SDS-PAGE was performed as described in section 2.6.1. 
using the method of Laemmli, (1970). 
3.2.5. Molecular identification of Campylobacter concisus 
3.2.5.1. peR amplification of 23S rDNA 
All C. concisus isolates used in this study, were identified by PCR amplification of the 23S 
rDNA using the method described by Bastyns et al. (1995). This method was modified by 
using the two reverse primers (CONI and CON2) independently rather than as a mixture and 
was used to group the clinical isolates. Segments of the 23S rDNA were amplified using the 
following primer mix sets (see table 3.1 for primer sequences): 
Mix A: forward primer MUCl and reverse primer CONI. 
Mix B: forward primer MUCl and reverse primer CON2. 
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:Mix C: forward primer MUCl and an equal volume of both reverse primers CONI and 
CON2. 
PCR amplification of the 23S rDNA in C. concisus was performed as described in 2.7.3. 
using a 60°C annealing temperature, with templates of chromosomal DNA as described in 
2.7.1.2 and was then repeated using DNA templates extracted by the rapid boiled cells method 
as described in 2.7.1.3. C. concisus clinical isolates were grouped according to their peR 
product with either of the reverse primer sets A or B, as compared with the type strains ATCC 
51561 and ATCC 51562. Primer mix set C was used as a positive control for detecting all C. 
concisus tested strains, while DNA samples extracted from C. mucosalis ATCC 43264, C. 
coli NCTC 11366, C. jejuni 81116, and C. hyoilei (RMIT 0032A) were used as negative 
controls in this PCR amplification. 
3.2.5.2. peR amplification of a O.5-kb C. concisus species-specific fragment 
c. concisus isolates were subjected to PCR amplification following the PCR identification 
protocol described by Matsheka et al. (2001). This PCR protocol is based on the DNA 
sequence of the 1.6 kb "BglII-XbaI" fragment of C. concisus, which was isolated from a C. 
concisus genomic library and has three ORFs regions (Matsheka et al., 2001). In this study 
the 0.5 kb ORF3 region "HindlII fragment" in chromosomal DNA of C. concisus strains was 
amplified using the forward primer 5F cisus (table 3.1) and the reverse primer 6R cisus (table 
3.1). C. jejuni 81116, C. jejuni 108, C. jejuni 007, C. coli 351, C. coli CSIRO 15 and C. 
mucosalis ATCC 43264 strains were used as controls. Chromosomal DNA templates for 
PCR were either extracted as described in 2.7.1.2. or prepared by boiling bacterial cells as 
described in 2.7.1.3. PCR amplifications were repeated at least three times to ensure the 
efficiency of this method. 
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Table 3.1. DNA sequences of primers used in PCR amplifications for the molecular 
identification of Campylobacter concisus strains. 
-Primer Primer Sequence Reference 
MoCl 5'-ATGAGTAGCGATAATTGGG-3' Bastyns et al., (1995) 
CONI 5'-CAGTATCGGCAATTCGCT-3' Bastyns et al., (1995) 
CON2 5'-GACAGTATCAAGGATTTACG-3' Bastyns eta!., (1995) 
5F cisus 5'-AGCAGCATCTATATCACGTT-3' Matsheka, eta!., (2001) 
6Rcisus 5'-CCCGTTTGATAGGCGATAG-3' Matsheka, eta!., (2001) 
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3.3. Results 
3.3.1. Phenotypic properties of C. concisus isolates 
The colony of C. concisus on blood agar medium is smaller than a C. jejuni colony (less than 
lmm in diameter) and has a yellow to grey colour. Typical bacterial cells are Gram-negative, 
slightly curved, small thin rods. However, long curved rods were observed in smears 
prepared from pure cultures incubated for more than 72 h (figure 3.1). Alpha and beta 
haemolytic zones on blood agar were noticed underneath colonies in 3-5 days old cultures in 
most C. concisus strains. 
Growth rates of different RCH strains were variable under the same incubation conditions 
with some strains showing a stable weaker growth even with second and third time 
subcultures. However, when the campylobacter antibiotic supplement (Skirrow supplement) 
was used with blood agar medium, the growth of all C. concisus strains was weaker with only 
few small colonies noticed after more than three days of incubation. Therefore the use of 
"Skirrow" supplement was discontinued, and blood agar medium without supplement was 
always used to grow C. concisus strains and other Campylobacter spp. used in this study. 
3.3.2. Biochemical characterisation of C. concisus 
All C. concisus isolates were oxidase positive, catalase negative, and H2S was produced in 
variable amounts, when tested using conventional methods, consistent with the biochemical 
reactions for reference C. concisus strains (table 3.2). All strains grew well at 42°C after 48 h 
of incubation, while most strains failed to grow on MacConkey agar, except strains (RCH7, 
RCH9, RCHll, and RCH12) which grew weakly on this medium (table 3.2.). 
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Table 3.2. Biochemical properties of C. concisus clinical strains. 
C. concisus Oxidase 
isolates production 
j\TCC51561 + ve 
ATCC51562 + ve 
RCH3 +ve 
RCH4 +ve 
RCH 5 +ve 
RCH6 +ve 
RCH7 +ve 
RCH 8 +ve 
RCH9 +ve 
RCH 10 +ve 
RCH 11 +ve 
RCH 12 +ve 
RCH 13 +ve 
RCH 14 +ve 
RCH 15 +ve 
RCH 16 +ve 
RCH 17 +ve 
RCH 18 +ve 
RCH 19 +ve 
RCH20 +ve 
RCH21 +ve 
Catalase 
production 
- ve 
- ve 
- ve 
- ve 
- ve 
- ve 
- ve 
- ve 
- ve 
- ve 
- ve 
- ve 
- ve 
- ve 
- ve 
- ve 
- ve 
- ve 
- ve 
- ve 
- ve 
H2Son 
KIA 
+ve 
+ve 
+ve 
+ve 
+ve 
+ve 
+ve 
+ve 
+*ve 
+*ve 
+ve 
+ve 
+ve 
+ve 
+ve 
+ve 
+ve 
+ve 
+ve 
Growth on 
MCA 
- ve 
- ve 
-ye 
- ve 
- ve 
- ve 
+ve 
- ve 
+*ve 
+*ve 
- ve 
- ve 
- ve 
- ve 
- ve 
- ve 
- ve 
- ve 
- ve 
Growth at 
42 cC 
+ve 
+ve 
+ve 
+ve 
+ve 
+ve 
+ve 
+ve 
+ve 
+ve 
+ve 
+ve 
+ve 
+ve 
+ve 
+ve 
+ve 
+ve 
+ve 
+ve 
+ve 
+ve; positive reaction or full growth, -ye; negative reaction or no growth, +* ye; weak 
reaction or weak growth 
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3.3.3. Antibiotic resistance patterns of C. concisus ,isolates 
C. concisus isolates RCH 3-21 and both C. concisus type strains ATCC 51561 and ATCC 
51562 were able to grow normally on HBA media supplemented with up to 20 fAg/ml 
nalidixic acid, but when a higher concentration of 30 fAg/ml nalidixic acid was used, isolates 
RCH 14, RCH 17, and RCH 19 failed to grow after 4 days of incubation. Therefore these 
three strains were considered as intermediate regarding their resistance to nalidixic acid while 
other C. concisus tested strains were resistant to nalidixic acid (table 3.3). 
C. concisus isolates showed variable resistance to cephalothin, with most of the isolates being 
unable to grow on 10 fAg/ml cephalothin. These strains were considered susceptible as the 
minimum inhibitory concentration (MIC) for cephalothin in campylobacters is 8 fAg/ml 
(Nachamkin, 1995). Only isolates RCH 6, RCH 7, and RCH 11 were able to grow on higher 
cephalothin concentrations of up to 30 fAg/ml and were considered resistant. Isolates RCH 8 
and RCH 21 were considered intermediates regarding their antibiotic resistance to cephalothin 
(table 3.3). 
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Table (3.3). Antibiotic resistance patterns of C. concisus isolates against nalidixic acid and 
cephalothin, recorded as the ability of the strains to grow on HBA media containing 10,20, or 
30 !-tglml of nalidixic acid or cephalothin. 
Resistance for Resistance for 
Strain No. Nalidixic acid Cephalothin 
ATCC 51561 R S 
51562 R S 
3 R S 
RCH4 R S 
RCH5 R S 
RCH6 R R 
RCH7 R R 
RCH8 R I 
RCH9 R S 
RCH 10 R S 
RCH 11 R R 
RCH12 R S 
RCH 13 R S 
RCH 14 I S 
RCH 15 R S 
RCH 16 R S 
RCH 17 I S 
RCH18 R S 
RCH 19 I S 
RCH20 R S 
RCH21 R I 
R; resistant, the tested strain was able to grow on concentrations up to 30 !-tg/ml of the 
antibiotic, S; susceptible, the tested strain failed to grow on 10 !-tg/ml of the antibiotic, and I; 
intermediate, the tested strain grew weakly on 10 !-tg/ml of the antibiotic, while it failed to 
grow on higher concentrations. 
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3.3.4. Analysing protein profile patterns for C. condsus 
The protein profiles for the whole celllysates (WCL) of C. concisus strains were studied and 
found to be very variable, complex, and it was difficult to use these profiles for grouping the 
clinical isolates into different groups based on cellular protein patterns. Therefore the outer-
rnernbrane protein profiles were used for the initial grouping of C. concisus strains as they 
were less complex due to the selective removal of the cytoplasmic proteins, which allowed for 
clearer differentiation of the outer cell membrane proteins by SDS-PAGE analysis. The outer 
rnernbrane protein profiles (OMPs) for C. concisus isolates were also divergent. However, 
using OMP profiles, C. concisus isolates could be assigned into six main according to the 
sirnilarities between their patterns when compared with the two C. concisus reference strains 
ATCC 51561 and ATCC 51562. The OMP protein profile for the reference strain C. 
mucosalis ATCC 43264 (a closely related species), was completely different and 
demonstrated no similarity with any of the OMP profile groups of C. concisus isolates (figure 
3.2. and table 3.4.). 
Outer membrane protein profile (OMP) for the reference strain ATCC 51561 was similar to 
the profile of strain RCH14 and both were grouped together as OMP group I (figure 3.2, lanes 
3 and 16) while the OMP profile for the reference strain ATCC 51562 was different from that 
of group I strains and was classified as OMP group II with C. concisus strains RCH3, RCH4, 
RCH5, and RCH7 (figure 3.2, lanes 4, 5, 6, 7, and 9). Other strains, which shared certain 
similar OMP patterns, were grouped into OMP groups Ill, IV, and V (figure 3.2.). However, 
the OMP profile for strain RCH12 was unique and different from OMP profiles of other 
groups, and therefore was classified as OMP group VI (figure 3.2, lane 14). The percentage 
of each OMP group (%) of the total number of C. concisus isolates and isolate numbers 
belonging to each group are listed in (table 3.4.). Furthermore, the lipid-associated proteins 
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(LAP) with molecular weights under 20 kDa in all C. concisus tested isolates are clearly 
variable in their rocket-tail effect as is indicated by the black arrows in (figure 3.2), this will 
also supports the idea that C. concisus strains are divergent in their OMP profiles. 
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Table 3.4. Grouping of 21 C. concisus strains based on their SDS-PAGE profiles for outer 
membrane proteins 
OMP C. concisus clinical strains Percentage of the 
groupS total number of 
isolates 
Group I RCH14, and type strain ATCC 51561 9.52% 
Group 11 RCH3, RCH4, RCH5, RCH7, and type 23.8% 
strain ATCC 51562 
Group III RCH6, RCHll, RCH16, and RCH21 19.04% 
Group IV RCH8, RCH13 , RCH15, RCH17, and 23.8% 
RCH18 
Group V RCH9, RCHIO, RCH19, and RCH20 19.04% 
Group VI RCH12 4.76% 
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Figure 3.2. SDS-PAGE for outer membrane protein profiles (OMPs) of C. concisus strains 
visualised by Coomassie blue stain. Lanes 1 and 24, low molecular weight protein markers. 
Lane 2, OMPs for C. mucosalis ATCC 43264; lane 3, OMPs for C. concisus ATCC 51561; 
lane 4, OMPs for C. concisus ATCC 51562. Lanes 5-23 OMPs for C. concisus clinical 
isolates RCH 3-21. Black arrows indicate different visualizations of the lipid-associated 
proteins (LAP) in C. concisus isolates. 
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3.3.5. Molecular identification of C. concisus 
3.3.5.1. peR amplification of 23S rDNA 
The identity of C. concisus clinical isolates was confirmed following the method described by 
Bastyns et. al., (1995), using primers designed to amplify the 23S rDNA region. The forward 
primer MUC1 and a mixture of both reverse primers CONI and CON2 (primer mix C) were 
used to obtain a 306 bp PCR product from all C. concisus isolates including the two reference 
strains ATCC 51561 and ATCC 51562. No PCR product was detected when DNA samples 
extracted from C. mucosalis ATCC 43264, C. coli NCTC 11366, C. jejuni 81116, and C. 
hyoilei (RMIT 0032A) were used as templates for PCR amplification, confirming the 
specificity of this method. 
Furthermore, by modifying this method for PCR amplification (Bastyns et al., 1995) using 
combinations of either MUC1-CON1 (primer mix A) or MUC1-CON2 (primer mix B), it was 
possible to classify clinical C. concisus isolates from gastroenteritis cases in children into two 
molecular groups A and B. These two molecular groups were then referred to as 
genomospecies A and genomospecies B (figure 3.3.). The majority of C. concisus RCH 
isolates (15/21), including RCH 3, 4, 5, 7, 8, 9, 10, 12, 13, 15, 17, 18, 19, 20, and the type 
strain ATCC 51562, (71.4 %) produced a 306 bp PCR product when primer mix A was used 
and were assigned to genomospecies A. Whereas only five C. concisus RCH isolates (6, 11, 
14, 16, 21) and the type strain ATCC 51561 (6/21; 28.6 %) produced a 306 PCR product 
When primer mix B was used, and were assigned to genomospecies B (table 3.5). A weak 
binding (non-specific binding) with primer mix A was some times noticed in reactions at low 
annealing temperatures (5YC) for some C. concisus strains assigned to genomospecies B 
(figure 3.3 lane 7 and lane 10), and also with primer mix B for the C. mucosa lis control strain. 
However, this weak reaction could be eliminated by using higher annealing temperatures 
(60'C-65'C). 
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3.3.5.2. peR amplification of a C. concisus species'-specific O.S-kb fragment 
The method of Matsheka et al. (2001) was used more recently to confirm the identity of C. 
concisus strains used in this study. A peR product of 500 bp was detected in all tested C. 
concisus strains using DNA templates from either clean extracted chromosomal DNA (figure 
3.4.), or from boiled bacterial cells (figure 3.5.). These results confirm that all C. concisus 
isolates used in this study were previously successfully identified using both biochemical and 
molecular methods (protein profiling and 23S rDNA peR amplification). 
No peR product was detected for other Campylobacter spp. strains including the closely 
related species C. mucosalis, although, non specific binding of primers was noticed in the 
higher molecular weight region for C. mucosa lis, ATCC 43264 and at a lower molecular 
weight region for C. coli 351 strains (figure 3.5.). 
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501 
404 
331 
242 
190 
147 
110 
M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
306 bp peR product 
Figure 3.3. PCR typing for C. cOllcisus clinical isolates showing the presence or absence of a 
306 bp peR product in different peR primer mixes. a, peR primer mix A. b, peR primer 
mix B. c, PCR primer mix C. M, pUC19/HpaII low molecular weight marker. Lanes 
numbered 1-3 are for strain RCH3, 4-6 for RCH5, 7-9 for RCH6, 10-12 for ATCC 51561 and 
13-15 for ATCC 51562. PCR products in (a) indicating strains from molecular group A, 
while a PCR product in (b) indicates molecular group B strains. 
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Tablc 3.5. Molecular grouping of C. concisus clinical isolates based on PCR amplification of 
the 23S rDNA region, also indicating the OMP profiles grouping of these clinical isolates by 
SDS-PAGE analysis. 
-C concisus peR product PCR product 23S rDNA OMP profiles 
strains with mix A with mixB PCR grouping grouping 
-ATCC 51561 + B I 
ATCC 51562 + A 11 
RCH3 + A 11 
RCH4 + A 11 
RCH5 + A 11 
RCH6 + B III 
RCH7 + A 11 
RCH8 + A IV 
RCH9 + A V 
RCHlO + A V 
RCH11 -L B III I 
RCH12 + A VI 
RCH13 + A IV 
RCH14 + B I 
RCH15 + A IV 
RCH16 + B III 
RCH17 + A IV 
RCH18 + A IV 
RCH19 + A V 
RCH20 + A V 
RCH21 + B III 
125 
kb 
11.5 
5.1 
2.5 
1.99 
1.16 
0.8 
0.51 
M 1 2 3 4 5 6 7 8 9 10 
500 bp PCR product 
Figure 3.4. PCR amplification of the specific O.5-kb HindlII fragment in C. concisus isolates 
and other Campylobacter sp. strains using purified DNA templates from C. concisus strains 
ATCC 51561, ATCC 51562, RCH3,RCH4, RCH5, RCH6, and RCH7 in lanes 1-7. Lanes 8, 
9 and 10 DNA templates from C. jejuni 007, C. jejuni 108 and C. coli CSIRO 15. A PCR 
product of 500 bp was visualised on the ethidium bromide stained gel for all C. concisus 
samples while no product was detected for isolates of other Campylobacter spp. M· ,
lambda/Pst I marker. 
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Figure 3.5. PCR amplification of the 0.5-kb HindIII fragment in C. concisus isolates and 
other Campylobacter sp. strains, using DNA templates extracted from boiled cells. M' ,
lambda/ Pst I marker, lanes 1-8; C. concisus isolates RCH8- RCH15. Lane 9; C. mucosalis 
ATCC 43264, lane 10; C. coli 351 and lane 11; C. jejuni 81116. PCR products were 
produced using templates from all C. concisus strains used, while non specific binding with 
no clear PCR product was noticed for isolates of other Campylobacter spp. 
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3.4. Discussion 
The C. concisus species as presently defined as both genomically and phenotypically diverse 
and can be regarded as a complex of isolates. Therefore phenotypic identification can be both 
challenging and misleading because of the fastidious growth requirements, the asaccharolytic 
nature and possession of few distinguishing biochemical characteristics of the isolates 
(Vandamme, et al., 1989; On, 1994). 
All C. concisus clinical isolates tested in this study were fastidious, Gram negative, slightly 
curved, motile microorganisms. They were positive for oxidase, negative for catalase, and 
were able to grow at 42OC, yet, they differed in their ability to grow on MacConkey agar 
(MCA) and produce H2S on Kligler iron agar (KIA). C. concisus strains are known to grow 
at 42°C, have oxidase and nitrate reduction activities, but they neither ferment carbohydrates 
nor produce the catalase enzyme. The low biochemical activity of C. concisus, makes it hard 
for identification by conventional phenotypic techniques (Matsheka et al., 2001). However, 
On (1994) has used phenotypic characterisation (based on 64 phenotypic characters), to 
positively differentiate two C. concisus isolates, which were previously misidentified as C. 
mucosa lis by the API Campy identification system (Figura et al., 1993). 
Most clinical C. concisus isolates grew weakly on Skirrows medium and required an 
incubation periods of 3-5 days at 37°C in a hydrogen-enriched micro aerobic atmosphere. The 
antibiotic resistance pattern for C. concisus RCH isolates on HBA media supplemented with 
30 J..Lg/ml of nalidixic acid was consistent with all 21 tested strains demonstrating resistance to 
this antibiotic. In contrast, only three strains were resistant to 30 J..Lg/ml cephalothin while 18 
strains were susceptible to this antibiotic. In general Campylobacter spp. other than C. jejuni, 
C. coli, and C. lari are sensitive to the antibiotics used in most conventional selective media, 
such as cephalothin, colistin, and polymyxin B. Hence, as most diagnostic laboratories are 
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not using optimal isolation techniques, Campylobacter spp. other than C. jefuni/coli, are 
undoubtedly being under diagnosed as causes of gastrointestinal disorders, as a consequence 
of inappropriate isolation and identification methods (Engberg et al., 2000). 
The outer membrane proteins (OMPs) of Gram-negative bacteria are the interface between the 
pathogen and the host and could play an important role in pathogenesis. These proteins are 
subject to different selection pressures and exhibit varying degrees of inter-strain 
heterogeneity that can be used to assess intra-species diversity and determine the 
epidemiological relationships (Dabo et aI., 1997; Lin et al., 2002). In this study six different 
OMP protein profile patterns (table 3.4; Figure 3.2) were detected using SDS-PAGE analysis, 
but we could not establish any correlation between the OMP profiles groups, and the 
antibiotic resistant patterns of C. concisus against cephalothin or nalidixic acid (tables 3.3 and 
3.4). Although the OMP protein profiles of C. concisus RCH clinical isolates and of C. 
concisus type strains are not similar (heterogenic) in general, they are easily distinguishable 
from the profile of the C. mucosa lis reference strain. These results indicate the heterogeneity 
of these C. concisus strains isolated from cases of gastroenteritis at the Royal Children's 
Hospital in Melbourne. Aabenhus et al. (2002b) identified and differentiated C. concisus 
isolates from immunocompromised patients with diarrhoea, into two main groups depending 
on the protein profile patterns of whole celllysates, with 85% of the isolates found to be from 
the same group, which supports the complex nature of this species. Moreover, heterogeneity 
of OMP protein profiles has been recently reported in Pasteurella multocida isolates (Davies 
et al., 2004). Thirteen distinct OMP profiles (OMP types) for this species, were identified 
mainly by molecular mass heterogeneity of the heat modifiable (OmpA) and porin (OmpH) 
proteins, with differences in 20-30 minor proteins. Moreover, 85% of the isolates were 
shown to be represented by five OMP types with 39% of the isolates belonging to a single 
OMP type. The researchers also indicated that there was no correlation between the OMP-
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type and disease status (i.e. pneumonia or mastitis), or between OMP-type and geographic 
origin (Davies et al., 2004). 
Molecular methods based on PCR amplification can provide an alternative to culture methods 
for the detection of Campylobacter in clinical specimens. The application of PCR-based 
assays to detect Campylobacter species in clinical and food samples have been previously 
reported by different research groups (Maher et al., 2003). These reports described 
amplification of a number of DNA targets including the campylobacter flagellin gene, 16S 
rRNA, and the 16S/23S rRNA intergenic spacer region (Giesendorf and Quint, 1995; Lawson 
et al., 1999; Collins et al., 2001). Furthermore, molecular identification and typing of C. 
concisus isolates has shown this species to be a complex species, which represents a 
taxonomic 'continuum', comprising several genomospecies (Matsheka et. al., 2002). 
Immunodiffusion analysis (Vandamme et al., 1989) and numerical analysis of AFLP profiles 
(On & Harrington, 2000) have also indicated the presence of two distinct molecular groups 
(genomospecies ). 
In this study the classification of the C. concisus RCH clinical isolates and the two type 
strains into two molecular groups (genomospecies), was successfully achieved by modifying 
the method for PCR amplification of the 23S rDNA region (Bastyns et al., 1995) and using 
combinations of either MUC1-CONl or MUC1-CON2 (figure 3.3. and table 3.5), where the 
majority (around 71%) of the isolates, 15/21 including the type strain ATCC 51562, were 
grouped in molecular group A (genomospecies A), while only 5 isolates and the type strain 
ATCC 51561 (around 29%) were grouped in molecular group B (genomospecies B). 
Interestingly, the sequences of the two reverse primers, CON 1 and CON2, are significantly 
different, yet yield a similar sized PCR fragment (306 bp), indicating a significant genomic 
difference in the 23S rDNA sequence between the two genomospecies groups. However, at 
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low annealing temperatures (55°C), there was a weak binding (light PCR product) with primer 
mix B for the C. mucosalis control strain, which was eliminated by using higher annealing 
temperatures (60°C-65°C). This was also reported by Engberg, et al. (2000) as a 308 bp PCR 
product was also obtained from Campylobacter showae and from Wolinella succenogenes in 
preliminary set up experiments when a mixture of the two reverse primers (CON1 +CON2) 
was used to amplify the specific 23S rDNA fragment in C. concisus isolates from Denmark 
(Bastyns et al., 1995; Engberg, et al., 2000). 
The majority of PCR group B strains showed an identical OMP profile pattern (Figure 3.2, 
lanes 8, 13, 18, and 23) except for the type strain ATCC 51561 and strain RCH 14 which 
appear to be missing major outer-membrane polypeptide bands in the 43 kDa region (Figure 
3.2, lanes 3 and 16 respectively). Therefore, by adding up the two strains from OMP group I 
(9.52%) and the four strains from OMP group In (19.04%), the final percentage of 28.56% is 
close to the percentage of 28.6% for the isolates assigned to PCR group B (genomospecies B), 
which was achieved in this study by modifying the PCR grouping method which was based 
on the amplification of the 23S rDNA region in C. concisus by Bastyns et al., (1995). 
Whereas isolates assigned to genomospecies A demonstrated more diversity in their SDS-
PAGE outer membrane protein profile patterns (Figure 3.2, lanes 4-7, 9-12, 14-15, 17, 19-22), 
yet, the total number of strains assigned to OMP profile groups n, IV, V, and VI (15/21) with 
a total percentage of (71.36%) is similar to the number and percentage of (71.4%), for the 
tested C. concisus strains which were assigned to PCR group A (genomospecies A). 
To further confirm the identity of C. COl1nsus RCH strains, the method described by 
Matsheka et al., (2001) was applied to all C. concisus strains used in this study as well as to 
other Campylobacter spp. isolates. The detection of a 0.5 kb C. concisus species-specific 
PCR product in all RCH clinical isolates confirmed the strains to be C. cOl1cisus, while no 0.5 
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kb PCR product was detected for isolates representing other Campylobacter spp. (figure 3.4) 
including the closely related species C. mucosa lis. However, some low intensity, non-specific 
binding was noticed for C. mucosalis ATCC 43264 and for C. coli 351 indicating less 
sensitivity, which could be due to some sequence similarities with C. concisus in the PCR 
amplified region (figure 3.5), which could be resolved at higher stringency. Furthermore, 
when C. mucosa lis ATCC 43264 was used as a control strain in the 23S rDNA PCR 
amplification method (Bastyns et al., 1995) under low stringency (i.e. lower annealing 
temperature), a 306 bp PCR product was produced for C. mucosalis, thus confirming that 
those two species are closely related as previously indicated by other researchers (Figura et 
al., 1993; On, 1994; Lastovica et aI., 1994). 
Therefore, it can be concluded that these results support the complex nature of the C. concisus 
species by demonstrating different protein profiles within the two molecular groups 
(genomospecies) for C. concisus isolates involved in clinical cases of diarrhoea with the 
majority of cases belonging to molecular group A (genomospecies A). 
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Detection 
Chapter Four 
and Quantification of Hemolytic Activity 
Campylobacter concisus 
4.1. Introduction 
. In 
In the last decade, both cell- associated and secreted hemolytic activities, which could be 
related to pathogenicity, have been reported to be produced by some Campylobacter spp. 
such as C. coli and C. jejuni (Wassenaar, 1997; Pickett, 2000). Arimi et al. (1990) reported 
that 92.3% of C. jejuni strains and 21.7% of C. coli strains showed positive hemolytic 
activity on sheep blood agar plates after incubation at 42Co for 4 days under microaerophilic 
conditions, while the same strains were nonhemolytic on plates incubated at 37 Co. Later, 
Pickett et aI., (1992), used the contact hemolysin to detect hemolytic activity from several C. 
jejuni strains that did not appear hemolytic when plated on blood agar media. This hemolytic 
activity in C. jejuni and other Campylobacter spp. is now considered as a potential virulence 
factor for the organism and may contribute to campylobacter gastroenteritis (Tay et al., 1995; 
Misawa et al., 1995; Pickett, 2000). Furthermore, Guevremont et aI., (2004) reported that 
hemolytic activity was detected in 71 % of Campylobacter spp. isolated from sporadic cases 
of human diarrhoea and in 63% of Campylobacter spp. strains isolated from swine cecal 
contents, during the same period in the same geographical area. However, enterotoxin 
production was not detected from any of those isolates (Guevremont et aI., 2004). 
Secreted hemolytic activity has been reported in culture filtrates of C. jejuni isolates 
(McCardell et al., 1986; Hossain et al., 1993), however, the characterisation of these 
activities is still preliminary as there are no reports identifying any likely hemolysin genes 
from C. jejuni (Pickett, 2000). 
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Growth of C. concisus RCH strains on blood agar plates, produced clear hemolytic zones E~­
hemolysis) or greenish hemolytic zones (a-hemolysis) under the colonies, especially in aging 
cultures (Istivan et al., 1998). This observation suggested the possible presence of a cell-
associated hemolytic activity in C. concisus strains isolated from children with symptoms of 
mild to severe bloody diarrhoea. Therefore, investigations were undertaken on the presence 
of cell-associated or secreted hemolytic activity in C. concisus RCH clinical isolates and the 
most suitable methods for detecting and quantifying this activity. This investigation was 
undertaken to determine if this hemolytic activity could be an indication for the possible 
pathogenic role of C. concisus in gastroenteritis. 
The experimentation undertaken in this chapter were to determine: 
• The presence of hemolytic activity in C. concisus clinical and type strains on 
different types of blood erythrocytes, by using different hemolysin assays for 
detecting cell-associated and secreted hemolytic activities. 
• Quantitative detection of hemolytic activity in C. concisus bacterial cells (cell-
bound) and culture filtrates (secreted) from various clinical isolates. 
• The influence of iron limitation on the hemolytic activity of bacterial cells and 
culture filtrates grown under iron-restricted conditions. 
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4.2. Materials and Methods 
4.2.1. Collection of blood and preparation of erythrocyte suspensions 
Erythrocytes from human, rabbit, sheep, cattle, horse, rat, and chicken were used to study the 
hemolytic effect of C. concisus bacterial cells or culture filtrates, on blood erythrocytes, by 
the blood agar diffusion assay (see section 4.2.2.1) and later for the quantitative detection of 
hemolytic activity by the contact or liquid hemolysin assays (see section 4.2.3). Defibrinated 
blood was collected in Alsever's solution and was kept at 4°C for 2-5 days (2.2.3.). After the 
red blood cells pellet was collected it was washed three times in PBS and used to prepare 
10% (v/v) blood agar plates for the diffusion assay as described in 2.3.2. For the quantitative 
detection of hemolytic activity, 2% (v/v) erythrocyte suspensions in PBS were freshly 
prepared daily from the different species (types) of blood as described in 2.4.2, to be used in 
the contact and the liquid hemolysin assays, as described in 2.4.3 and 2.4.4 respectively. 
4.2.2. Evaluation of methods for detecting hemolytic activity 
4.2.2.1. Blood agar diffusion assay 
The presence of cell-bound hemolysin(s) was determined by adding a 100 III aliquot of C. 
concisus cell suspension (109 cfu) in PBS for each tested strain separately to wells in blood 
agar plates prepared as described in 2.4.1. The presence of any secreted hemolysins was 
determined by adding a 100 III aliquot of C. concisus broth culture supernatants (S) filtered 
through 0.221lm syringe filters to the wells in blood agar. Moreover, culture filtrates (F) and 
retentates (R), obtained by subjecting culture supernatants (S) to an ultra-filtration process 
USing an ultrafiltration unit with a 10,000 MW cut off YM filter were also examined for the 
presence of secreted hemolytic activity by this method. Negative controls of a similar 
volume (100 Ill) of PBS and uninoculated broth were also added in wells on the blood agar 
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medium. All 19 RCH isolates and two C. concisus reference strains were tested for 
hemolysis using different types of blood (horse, sheep, rabbit, and chicken erythrocytes). 
Plates were incubated at 37 OC in microaerophilic conditions for 2-4 days as described in 
2.3.4. Moreover, samples from all culture supernatants (S), retentates (R), and filtrates (F) 
used in this assay and other hemolysis assays, were incubated separately under similar 
conditions (2.3.4.) to confirm that those filtrates were free from contaminating bacterial cells. 
After incubation, all plates were examined for the presence of a greenish (a) or clear E~) 
hemolytic zone around the well which was considered as a positive result. The diameters of 
the hemolytic zones were also an indication for the amount of hemolysin produced by the 
tested strain on a certain type of blood. All samples were tested in triplicate. 
4.2.2.2. Microtitre plate hemolysin assay 
Hemolytic activity for C. concisus bacterial suspensions and culture filtrates were tested 
using sheep, rabbit, and chicken erythrocytes. Brucella broth cultures were centrifuged at 
3000 xg to pellet the bacterial cells. The cell pellet was then washed three times in PBS 
before preparation of 1010 cfu/ml bacterIal suspensions in PBS. All broth supernatants (S), 
filtered through MK22~m syringe filters, were subjected to an ultra-filtration process using an 
ultrafiltration unit (Amicon) with a 10,000 MW cut off YM filter. The filtrates (F) and the 
retentates (R) were then tested for hemolytic activity using the V -bottomed micro titre plates 
as described in 2.4.5. Bacterial suspensions and broth culture supernatants from other 
Campylobacter spp. were also tested in this assay. Negative controls of PBS and 
uninoculated broth were also used and culture filtrates were tested for sterility as described in 
4.2.2.1. All samples were tested in duplicate. 
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4.2.3. Quantitative detection of hemolytic activity in C. concisus strains 
4.2.3.1. Contact hemolysin assay (using bacterial cells). 
109 cfu cell suspensions in PBS from all 19 RCH C. concisus isolates (RCH 3-21) and the 
two reference strains ATCC 51561 and ATCC 51562 strains, prepared as described in 2.4.2, 
were tested for the level of their hemolytic activity (as a percentage of complete erythrocyte 
lysis), using the method described in 2.4.3. Other Campylobacter spp. strains were also 
tested including, C. mucosalis ATCC 43264, C. coli 351, C. coli NCTC 11366 and C. jejuni 
81116. 2% (v/v) erythrocytes in PBS were freshly prepared for each type of blood then 
added to an equal volume of the bacterial suspension and assayed as described in 2.4.3. 
Negative (No hemolysis) controls of 1 % (v/v) erythrocytes in PBS and 1 % (v/v) erythrocytes 
in distilled water (complete lysis) were also prepared for each type of blood. All samples 
were tested in duplicate. 
4.2.3.2. Liquid hemolysin assay (using C. concisus culture filtrates). 
All C. concisus strains were grown in Brucella broth containing 2% (w/v) yeast extract as 
described in 2.3.4. The cell density was then estimated after 48-72 hours of incubation as 
described in 2.3.6. Broth cultures were centrifuged at 3000 xg to pellet the bacterial cells and 
the supernatants were then filtered through 0.22!-!m syringe filters. The filtered supernatants 
(S) were then subjected to an ultra filtration process using an amicon ultrafiltration unit with 
a 10,000 MW cut off YM amicon filter. The filtrates (F) and the retentates (R) were then 
tested for hemolytic activity on human, rabbit, sheep, and chicken erythrocytes, as described 
in 2.4.4. Negative controls of uninoculated brucella broth containing 2% (w/v) yeast extract 
were also used in each assay. Furthermore, all filtrates and retentates were tested for sterility 
as described in 4.2.2.1. to ensure that they are free from any bacterial cells. 
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4.2.4. The influence of iron limitation on hemolytic activity 
Iron depleted conditions were generated in liquid cultures by adding different concentrations 
of the iron chelator EDDA to C. concisus growth medium. A 2S mg/ml stock solution of 
EDDA was prepared by dissolving 2SO mg of EDDA in 1 ml of SN NaOH (sodium 
hydroxide), the pH was then adjusted to be between 7-8 with SM HCI (hydrochloric acid), 
before making it up to a final volume of 10 ml with distilled water. The 25 mg/ml EDDA 
stock was dispensed into small tubes and kept at -20 OC. The effect of four different 
concentrations (12.5ftg/ml, 2Sftg/ml, 50ftg!ml, and 100ftg/ml) of EDDA on hemolytic 
activity of C. concisus strains was studied as follows: EDDA stock solution was added to 
Brucella broth supplemented with 2% (w/v) yeast extract to achieve the final four different 
levels of iron restricted conditions in the growth medium. The batches of broth with EDDA 
were named as EDDA 12.S, EDDA 2S, EDDA SO, and EDDA 100. Three millilitres of each 
batch of the broth with EDDA were then inoculated with 1ml of 109 cfu of a 2 days old C. 
concisus broth culture grown as described in 2.3.4. The iron depleted cultures were 
incubated under microaerophilic conditions at 37 QC for 18-24 hours. The cell pellets and 
culture supernatants were collected after incubation and tested for hemolytic activity on 
sheep erythrocytes, by the contact (2.4.3.) or by the liquid (2.4.4.) hemolysin assays 
respectively. Six C. concisus strains (RCH3, RCHS, RCH6, RCH8, RCHll, and RCH12) 
were tested in this method. Negative controls of aliquots with similar concentrations of 
EDDA (12.Sftg/ml, 2Sftg/ml, 50ftg/ml, and 100ftg/ml) in uninoculated brucella broth were 
also used in each assay. Furthermore, all filtrates and retentates were tested for sterility as 
described in 4.2.2.1. to ensure that they are free from any bacterial cells. 
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4.3. Results 
4.3.1. Evaluation of methods used for the detection of hemolytic activity 
4.3.1.1. Blood agar diffusion assay 
Alpha (a) or beta (B) hemolytic activity for bacterial suspensions was detected on human, 
sheep, rabbit, or chicken blood agar, for only 9 of the 21 C. concisus tested strains, using the 
diffusion method described in (4.2.2.1). Therefore these strains were assigned into 3 groups 
depending on their hemolysis pattern on the different types of blood (table 4.1). Group I 
included 6 strains producing B-hemolytic zones on rabbit, human and chicken blood agar 
plates, and a-hemolytic zones on sheep blood agar. The second group (group II) included 3 
strains, which have the same hemolytic pattern as group I strains on human, rabbit, and sheep 
blood but they were non-hemolytic on chicken blood even after 3 days of incubation. Group 
II strains were also found to be resistant to 30 flg/ml cephalothin (See chapter 3; table 3.3). 
The strains in group III (12 isolates) did not show any hemolytic activity on any type of 
blood agar as compared to groups I and II (table 4.1). Horse blood was not suitable for 
testing the hemolytic patterns of C. concisus strains (a or B hemolysis patterns) because of 
the variability of hemolysis patterns that were obtained for these isolates. Therefore, the 
results for hemolysis on horse blood were not included in table 4.1. 
Hemolytic activity was also detected when culture supernatants (S) and culture retentates (R) 
from some C. concisus strains were tested using the blood agar diffusion assay (4.2.2.1.) to 
determine if hemolysis was due to secreted proteins. Supernatants and retentates from strains 
assigned to hemolytic groups I and II (table 4.1) showed variation in hemolytic activity by 
blood agar diffusion method, while the culture filtrates (F) from all C. concisus tested strains 
did not show any hemolytic activity except for the filtrates from strain RCH 12 which gave 
clear and wide B-hemolytic zones when tested on chicken blood agar as indicated in the 
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diagram in figure 4.1. The sterility of culture supernatants, culture retentates and filtrates 
was confirmed by the absence of any turbidity (bacterial growth) in the incubated control 
samples. 
4.3.1.2. Microtitre plate assay 
Hemolytic activity was detected in culture supernatants, culture retentates and culture 
filtrates from different C. concisus strains which were assigned to hemolytic groups I and II 
(table 4.1), with higher levels (rates) of hemolysis occurring in group I strains, as compared 
to no hemolysis negative controls and complete lysis positive controls used in each assay 
(figure 4.2). Hemolytic activity was also detected in all tested C. concisus bacterial cells 
using different types of blood erythrocytes by the microtitre plate assay, with human 
erythrocytes and rabbit erythrocytes giving higher rates (levels) of hemolysis as compared to 
sheep, chicken, and horse erythrocytes (table 4.2). 
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Table 4.1. Hemolysis patterns of C. concisus strains by the blood agar plate method using 
109 cful ml bacterial cell suspensions in PES. 
C. concisus Hemolysis Hemolysis Hemolysis Hemolysis 
hemolytic on human on rabbit on sheep on chicken 
group blood agar blood agar blood agar blood agar 
Group I p Il a Il 
RCH3 
RCH5 
RCH12 
RCH15 
RCH19 
ATCC51562 
Group 11 p P a -ye 
RCH6 
RCH7 
RCHll 
Group III -ye -ye -ye -ye 
RCH4 
RCH8 
RCH9 
RCH10 
RCH13 
RCH14 
RCH16 
RCH17 
RCH18 
RCH20 
RCH21 
ATCC51561 
a; greenish zone ofhemolysis around the wells in the blood agar plate. 
P; clear hemolytic zones around the wells. 
-ye; no hemolysis 
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Figure 4.2. Detection of hemolytic activity on sheep RBCs in culture retaintates (R) from 
Brucella broth culture for C. concisus strain RCH12 in A, and RCH13 in B. Four two fold 
dilutions in PBS for each retaintate were prepared as 1:2 in well 1, 1:4 in well 2, 1:8 in well 
3, and 1:16 in well 4. No hemolysis (negative) control for sheep erythrocytes in PBS in wells 
Cl & C2, and complete erythrocyte lysis (positive) control in wells C3 & C4. Photographs 
were taken after 16 h incubation at 37 DC. 
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Table 4. 2. Hemolytic titres for C. concisus bacterial cells using different types of blood by 
the micro titre plate assay. 1:4, 1:8, and 1:16 are the two fold ,dilutions prepared of 1010 cfu in 
PBS in the v-bottom microtitre plate. Erythrocytes were added to each well before 
incubation, then the highest dilution for hemolytic activity was recorded for each isolate. 
C. concisus Human Rabbit Sheep Chicken Horse 
strains RBCs RBCs RBCs RBCs RBCs 
ATCC51561 1:8 1:8 1:8 1:4 1:8 
ATCC51562 1:16 1:16 1:16 1:8 1:16 
RCH3 1:16 1:16 1:16 1:16 1:16 
RCH4 1:8 1:16 1:8 1:4 1:8 
RCH5 1:16 1:16 1:16 1:16 1:16 
RCH6 1:16 1:16 1:8 1:8 1:8 
RCH7 1:16 1:16 1:16 1:8 1:8 
RCH8 1:8 1:8 1:8 1:8 1:8 
RCH9 1:16 1:16 1:8 1:8 1:16 
RCHI0 1:16 1:16 1:8 1:8 1:8 
RCHll 1:16 1:16 1:16 1:4 1:16 
RCH12 1:16 1:16 1:16 1:16 1:16 
RCH13 1:16 1:16 1:8 1:4 1:4 
RCH14 1:8 1:8 1:8 1:4 1:8 
RCH15 1:16 1:16 1:16 1:16 1:16 
RCH16 1:8 1:16 1:8 1:8 1:8 
RCH17 1:16 1:16 1:8 1:8 1:8 
RCH18 1:8 1:8 1:8 1:4 1:4 
RCH19 1:16 1:16 1:16 1:16 1:4 
RCH20 1:16 1:16 1:8 1:8 1:8 
RCH21 1:8 1:16 1:8 1:8 1:16 
RBCs; red blood cells (erythrocytes) 
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4.3.2. Quantitative detection of hemolytic activity in C. concisus 
4.3.2.1. Contact hemolysin assay (for cell-bound hemolysins) 
Variable levels of hemolysis (percentage of lysed erythrocytes in the tested sample compared 
to complete blood lysis positive controls) were detected in all C. concisus and other 
Campylobacter spp. tested strains. Human and. rabbit erythrocytes were more sensitive to 
hemolysis (producing higher hemolytic rates) for all Campylobacter spp. strains tested as 
compared with sheep, horse, and chicken erythrocytes (figure 4.3). 
4.3.2.2. Liquid hemolysin assay (for secreted hemolysins) 
Secreted hemolytic activity was detected in C. concisus culture supernatants (S), and 
retentates (R), yet with lower hemolytic rates as compared to the cell associated hemolytic 
activity detected in bacterial cells by the contact hemolysin assay (figures 4.3 and 4.4). This 
hemolysin expressed similar levels of hemolysis on most types of erythrocytes used in the 
hemolysin assay. More stable hemolysis was obtained when chicken or sheep erythrocytes 
were used for the liquid hemolysis assay (figure 4.4). However, hemolysis rates for 
supernatants and retentates were unstable and variable for the same strain when tested at 
different times after extraction and also from cultures at different growth rates. Most strains 
lacked hemolytic activity when their culture filtrates (F) were tested except for C. concisus 
strain RCH 12 as various levels of hemolytic activity were constantly detected in culture 
filtrates (F) from this strain on blood agar plates (see section 4.3.1.1.) and by the liquid 
hemolysin assay (Figure 4.4). 
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4.3.3. The influence of iron limitation on hemolytic activity of C. concisus 
The influence of iron restriction on hemolytic activity of C. concisus was determined. 
Hemolytic levels of bacterial cells grown in brucella broth in the presence of 12.5 f-tg/ml 
EDDA, were approximately 10% higher than the hemolytic levels of cells grown under 
normal conditions (without the presence of the iron chelator EDDA) when tested by the 
contact hemolysin assay on sheep erythrocytes (Figure 4.5). However, the hemolytic activity 
decreased for C. concisus bacterial cells grown at EDDA concentrations higher than 12.5 
t-tg/ml in the growth medium. Hemolysis levels of these cells was reduced from 80% at 12.5 
t-tg/ml EDDA to approximately 30% at 100 [tg/ml EDDA for most of the C. concisus tested 
strains (figure 4.5), which can be explained by the inhibitory effect of EDDA concentrations 
higher than 12.5 !-tg/ml, on the growth or on hemolysin production of C. concisus bacterial 
cells. A similar effect was also detected when the culture supernatants from the previous 
cultures were tested for hemolytic activity on sheep erythrocytes by the liquid hemolysin 
assay (figure 4.6.). No lytic effect was detected for the different EDDA concentrations used 
in C. concisus growth medium on blood erythrocytes, as negative controls were examined by 
incubating uncultured Brucella broth containing similar EDDA concentrations with blood 
erythrocytes for the liquid hemolysin assay. The results from both the contact and the liquid 
hemolysin assays indicated that iron deficiency in the growth medium can enhance (to some 
extent) both secreted and cell-bound hemolysins in C. concisus clinical strains. 
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4.4. Discussion 
In this study, hemolytic activity in C. concisus clinical strains and other Campylobacter spp. 
strains was tested by more than one of the hemolysis assays using a series of different blood 
erythrocytes (human, horse, sheep, rabbit, and chicken erythrocytes), to determine the 
interaction of the hemolysin(s) with the different membrane composition of those 
erythrocytes. Many C. concisus strains were hemolytic on blood agar plates, with some 
strains being more hemolytic than others on certain types of blood agar plates (table 4.1). 
Furthermore, it was not possible to relate the hemolytic patterns of the C. concisus strains on 
blood agar plates to their protein profile or to their PCR grouping (chapter 3). However the 
hemolytic group I strains were all from genomospecies A, while both groups Il and III 
contained strains assigned to genomospecies A and B. Results obtained from different 
studies have shown that some factors affect hemolytic activity in Campylobacter spp. such as 
certain media and atmosphere conditions. Moreover, the detection of hemolytic activity, was 
better observed on aging cultures suggesting that it could be an intracellular component that 
is released or exposed when bacteria die and lyse (Arimi et al., 1990; Misawa et al., 1995). 
When the micro titre plate assay was used to detect hemolytic activity in C. concisus bacterial 
cells, the highest levels (titres) of hemolytic activity were detected from strains ATCC 
51562, RCH3, RCH5, RCH7, RCH12, RCH12, RCH15, and RCH19, followed by strains 
RCH6, RCH9, and RCHll (table 4.2), all these strains were previously assigned to 
hemolytic groups, I and Il (table 4.1). Furthermore, lower levels hemolytic activity were also 
detected in bacterial cells from group III strains which were not hemolytic when previously 
tested on blood agar (Tables 4.1 and 4.2). C. concisus strains RCH4, RCH8, RCH14, RCH 
16, RCH 18, and ATCC 51561 produced the lowest hemolysis levels when compared to 
strains from the same group (Ill) and to strains from groups I and Il. When hemolytic levels 
(titres) on different types of blood erythrocytes were compared, higher levels (titres) for 
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hemolysis were detected on human and rabbit erythrocytes when compared to sheep, chicken 
and horse blood from all tested strains (table 4.2). These results indicate that the microtitre 
plate assay is more sensitive than the blood agar diffusion method to test for hemolytic 
activity, and that human and rabbit erythrocytes are more sensitive to C. concisus 
hemolysin(s). The species specificity of red blood cells hemolysis and the difference in the 
hemolytic activity levels for different Campylobacter spp. strains on various blood 
erythrocytes has been previously reported for C. jejuni (Hossain et al., 1993), and H. pylori 
(Drazek et al., 1995). Similarly, Tay et al., (1995) have reported clear hemolytic zones in 
56% of C. jejuni clinical isolates in blood agar plates. They also reported a quantitative 
identification of cell-associated, hemolytic activity in 94% of C. jejuni isolates in a low titre, 
ranging from 1-64, by using the microplate technique. 
Hemolytic activity was detected in all the 19 C. concisus RCH isolates and the two reference 
strains ATCC 51561 and ATCC 51562 by using both the contact hemolysin assay and the 
liquid hemolysin assay (figures 4.3 and 4.4). The modified contact hemolysin assay was also 
found to be more sensitive for detecting hemolytic activity in C. concisus and other 
Campylobacter spp. strains, as variable levels of hemolysis were detected from all tested 
strains on different types of blood erythrocytes with human and rabbit erythrocytes producing 
higher hemolytic rates for all Campylobacter spp. tested strains as compared with sheep, 
horse, and chicken erythrocytes (figure 4.3). Higher rates of hemolysis were detected for the 
hemolytic groups I and Il strains as compared with hemolysis rates for the group III strains. 
The results from the contact hemolysin assay are similar to those obtained by the microtitre 
plate assay for C. concisus isolates. Furthermore, the hemolysis rates (values) for C. jejuni 
81116 and for C. coli 351 when tested by the contact and the liquid hemolysin assays were 
similar to the hemolysis rates (values) for the C. COl1cisus hemolytic group Il strains (figure 
4.3). This was not unexpected as Pickett et al. (1992), demonstrated that several C. jejuni 
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strains which did not appear hemolytic when plated on blood agar media, were hemolytic 
when tested by the contact hemolysin assay and that hemolysin production was strain 
dependent. Moreover, various levels of hemolytic activity were constantly detected in 
culture filtrates (F) from C. concisus strain RCH 12 on blood agar plates (see section 4.3.1.1.) 
and also by the liquid hemolysin assay, indicating the possible presence of a secreted 
hemolysin with a molecular mass smaller than 10,000 kDa. It is possible that this type of 
hemolytic activity is a consequence of the action of one of the hemolytic cytotoxins possibly 
produced by C. concisus, as has been suggested for similar hemolytic activity in C. jejuni 
(Pickett, 2000). 
It could be suggested from the results of both the contact and the liquid hemolysin assays that 
there might be more than one hemolysin produced by the C. concisus RCH isolates. A stable 
cell-associated hemolysin which is enhanced in older cultures was detected at various levels 
in all isolates with human and rabbit erythrocytes being more susceptible than the 
erythrocytes of other species used in the assay (table 4.2 and figure 4.3). The secreted type 
of hemolytic activity was only detected in fresh C. concisus culture supernatant and culture 
retentates and could be regarded as a non-consistent, secreted hemolysin which is produced 
at earlier stages of the bacterial growth. This secreted hemolysin expressed less differential 
action on the different types (species) of blood erythrocytes. However more consistent 
hemolysis patterns were obtained when chicken or sheep erythrocytes were used for the 
liquid hemolysis assay (figure 4.4). 
Both heat-labile and heat-stable hemolytic activities have been reported in culture filtrates of 
C. jejuni isolates (Hossain et al., 1993). Similarly the hemolysin showed a spectrum of 
activity against erythrocytes from different animals with rabbit erythrocytes being the most 
susceptible (producing the highest hemolytic titers) and chicken erythrocytes being the least 
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susceptible to the hemolysin. However this pattern was obtained in C. concisus for the cell-
bound but not for the secreted hemolysin. Interestingly, Misawa et al. (1995) reported that 
hemolytic activity of C. jejuni on blood agar medium was not influenced by the species of 
blood, yet they also indicated that human and rabbit erythrocytes were more suitable for the 
detection of a-hemolysis on blood agar plates. This differential action of the hemolysin on 
erythrocytes from different species could be explained by the difference in the lipid 
composition of the erythrocytes cell membranes from different species (Voelker, 1996), 
which might be affected by the membrane-hemolysin interaction. 
Iron is an essential element for all living organisms including pathogenic bacteria, which 
obtain iron throughout the process of infection. The restriction of free iron by mammalian 
hosts is a non-specific defense mechanism therefore bacterial pathogens have evolved 
systems to obtain free iron during infection (Payne and Finkelstein, 1978). Hemolysins and 
siderophores have been implicated as virulence factors in several bacterial species, which 
appear to function by increasing the availability of iron to the pathogen. Siderophores 
usually act similarly to chelators by directly removing the extracellular, transferrin-bound 
iron, while hemolysins can increase the level of available iron in the host via lysis of 
erythrocytes and subsequent release of heme from hemoglobin (Stoebner and Payne, 1988). 
Iron limitation has a detectable effect on hemolytic activity of C. concisus strains when 
comparable amounts of C. concisus cells grown under varying iron limitation conditions 
Were assayed for hemolysis. Growth of C. concisus in an iron-deprived medium showed a 
significant elevation in hemolysis levels in cultures containing <25 [lg/ml EDDA compared 
to Brucella broth cultures grown without EDDA or to those containing higher concentrations 
of EDDA (Figures 4.5 and 4.6). This could be explained by the fact that hemolysin 
production in C. concisus was enhanced when iron was restricted in the growth medium. 
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However, higher concentrations of the iron chelator in the growth medium (>25 [!g/ml 
EDDA) slowed the growth rate of the cultured bacteria and affected hemolysin production as 
only small pellets of bacterial cells were collected from cultures containing 50[!g/ml EDDA, 
and the growth was almost completely inhibited at 100[!g/ml EDDA. In a related study 
(Smith et al., 1998) growth of C. hyoilei strain RMIT 0032A under a similar iron depleted 
conditions, was stronger than that of C. concisus strains, moreover the patterns of hemolytic 
activity of C. hyoilei bacterial cells and culture supernatants grown under similar conditions 
were different, as hemolysis rates were consistent when both the contact and the liquid 
hemolysin assays were applied on cultures grown without EDDA and in the presence of 12.5 
[!g/ml EDDA. The hemolytic rate for C. hyoilei bacterial cells only increased at EDDA 
concentrations> 12.5 [!g/ml, while the hemolytic activity of the culture supernatants was not 
affected. Moreover, low levels of hemolysis were also measured in cells and culture 
supernatants grown in the presence of 100 ~g/ml EDDA (Smith et al., 1998). This may be 
explained by the presence of different types of iron regulated protein hemolysins in these 
Campylobacter species. 
Other researchers have shown similar effects for iron restriction on hemolysin production, as 
hemolysin synthesis reported to be regulated by iron in the Gram negative pathogens, E. coli 
(Waalwijk et ai., 1983), Vibrio cholerae (Stoebner & Payne, 1988), and C. jejuni (Hossain et 
al., 1993). Furthermore, Hossain et al. (1993) indicated that the hemolysins produced by C. 
jejuni may be involved in iron acquisition in vivo, although Pickett et ai. (1992) reported that 
hemolytic activity in C. jejuni did not appear to be iron regulated. The protein profiles 
expressed by Campylobacter spp. strains grown in iron-limited environments are markedly 
different than those grown in normal conditions, with both single and two-dimentional 
electrophoresis highlighting the presence of many proteins up-regUlated by iron limitation, 
including the synthesis of envelope-associated proteins in response to iron stress (Field et ai., 
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1986; Pickett et al., 1992; Ketley, 1995; Leach, 1997). Therefore the presence of iron-
regulated hemolysin(s) in C. concisus suggests a potential role for this hemolysin(s) as a 
virulence factor in the disease caused by this microorganism. Attempts to clone a hemolysin 
gene from C. jejuni, in an expression library in E. coli have only resulted in hemolytic clones 
containing a gene encoding for a 36 kDa typical lipoprotein. However, this gene has 
sequence homology to the periplasmic-binding-protein dependent system for ferric 
siderophores, and may represent the siderophore-binding protein component of an iron 
acquisition system of C. jejuni and not a true hemolysin (Park and Richardson, 1995). 
In the previous chapter (Chapter 3) a new typing scheme for C. concisus based on protein 
profiles and on the 23S rDNA PCR amplification was established. In this chapter the 
relationship of hemolytic pattern to the phenotypic and molecular typing schemes in C. 
concisus RCH strains was evaluated. Strains which were assigned to genomospecies (PCR 
group) B showed less hemolysis in all assays, including the reference strain ATCC 51561 
and all other isolates with similar protein profiles. Conversely, strains with protein profiles 
similar to C. concisus reference strain ATCC 51562, which were also assigned to 
genomospecies (PCR group) A (see chapter 3), showed higher hemolytic activity levels 
(table 4.2; figures 4.3; and 4.4). Interestingly C. concisus strains RCH 3, RCH 6 and RCH 7, 
which were previously reported to be highly invasive by Russell and Ward (1998), were also 
strongly hemolytic when tested using the blood agar diffusion assay. Those strains also 
showed high levels of hemolysis on erythrocytes from variety of species indicating that these 
strains could represent more virulent isolates than other C. concisus RCH strains. Moreover 
other tested Campylobacter spp. strains, including C. jejuni 81116 and C. coli 351 had 
hemolysis rates similar to the hemolytic rates of C. concisus strains assigned to 
genomospecies B. As strains assigned to genomospecies A produced higher levels of 
hemolytic activity than those assigned to genomospecies B, it is possible that these 
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genomospecies A strains are more virulent than strains from other genomospecies. However, 
the clinical histories for the RCH clinical isolates did not clearly show any difference in the 
severity of the symptoms of gastroenteritis in infected children (Table 1.2). Hence, the 
presence of one or more hemolysins in C. concisus clinical isolates could be an indication for 
the possible etiologic role of these strains in gastroenteritis. 
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Chapter Five 
Extraction and Characterisation of the Cell-associated Hemolytic Activity 
in C. concisus 
5.1. Introduction 
Cell-associated hemolytic activities have been reported to be produced by some C. coli and C. 
jejuni strains which could be related to pathogenicity (Wassenaar, 1997; Pickett, 2000). 
Phospholipase A activity such as the calcium-dependent outer membrane in C. coli has been 
reported to be haemolytic on different types of erythrocytes (Grant et al., 1997). 
Phospholipids and proteins represent the major chemical constituents of the host cell 
envelope. Therefore, enzymes capable of hydrolysing these chemical classes, such as the 
membrane-damaging toxins (cytolysins), are likely to be involved in the membrane disruption 
processes that occur during host cell invasion. Consequently, a wide variety of bacteria have 
evolved enzymes (Phospholipases) capable of hydrolysing phospholipids, which are key 
components of all eukaryotic bilayer membranes (Waite, 1996; Songer, 1997). Both secreted 
and membrane-bound phospholipase A2 (PLA2) activities have been described in bacteria, 
fungi, and in protozoa. These include the extracellular PLA2 activity in two species of the 
genus Rickettsia (Rickettsia rickettsii and Rickettsia prowazekii). Ojcius et aI., (1995) found 
that this hemolytic PLA2 activity requires divalent cations (Ca2+, or Mg2+), and is enhanced by 
an acidic pH. The researchers and suggested that this activity may mediate cell host lysis, 
hence contributing to bacterial escape from early phagosomal compartments. A calcium-
dependent PLA2 is also known to facilitate host cell penetration in Toxoplasma gondii (Saffer 
et al., 1991). Moreover, cytolytic activity and virulence in Entamoeba histolytica, was 
reported to be related to a phospholipase A protein which is associated with the plasma 
membrane (Ravdin et al., 1998). 
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Membrane-bound and secreted phospholipases active against·the membranes of erythrocytes 
are wide spread among bacterial pathogens. Studies indicate that they are hemolytic and 
could be responsible for tissue damage during infection (Songer, 1997). These include the 
hemolytic phospholipase A in C. coli (Grant, et al., 1997), Yersinia enterocolitica (Schmiel et 
al., 1998), and phospholipase Al in Aeromonas species (Merino et aI., 1999). Two 
phospholipase A activities secreted by several Legionella spp. were considered as possible 
powerful agents of Legionellae in causing lung disease. These PLA activities were suggested 
to be related to destruction of lung surfactant and epithelial cells in such infections (Flieger et 
al.,2000). Further studies indicated that phospholipase A activity in Legionella pneumophila 
is secreted via a type II secretion system, and is distinguished by specificity for certain 
phospholipids (Flieger et al., 2001 & 2002). 
H. pylori is known to possess several different phospholipase activities, which have been 
linked to the degradation of the phospholipid components of the mucosal barrier. The gastric 
mucus contains abundant surface-active phospholipids, with most prominent constituents of 
phosphatidylcholine (PC 34%-45%) and phosphatidylethanolamine (PE 18%-32%). 
Therefore, PH-activated PLAz of H. pylori is suggested to act as an initial mucosal barrier 
breaker and is considered to have a pivotal role in the pathogenesis of peptic ulcer (Berstad et 
al.,2002). 
In this study cell-bound haemolytic activity was detected in all C. concisus RCH isolates and 
the two reference strains ATCC 51561 and ATCC 51562 using the contact hemolysin assay 
on washed bacterial cells as described in chapter 4. The experimental procedures performed 
in this chapter were designed to: 
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• Confirm the cell-bound and proteinaceous nature of C. concisus hemolysin. 
• Extract the cell-bound hemolysin from C. concisus bacterial cells. 
• Test and characterise each product during the extraction steps. 
• Use the ultrafiltration technique to separate the different molecular weight 
components of the extracted product. 
• Identify the nature of the extracted hemolysin as a protein or as 
lipopolysacharide (LPS). 
• Test for lecithinase activity in bacterial cells and in haemolytic extracts. 
• Test the immunogenic effect of the extracted hemolysin. 
• Study the toxic effect of the hemolytic extract on tissue culture cell lines. 
• Test the effect of different physical and chemical treatments on the hemolytic 
activity of the extracted hemolysin(s). 
• Identify the type of lipid substrates that could affect the haemolytic activity of 
the cell-bound hemolysin. 
• Detect the presence and type of phospholipase activity in the hemolytic extract. 
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5.2. Material and Methods 
5.2.1. Campylobacter spp. strains, growth and cell suspension preparation 
Campylobacter strains used in the study were C. concisus clinical isolates assigned to both 
molecular groups (genomospecies A and B) as indicated in 3.3.4.1. and in table 3.5. The 
selecteq strains were RCH 3-RCH 12, RCH 14-RCH 16, ATCC 51561, and ATCC 51562. 
C. coli NCTC 11366, C. coli 351 and C. jejuni 81116 were also used as controls in this 
study. All strains were grown on horse blood agar, and incubated as described in 2.3.4. 
The bacterial cell pellet was harvested and washed twice with phosphate buffered saline 
(PBS) for the contact hemolysin assay, or with 10 mM Tris buffer pH 7.4 for the 
quantitative phospholipase A2 detection assay. Bacterial suspensions were prepared at 1010 
cfu mrl in PBS or Tris buffer and used when needed. 
5.2.2. Sonication and extraction of the cell-bound hemolysin from bacterial 
cells: 
Cell suspensions of 1010 cfu mrl for Campylobacter spp. strains listed in 5.2.1. were sonicated 
on setting 6 of a Branson sonicator for 4 x 30 second bursts with cooling for 30 seconds on 
ice between each burst. The sonicated cell suspensions were centrifuged at 5000 xg at room 
temperature. The cell pellet was then tested for hemolytic activity and was further treated to 
extract the hemolysin, while the supernatant was centrifuged again at 15000 xg for 15 minutes 
at 4 QC. The cell debris was separated from the supernatant and was called total membrane 
(TM) and each portion was tested for hemolytic activity by the hemolysin assays described in 
2.4. To extract the cell-bound hemolysin, cell debris from the previous preparation was 
incubated 16-20 hours at 37 QC in PBS with 0.05% (v/v) tween 20 and 1 mg/ml lysozyme 
(Deshpande et ai., 1997). After incubation the cell debris was separated by centrifugation at 
10000 xg for 15 minutes at 4 QC and the supernatant filtered through 0.22 fl filters, before 
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assaying for hemolytic and phospholipase A2 activities. This fraction was designated as crude 
hemolysin extract (CRE) and was then subjected to ultrafiltration by passing through 100 kDa 
and 30 kDa MW cut off YM filters. Retentates (RlOO, R30) and filtrates (FlOO, F30) from 
each ultrafiltration process were tested for hemolytic activity by the liquid hemolysin assay 
(2.4.4). Protein concentrations in CRE, RE and bacterial cells were estimated by the 
modified Lowry method (Markwell, et al., 1987). 
5.2.3. Proteolytic treatment 
C. concisus bacterial cells from four clinical isolates (RCR3-RCH6), and the two reference 
strains ATCC 51561 and ATCC 51562 were washed and re-suspended to 5 x 109 cfu in PBS 
and the protein content in each sample was estimated following the method of Markwell et al. 
(1987). 10 mg/ml pronase solution was added to the cell suspensions at a ratio of 3:1 (w:w) 
cell protein: pronase and the reaction mixture was incubated at 37 QC for 30 min. Pronase 
activity was then stopped by heating the reaction mix for 30 minutes at 65 QC and the pronase 
treated cells washed in PBS to remove residual pronase prior to assaying for hemolytic 
activity. Controls used were bacterial cell suspensions without pronase treatment; 
suspensions without pronase treatment heated at 65QC for 30 minutes; as well as the negative 
and positive hemolysis controls. Remolysin extract (HE) from strain RCH 3 (containing 0.6 
mg/ml protein) was also treated with pronase at a ratio of 3:1 (w:w) HE: pronase before 
testing for hemolytic activity (2.4.4) and immunoblotting (2.6.1.8) to characterise the nature 
of the hemolysin. In a second test 1mg/ml trypsin in PBS was also used with similar C. 
concisus cell suspension samples in two ratios of 3:1 and 5:1 (w:w) of cell protein: trypsin, 
samples were incubated at 37 QC for 30 min and then tested for haemolytic activity as 
previously explained. 
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5.2.4. Estimation of polysaccharide content in the hemolytic extract 
The polysaccharide content in the hemolytic extract (HE) was estimated by the anthrone 
method (Spiro, 1966), to exclude the effect of LPS in the extracted bacterial hemolysin. The 
anthrone reagent was freshly prepared by dissolving 0.2 g of anthrone in 100 ml of 70% (v/v) 
sulphuric acid. Twenty micro litres of HE samples were made to a final volume of 1 ml with 
Milli-Q water. Glucose standards were prepared as 0, 10, 20, 50, 100, and 250 )lg/ ml and 
were all kept on ice for 10 min with all tested samples before adding 5 ml of anthrone reagent 
and then further incubated on ice for 10 min. The standards and samples were mixed by a 
vortex and then placed in a boiling water bath for 10 min. Mter cooling at room temperature 
for 30 min, the absorbance was read at 600 run. The final values of polysaccharides were 
expressed as a percentage of sugar in the total protein content. All C. concisus hemolytic 
extracts were tested for the presence of polysaccharides in addition to a positive control of 
extracted LPS from C. jejuni strain 81116 containing 500 flg/ml LPS (Biotechnology 
laboratory, RMIT University) 
5.2.5. Detection of lecithinase activity in C. concisus bacterial cells and in 
hemolytic extracts 
Egg yolk agar plates (EYA) prepared as described in 2.3.2. were used to test for presence of 
lecithinase activity (Phospholipase C) in C. concisus strains and in all hemolytic extracts (HE) 
samples. EY A plates were inoculated with C. concisus clinical strains and incubated under 
microaerophilic conditions as explained in 2.3.4. The medium was then checked for the 
presence of any white opaque zones around the colonies as an indication for a phospholipase 
C (lecithinase) activity. A Bacillus cereus strain was used as a positive control in this test. 
Likewise all C. concisus hemolytic extracts were tested for lecithinase activity on EYA in a 
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procedure similar to the blood agar hemolysin assay explained in 2.4.1. 100 III samples of 
each hemolytic extract were added separately into wells in EYA and incubated as in 2.3.4. 
and were then tested for the presence of white opaque zones around the wells. A hemolytic 
phospholipase C extract from Clostridium peljringens (Biotechnology laboratory, RMIT 
University), was used as a positive control in this method. 
5.2.6. Quantitative detection of phospholipase Az activity In hemolytic 
extracts 
Phospholipase A2 activity of crude hemolysin extracts (CHE) and hemolytic extracts (HE) in 
Tris buffer pH 7.3 from C. concisus type strains ATCC 51561, 51562 and clinical isolates 
RCH 3, RCH 6, RCH 15 was detected using the secretory phospholipase A2 correlate-enzyme 
™ kit from Assay Designs, which also included a PLA2 positive control, following the 
manufacturer instructions. CHE samples from C. jejuni 81116, C. coli NCTC 11366 and C. 
coli 351 were also tested in this assay. All samples were tested for hemolytic activity, 
lecithinase activity on egg yolk agar plates, and protein content was estimated by the modified 
Lowry method (Markwell et al., 1987) before they were used in the kit. A strongly hemolytic 
crude extract of Clostridium perfringens with phospholipase C but no phospholipase A 
activity (Biotechnology laboratory, RMIT University) was used to confirm the sensitivity of 
the phospholipase A2 detection kit. 
5.2.7. Effect of C. concisus antiserum on hemolytic activity 
HE samples from different C. concisus strains were incubated with antiserum raised against 
whole bacterial cells from C. concisus strain RCH 6, as explained in 2.6.2.2. Twenty 
microlitres of hemolytic extract samples were incubated with an equal volume of undiluted 
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antiserum at room temperature for 2h before they were spotted on rabbit blood agar. A 
positive control of untreated HE sample mixed with an equal volume of PBS was also tested 
on the same medium in addition to a negative control of the undiluted antiserum only. 
Alternatively, HE samples from selected C. concisus strains were incubated for 1 h with equal 
volumes of two serial dilutions of the antiserum in PBS (1:10 and 1:100) and also with an 
undiluted antiserum before they were tested for hemolytic activity by the microtitre plate 
hemolysin assay as described in 2.4.5. 
5.2.8. SDS-PAGE and immunoblotting for hemolytic extracts 
SDS-PAGE protein profiles for whole celllysates (WCL), outer-membrane proteins (OMPs), 
total membrane extracts (TM), crude hemolysin extracts (CHE) and hemolytic extracts (HE) 
for selected C. concisus strains were analysed to find a shared protein fragment that could be 
the possible hemolysin molecule. Fifty micro grams of protein content from each sample were 
loaded on SDS-PAGE gel and protein profiles were visualised after electrophoresis by 
coomassie blue staining. For western blotting, crude hemolysin extract CHE, HE, pronase-
treated HE, TM and OMPs from selected C. concisus isolates were solubilised in papJ~­
mercaptoethanol loading buffer, separated on a 12.5% SDS-polyacrylamide gel, and 
transferred electrophoretically onto nitrocellulose membrane, following the methods 
described in 2.6.1. Polyclonal antiserum against whole bacterial cells of C. concisus RCH 3 
and RCH 6 raised in mice was used for immunoblotting as described in 2.6.2. 
5.2.9. The effect of different hemolytic fractions on eHO cell lines 
The cytotoxic activity of HE and CHE was tested on CHO cells. The cell lines were routinely 
cultured in 25 ml tissue culture flasks containing DMEM supplemented with 10% (v/v) 
newborn calf serum as in 2.5.1. When used for cytotoxicity, an aliquot of 0.1 ml of 1 x 105 
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eRO cells prepared as described in 2.5.2. was added into each well in a 96 well culture tray. 
100 III samples of serial two fold dilutions of CRE or HE (extracted from five different C. 
concisus strains), were then added separately to each well and incubated at 37°C with 5% 
C02. The cells were tested for cytotoxic effect (visible rounding or cell damage) at 16, 24, 48 
and 72 hours. Filtrates from 30 kDa MW cut off filters (F30) were also tested on CHO cells 
for cytotoxic activity. All CHE, HE and F30 samples were also tested for hemolytic activity 
(2.4.4) before they were used in the cytotoxicity assay. 
5.2.10. The effect of heat and cold treatments on hemolytic activity 
Heat stability of the cell-bound hemolytic activity in C. concisus bacterial cells and in 
hemolytic extracts was examined. Bacterial cell suspensions in PBS and HE samples from 
selected strains assigned to both genomospecies, were heated in a water bath at different 
temperatures (45°C, 60°C, 75 °c and 100°C) for 5, 10, 15, 20, and 30 minutes. Samples 
were then cooled on ice for 5 min and assayed for hemolysis by the contact or liquid 
hemolysin assay (2.4.3. and 2.4.4). Moreover, cold stability of the cell-bound hemolytic 
activity was also tested in C. concisus cell pellets and in hemolytic extracts from samples 
which were kept at -20°C and -70 °C for 2-4 months. Frozen samples for all C. concisus 
isolates were thawed at room temperature and were then tested for hemolytic activity by the 
contact or the liquid hemolysin assays. Controls of non heat-treated samples were also used 
in each assay. 
5.2.11. The effect of different cations on hemolysis 
Calcium chloride (CaClz), magnesium chloride (MgClz), and ferrous chloride (FeClz) were 
added separately to C. concisus cell suspensions or to HE for strains RCH 3 and RCH 6 in 
final concentrations of 1 IlM, 10 fA,M, 20 IlM, 40 IlM, 50 IlM, 100 IlM, 200 IlM, 500 IlM for 
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calcium and magnesium ions, while ferric ion was added in final concentrations of 1 !!M, 10 
""M, 20 !!M, 40 !!M and 50 !!M. These added amounts were selected after conducting a 
chemical analysis on the molar content of calcium, magnesium and iron in brain heart 
infusion broth supplemented with 1.5% yeast extract which was used to grow C. concisus 
strains used in this test. The deducted molar content was considered as a minimum 
concentration of the ion needed for growth of C. concisus under normal conditions. The 
selected concentrations of the cations were added separately to the bacterial suspension or HE 
and the mixture was incubated for 30 minutes at room temperature before an equal volume of 
2% rabbit erythrocytes in PBS was added to perform the hemolysin assays as described in 
2.4.3 and 2.4.4. The effect of the calcium chelator EGTA on hemolytic activity was also 
tested by adding it to the assay in a final concentration of 1 mM EGTA with or without the 
presence of CaCh under the same incubation conditions. Negative controls of 2% erythrocyte 
suspension in PBS incubated with similar concentrations of CaClz, MgClz, FeClz, and EGT A 
in PBS were also tested in each assay, to investigate the effect of these divalent cations 
concentrations on these erythrocytes. Moreover, this test was also conducted in a different 
order as similar concentrations of these cations were added to the erythrocyte suspension and 
incubated at room temperature for 30 min before the bacterial suspension or HE were added 
to the mixture and incubated as described in 2.4.3 and 2.4.4. 
5.2.12. The inhibitory effect of different lipid substrates on hemolytic 
activity 
Phospholipase inhibitors and protein kinase inhibitors resembling major classes of lipids 
found in biological membranes were tested in the liquid hemolysin assay to determine the 
nature of the C. concisus hemolysin. HE from RCH 3 was incubated for 30 minutes at room 
temperature with 20, 40, and 60 !!g/ml final concentrations of each of the following 
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compounds: staurosporine (a protein kinase inhibitor), sphingomyelin, phosphatidylglycerol, 
phosphatidylcholine (a phospholipase A inhibitor), p-nitrophenyl phosphoryl choline (a 
phospholipase C inhibitor), and phosphatidylethanolamine. The mixture was then assayed for 
hemolytic activity by the liquid hemolysin assay (2.4.4). Negative controls contained 2% 
rabbit erythrocyte suspension in PBS incubated with the same concentrations of inhibitors 
were also used. Inhibition of hemolytic activity was determined by a comparison of results 
from samples with and without lipid inhibitor. 
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5.3. Results 
5.3.1. Hemolytic activity in different cellular fractions 
As previously indicated hemolytic activity was detected in all C. concisus clinical isolates and 
type strains (chapter 4). The pellet of sonicated C. concisus cells showed similar hemolytic 
activity to the intact cells when tested using the contact hemolysin assay. No hemolysis was 
detected when the supernatants, collected after sonication and centrifugation of the cell 
suspension at 15,000xg were tested using the liquid assay. Conversely, the cell debris (TM) 
which was separated from this sup ern at ant was strongly hemolytic when tested for hemolytic 
activity indicating a membrane-bound hemolytic activity in all C. concisus isolates. 
However, sonication of cells did not release the hemolysin from cell debris but only the 
treatment of the sonicated cell pellet with lysozyme and tween 20 resulted in releasing this 
membrane-bound hemolysin. Consequently, the supernatant collected after this incubation 
step which was hemolytic for different types of blood erythrocytes, was named as crude 
hemolytic extract (CHE). Moreover, when CHE from different C. concisus strains was 
subjected to ultrafiltration with 100 kDa MW cut off filters, the resulted filtrate (FlOO) was 
strongly hemolytic when tested by the liquid hemolysin assay and by the blood agar plate 
assay (Figure 5.1 A and B) indicating that the molecular weight of the hemolysin molecule 
was < 100 kDa. Yet, when F100 was subjected to ultrafiltration using a 30 kDa MW cut off 
filter, the resulted filtrate was non hemolytic while the retentate R30 had a very strong 
hemolytic activity compared to FlOO, indicating that the molecular size of the hemolysin 
molecule was> 30 kDa. Therefore, it can be suggested that the molecular weight (size) of the 
membrane-bound hemolysin molecule is between 30-100 kDa. 
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5.1. 
Furthermore, the hemolytic activity of the R30 retentates was very strong as compared with 
the F100 fraction and with the crude hemolysin extract (CHE) respectively. Therefore R30 
was designated hemolysin extract (HE), as it caused complete lysis of different types of blood 
erythrocytes in 1-4 hours of incubation when tested by the liquid hemolysin assay. Rabbit 
and human erythrocytes were more susceptible for hemolysis than sheep and chicken 
erythrocytes. A similar pattern for hemolysis was observed when HEs from fifteen C. 
concisus isolates representing the two genomospecies were examined. However higher levels 
of hemolytic activity were noticed for strains assigned to genomospecies A. 
5.3.2. The effect of proteolytic treatment on hemolytic activity 
The membrane-bound hemolytic activity in C. concisus was sensitive to the proteolytic action 
of both pronase and trypsin, suggesting the proteinaceous nature of this hemolysis. Pronase-
treated cell suspensions, CHEs and HEs showed negligible hemolytic activity in comparison 
with control non-treated samples, when tested using the hemolysin assays (Table 5.1). 
Similarly, all trypsin-treated samples did not have any hemolytic activity when compared 
with untreated samples, which indicated the C. concisus hemolysin is a protein. 
5.3.3. Polysaccharide content and lecithinase activity of hemolytic extracts 
The test for the presence of polysaccharides (Spiro, 1966) in the hemolysin extract, which 
could have resulted from sonication of cells, showed that all tested HE samples contained less 
than 3 ~g/ml polysaccharides, as compared with a positive control of lipopolysaccharides 
extracted from C. jejuni strain 81116 containing 500 ~g/ml LPS. No lecithinase 
(Phospholipase C) activity was produced when C. concisus strains were cultured on EY A, as 
no opaque zones were produced around the bacterial growth (Figure 5.2. A) as compared to a 
Bacillus cereus lecithinase positive control. Similarly when CHE and HE samples and FlOO 
extracted from different C. concisus strains were tested on EY A, no phospholipase C 
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fad 
(lecithinase) activity was detected (Figure 5.2. B), as compared with the phospholipase C 
extract from Clostridium perfringens (Figure 5.2. C). 
5.3.4. Quantitative detection of PLA2 activity in C. conClSUS hemolytic 
extracts 
Different levels of phospholipase A2 (PLA2) activity, ranging from 25-135 units per 50fA,1 
sample were detected in crude hemolysin extract (CHE) from C. concisus clinical isolates and 
reference strains, representing both genomospecies, using the secretory phospholipase A2 
correlate-enzyme ™ kit (Figure 5.3), while PLA2 activity for CHE from C. jejuni 81116, C. 
coli NCTC 11366 and C. coli 351 controls was 20, 26 and 55 units respectively per 50 fA,1 
sample (Figure 5.3). Higher levels of phospholipase A2 activity were detected for HE (R30) 
of C. concisus strains with a range of 90-160 units per 50fA,1 sample. In HE samples 1-2 units 
of phospholipase A activity were detected for each micro gram of protein content compared to 
0.5-1 unit/ fA,g of protein content in CHE samples from strain RCH3 (Table 5.1). In general, 
higher PLA2 activity was detected in extracts from C. concisus isolates belonging to 
genomospecies A compared to the extracts from genomospecies B. Levels of phospholipase 
A2 activity for hemolytic extracts from C. jejuni 81116, C. coli NCTC 11366 and C. coli 351, 
were similar to the activity levels of group B C. concisus isolates (Figure 5.3). Furthermore, 
no PLA2 activity was detected when a phospholipase C extract (PlC) from Clostridium 
perfringens was tested using the secretory phospholipase A2 correlate-enzyme ™ kit (data not 
shown), confirming the specificity of the test kit. 
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~TablÉ (5.1.): Phospholipase A2 (PLA2) activity, hemolytic activity on 2% rabbit erythrocytes, 
and effect on Chinese hamster ovary (CHO) cell lines, for different bacterial cell fractions of 
C. concisus RCH 3 strain. Phospholipase A2 activity was quantitatively detected as units per 
50 f,ll of sample, (per 1 f,lg of protein content) by a commercial kit. Hemolysis rate was 
detected by contact hemolysin assay (a) or liquid hemolysin assay (b) as a percentage of 
complete hemolysis of rabbit blood erythrocytes. 
Tested sample Units of PLA2 activity; Hemolysis (%) Effect on 
(unit per ~g of protein CHO cells 
content) 
Intact bacterial cells NT 60 % a NT 
Sonicated cell NT 75 % a NT 
pellet 
Sup ern at ant from No activity No hemolysis b No effect 
sonicated cells 
Crude hemolysin 65 units; 80 % b Vacuolation 
extract (CHE) (1 unit f,lg-l protein) 
R30 hemolysin 120 units; 100 % b Cytolysis 
extract (HE) (2 units f,lg-l protein) 
Diluted hemolysin 50 units; 100 % b Vacuolation 
extract (1.4 units flg-1 protein) 
Pronase-treated NT No hemolysis NT 
hemolysin extract 
F30 No activity No hemolysis b No effect 
NT ::: not tested 
174 
100 
90 
80 
~ 70 
'S;; 
60 +=' 
o· 
co 
co 50 C. 
.... 
0 40 III 
.... 
'r.: 
:s 30 
20 
10 
0 
'J;~ 'J;~ 
,-;'" ,-;'" GG GG ~ ~ 
Campylobacter spp, 
Figure 5.3. Phospholipase Az activity in CHE from C. concisus strains ATCC 51561, ATCC 
51562, RCH 3, RCH 7, RCH 15, C. coli strains NCTC 11366 and 351, and C. jejuni 81116, 
Units of PLA2 activity were detected using the secretory phospholipase A2 correlate-enzyme 
™ kit. Units of activity (pIa) were measured and plotted according to the standards provided 
in the kit. 
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5.3.5. Neutralisation of hemolytic activity by C. cimcisus antiserum 
Hemolytic activity of different hemolytic extracts from C. concisus strains was neutralized 
when incubated with C. concisus antiserum raised against whole bacterial cells from strain 
RCH 6. A reduced hemolytic effect on rabbit blood agar was noticed as compared with 
untreated HE sample mixed with PBS (Figure 5.4). Furthermore, hemolytic activity for HEs 
from C. concisus strains (RCH 3, RCH 5, RCH 6, RCH 8, RCH 15 and the two reference 
strains ATCC 51561 and ATCC 51561) representing both genomospecies steadily reduced 
when REs were incubated with diluted and undiluted antiserum against C. concisus RCH 6 
before they were used in the microtitre plate hemolysin assay (2.4.5). The higher diluted 
antiserum (10-2) had a less inhibitory effect on hemolytic activity as compared with the 10-1 
dilution, the undiluted antiserum and with the untreated HE (Figure 5.5), indicating the 
immunogenic effect of this hemolysin. 
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5.3.6. SDS-PAGE analysis and western blotting of different hemolytic cell 
fractions 
The Coomassie blue stained protein gels for C. concisus whole cell lysates, aMPs, and for 
fractions resulted from different steps of the hemolysin extraction process indicated the 
presence of at least four shared protein bands in all fractions of the hemolytic extracts 
including, aMPs, TM extract, CRE, and RE from different strains assigned to both 
genomospecies. The most obvious (major) protein band in HE has a molecular weight of 35 
kDa, while the other three (minor) light protein bands have molecular weights of 39, 45, and 
67 kDa (Figure 5.6. lane 2). Those four bands were noticed to be consistent in crude 
hemolytic extracts (Figure 5.6. lane 3) and were also clear bands in the protein profile patterns 
of total membrane extracts (TM) and whole cell lysates (WCL) (Figure 5.6. lanes 4 and 5 
respectively). Therefore it could be suggested that one or more of these four protein bands are 
possible components of the hemolysin molecule in C. concisus. In western blots a major 
immunoreactive band of around 35 kDa and a number of minor immunoreactive bands (39 
kDa, 45 kDa, 67 kDa) from WCLs, aMPs, CREs and REs on the immunoblots were detected 
by poly clonal anti-whole cell C. concisus serum in standard samples (Figures 5.7 and 5.8), but 
were absent after pronase treatment of RE as compared with a similar but non-treated RE 
sample (Figure 5.7, lanes 6 and 7 respectively) confirming the proteinaceous nature of this 
hemolytic extract. As the 35 kDa major immunoreactive band was present in REs from all 
tested C. concisus strains it could highlight the possibility of this protein band to be related to 
the membrane-bound, hemolysin molecule. 
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Figure 5.6. SDS-P AGE protein profiles for different extracts from C. concisus RCH3 
strain, the brown arrow indicates the possible protein band (35kDa) for the extracted 
hemolysin. 1. MW marker; 2. RE (R30); 3. crude hemolytic extract (CRE); 4. total 
membrane extraction (TM); 5. whole celllysates for RCH3. 
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5.3.7. The cytotoxic effect of HE on CHO cell lines 
Addition of 100 III of diluted HE (0.2 mg/ml protein content) showed a vacuolation of CHO 
cells (Figure 5.9. C), while a similar volume of concentrated hemolysin extract (0.8 mg/ml 
protein content) caused a strong cytolytic effect only after 16 hours of incubation (figure 5.9. 
D). CHE had a weaker effect on the CHO cell line (Figure 5.9. B), vacuolation was only 
noticed after 36 hours of incubation with concentrated CHE. Both the cytolytic and the 
vacuolating effects were stable (irreversible) after 72 hours of incubation. The hemolysin 
filtrates (F30) showed no visible effect on the normal growth of CHO cells after 72 hours of 
incubation (data not shown). The effect of hemolytic concentrates (HE) on tissue culture 
CHO cells indicates the strong cytolytic (damaging) effect of the membrane-bound 
phospholipase hemolysin. Both diluted and crude hemolytic extracts caused a distinct stable 
vacuolation effect on cells, with similar effects shown by hemolytic extracts from both 
genomospecies. All CHE and HE samples with vacoulating or cytolytic effect on CHO cells 
had hemolytic effect on erythrocytes from different species when tested using liquid 
hemolysin assay, while the F30 hemolysin filtrates had no cytotoxic effect on CHO cells and 
were not hemolytic for any type of blood used in the assay. Phospholipase Az activity, 
hemolytic activity, and effect on CHO cell lines for different bacterial cell fractions are 
summarised in Table 5.1. 
183 

5.3.8. The effect of heat treatment on hemolytic activity 
C. concisus hemolysin activity was retained when cell suspensions were heated at 45°C, 60°C, 
7SoC and 100°C for 10, 20 and 30 minutes, as hemolytic activity was not affected even after 
the cells were heated at 60°C for 30 min, however the hemolytic activity of these bacterial 
cells decreased significantly (40 % loss) when the cells were incubated at 100°C for 30 
minutes indicating reasonable thermal stability (Figure 5.10. A). Yet, the hemolysin extract 
(HE) was more susceptible to heat treatment than whole cell suspensions, with 40% loss of 
total hemolysin activity after treatment at 75°C for 10 minutes (Figure 5.10. B). Hemolytic 
activity of cells and HE kept at -20°C and -70°C for several months showed no detectable 
change by both the contact and liquid assays (data not shown). 
5.3.9. The effect of calcium, magnesium, ferrous ions and EGTA on 
hemolytic activity 
Calcium ions had a notable effect on the hemolytic activity when added to the hemolysin 
assay mixture in variable concentrations as compared to controls. When C. concisus bacterial 
suspensions or hemolysin extracts were tested in the presence of calcium divalent cations, 
there was a 5-15% increase in hemolytic activity by adding 1-10 [!M CaCh to the assay 
mixture. However, higher concentrations (20-500 [!M) caused a gradual decrease in the 
hemolytic activity of HE (Figure 5.11). Removing calcium ions from the environment, by 
adding 1 mM EGTA as a calcium chelator, completely blocked the hemolytic activity which 
could not be restored by adding extra calcium ions (10-100 [!M) to the assay (Figure 5.11). 
Ferrous ions also had a significant effect on hemolytic activity of C. concisus when tested by 
the contact hemolysin assay, with 10 [!M FeCh decreasing the activity to 40% and with 20 
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I-tM FeClz to 20% of the total hemolysis. However, concentrations of 40 I-tM FeC12 or higher 
completely blocked the activity of this hemolysin (Figure 5.n). 
The addition of magnesium ions had a weaker effect on hemolytic activity compared to the 
effec:;t of calcium and ferrous ions. Hemolyticactivity was only reduced significantly when 
concentrations higher than 40 I-tM of MgClz were added to the contact hemolysin assay 
(Figure 5.11). Moreover, the addition of calcium, magnesium, or ferrous ions to the 
hemolysin assay did not seem to have any effect on blood erythrocytes, as compared with 
negative controls containing similar concentrations of these divalent cations. However, it was 
noticed that even higher concentrations < 20 /!M of calcium ion caused a significant increase 
in hemolytic activity when this test was conducted by incubating the red blood cells with 
CaClz before addition of the hemolytic extracts (data not shown). 
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5.3.10. The inhibitory effect of lipid substrates and phospholipase inhibitors 
on hemolytic activity 
Phosphatidylcholine (PC) caused reduction in hemolysis when used in the liquid hemolysin 
assay with the hemolysin extract (HE). Concentrations of PC up to 60 !!g/ml showed 60% 
reduction in hemolytic activity (Figure 5.12.), while concentrations higher than 60!!g/ml 
caused spontaneous lysis of the red blood cells compared to the negative control (PC treated 
erythrocytes without HE). Other lipid substrates including NPPC, the phospholipase C 
inhibitor, showed no or little effect on hemolysis (Figure 5.12.), indicating that 
phosphatidylcholine is the preferred substrate for this hemolytic extract. Furthermore, these 
results suggest that the cell-bound hemolytic activity of C. concisus may have resulted from a 
phospholipase A enzyme activity similar to the activity of outer-membrane phospholipase A 
ofE. coli (figure 5.13). 
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5.4. Discussion 
C. concisus strains show the presence of strong cell-associated hemolytic activity, with higher 
levels of hemolytic activity on human and rabbit erythrocytes when compared with C. jejuni 
and C. coli type strains (Istivan et aI., 1998). Further analysis indicated that hemolytic 
activity in all C. concisus isolates was membrane-bound, as sonication of cells did not release 
the hemolysin from cell debris and therefore, treatment with lysozyme and detergent was 
needed for effective hemolysin extraction. It was also concluded that the molecular weight of 
the membrane-bound hemolysin molecule is between 30-100 kDa. The extraction steps of the 
hemolytic extract involved ultrafiltration of crude hemolytic extract through the 100 kDa 
MWCO filters followed by a second filtration step with a 30 kDa MWCO filters which 
resulted with a non hemolytic filtrate. The hemolytic extract was sensitive to the proteolytic 
action of both pronase and trypsin, as it was completely inactivated with pronase and trypsin 
treatments, strongly suggesting the proteinaceous nature of this hemolysin. This was also 
confirmed by immunoblotting as the non hemolytic, pronase-treated HE did not react in any 
way with the C. concisus specific antiserum used for immunoblotting as compared with an 
active (non-pronase treated) HE sample from the same extracted product. Cold and heat 
treatments did not have significant effect on hemolytic activity of bacterial cells and REs. 
Therefore, C. concisus hemolysin was considered as a heat and cold stable protein. 
Further analysis showed that phospholipase Az activity was detected in HEs from all C. 
concisus isolates in addition to the strong hemolytic action on red blood cells (erythrocytes). 
Likewise all F30 non-hemolytic samples lacked phospholipase Az activity, suggesting that the 
hemolytic action on these erythrocytes was a result of the enzymatic activity of the outer 
membrane phospholipase A (OMPLA). Moreover, C. concisus strains from genomospecies A 
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showed higher rates of hemolytic and phospholipase Az activity compared to strains from 
genomospecies B and other tested campylobacter species strains. The variable rates for 
hemolytic and phospholipase A activity in different groups could be driven by the variations 
in virulence capabilities of these genomospecies, but this needs further investigation. 
An important point in the analysis of any extracted bacterial toxin is the effect of LPS, which 
may be associated with the protein fraction tested for hemolytic activity. In this study the 
REs were tested for presence of polysaccharides (Spiro, 1966). All REs showed negligible 
amounts of oligosaccharides in all tested samples, indicating that lysozyme and detergent 
treatments did not promote the extraction of LPS and/or capsule polysaccharides from the 
sonicated cells. Furthermore, by using the ultrafiltration steps, only molecules with a 
molecular weight range between 30-100 kDa were expected to be present in the hemolytic 
extracts. Therefore, the endotoxic LPS of campylobacters which is known to have a smaller 
molecular weight (Mills et al., 1985), should be excluded from the hemolytic extract by the 
ultrafiltration steps. Moreover, no lecithinase (Phospholipase C) activity was detected in C. 
concisus bacterial cells or REs when tested on EYA, indicating that the hemolytic activity 
was not a result of the presence of either LPS or lecithinase. 
SDS-PAGE analysis and immunoblotting showed that a 35 kDa protein band was present in 
all OMP, eRE and in hemolytic extracts with phospholipase Az activity which could be 
considered as a potential component of the hemolytic phospholipase A protein molecule. 
This may account for the retentates (R30) retaining macromolecules with phospholipase Az 
activity and hemolytic effect when tested on erythrocytes, while the filtrates (F30) did not 
show any effect (table 5.1). Protein molecules of approximately the same molecular weight 
with phospholipase A activity have been reported in other enteric bacteria such as 
phospholipase A in C. coli with a predicted molecular weight of 35 kDa (Grant et. al., 1997). 
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Furthermore, the predicted molecular weight for phospholipase Al in Serratia sp is 33.4 kDa 
(Song et aI., 1999), while it has been reported that the molecular weight for the OMPLA 
monomer in E. coli is 31 kDa (de Geus et al., 1983; Brock et al., 1998). The molecular 
weight of the enzyme monomer in C. concisus is approximately 35 kDa as shown by the 
major immunoreactive band on the blot. 
The effect of hemolytic concentrates (HE) on tissue culture CHO cells indicates the strong 
cytolytic (damaging) effect of the membrane-bound phospholipase A hemolysin. 
Furthermore this intracytoplasmic vacuole formation effect, similar to that caused by 
cytotoxic Helicobacter pylori was also detected when C. concisus bacterial cells were 
incubated with Intestine 407 cells, while performing adhesion tests (Musmanno et al., 1998). 
Hemolysins of Serratia marcescens and Haemophilus ducreyi have been reported to cause a 
damaging effect on human epithelial cells (Hertle et al., 1999; Wood et al., 1999). 
Phospholipase A in Legionella species has been reported to cause destruction of lung surfaces 
and epithelial cells (Flieger et al., 2000). Moreover, the phospholipases AI, A2 and C of H. 
pylori were linked to the degradation of the phospholipid components of the mucosal barrier 
and phospholipase A of H. pylori is thought to have a role in colonisation (Dorell et al., 1999; 
Tannaes et at., 2001; Xerry and Owen, 2001). 
Further studies are required to determine whether this hemolysin isolated from C. concisus 
produces a vacuolation effect on human epithelial cells similar to that produced by VacA 
toxin of H. pylori or VcVac from V. cholerae (Massari et aI., 1998; Coelho et al., 2000). 
Calcium ions had a remarkable effect on the hemolytic activity of C. concisus when added to 
the hemolysin assay mixture in variable concentrations. Furthermore, removing calcium from 
194 
the test environment by using the calcium chelator EGTA completely stopped this activity. 
Calcium ions were reported to be required for the catalytic activity of eukaryotic and 
prokaryotic phospholipase A (Weinberg, 1985; Songer, 1997), such as the strictly calcium-
dependent, outer-membrane phospholipase A (OMPLA) in E. coli (Dekker, 2000). Recently, 
calcium ions were found to play a catalytic and regulatory role in the formation and 
stabilisation of the active dimeric state of OMPLA, by binding to the active catalytic site of 
the inactive monomeric state of the enzyme. Therefore, preventing any uncontrolled 
breakdown of the surrounding phospholipids in the outer membrane of the bacterial cell 
(Kingma & Egmond, 2002). It is most likely that calcium also acts in a similar role in 
regulating the phospholipase Az activity of C. concisus. 
The ability to acquire iron is essential for bacteria to grow and consequently iron deficiency is 
a major factor involved in the induction of virulence determinants in pathogenic bacteria 
(Pickett et al., 1992). Yields of bacterial enzymes and toxins in complex medium can be 
modulated by iron, such as lecithinase production in Clostridium perfringens and the alpha-
hemolysin of Staphylococcus aureus, where the invasiveness of those pathogens is enhanced 
in strains that can release iron from host macromolecules (Weinberg, 1985). Ferric ions were 
also found to a have a significant effect on growth, outer membrane protein composition and 
siderophore synthesis in C. jejuni (Field et al., 1986). C. concisus hemolytic activity was 
reduced when ferrous ions were added to the hemolysin bioassay, with a sudden decrease in 
hemolytic activity of cells observed. Yet, a detectable increase in hemolysis rates was noticed 
when C. concisus cells and culture filtrates collected from an iron deficient medium (using 
EDDA as an iron chelator), were tested using the hemolysin assays as previously indicated in 
chapter four (Istivan et al., 1998). This is not unexpected since a similar regulatory effect of 
calcium and iron on hemolytic activity was reported for C. jejuni and C. coli hemolysins 
(Hossain et al., 1993; Grant et al., 1997). Therfore, supporting the theory that hemolytic 
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activity is an important virulence factor in C. concisus. These results can best be explained by 
the presence of an iron-regulated, heat-stable, calcium-dependent protein with hemolytic and 
phospholipase A2 activities in C. concisus similar to the hemolytic, calcium-dependent, 
phospholipase A in C. coli (Grant et al., 1997), and to the calcium-dependent OMPLA of E. 
coli which harbours phospholipase Al and A2 activities (Dekker, 2000). 
Lipase and phospholipase inhibitors have been used to study the nature, mode of action and 
structure of different phospholipases such as OMPLA in E. coli, (Ubarretxena-Belandia et al., 
1999). In this study, a phospholipase C inhibitor and protein kinase inhibitor lipid substrates 
failed to show any inhibitory effect whilst the C. concisus hemolytic extract could be 
inhibited by the lipid substrate phosphatidylcholine. Since the phospholipase A inhibitors 
interact with a specific active site of the enzyme (Dekker, 2000), reactivity in this case implies 
the high degree of similarity between the active sites in the phospholipase A2 in C. concisus 
and bacterial PLA2 which prefers phosphatidylcholine to phosphatidylethanolamine as a 
substrate (Matoba et al., 2002). Phosphatidylcholine is one of the main lipid components in 
the membranes of human and other mammalian erythrocytes which explains the strong 
hemolytic effect of C. concisus hemolytic extract on human and rabbit erythrocytes (Istivan et 
al., 1998). Membrane bound phospholipases (hemolysins) active against the membranes of 
erythrocytes are wide spread among enteropathogens including the phospholipase A in C. coli 
(Grant et al., 1997) and phospholipase A2 of H. pylori (Dorell et al., 1999). Furthermore, the 
pldA gene in Yersinia pseudotuberculosis encodes a phospholipase A which is active towards 
both phosphotidylcholine and sphingomyelin, which are the major phospholipid components 
of the outer leaflet of eukaryotic cell membranes (Karlyshev et al., 2001). Moreover, these 
researchers indicated that a PldA mutant strain of Y. pseudotuberculosis exhibited reduced 
phospholipase activity compared to the wild type strain. In addition in vivo attenuation of the 
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~I11utant was confirmed suggesting that PldA is an essential virulence factor in the murine 
sersiniosis model of infection (Karlyshev et al., 2001), 
Since hemolytic phospholipase A2 activity with cytolytic effect is considered as a virulence 
factor in pathogenic bacteria (Songer, 1997) and in strains of the closely related 
Campylobacter spp. of C. jejuni and C. coli (Brok et. al., 1998), the presence of similar 
activity in both genomospecies of C. concisus clinical isolates, supports the possible virulence 
role of this phospholipase/hemolysin in the pathogenicity of C. concisus. 
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Chapter Six 
Characterisation of the Phospholipase A Gene (pldA) of 
Campylobacter concisus 
6.1. Introduction 
Phospholipase A (PLA) is one of the few enzymes present in the outer membrane of Gram-
negative bacteria. It is strictly calcium dependent and displays broad substrate specificity. The 
pldA gene has been known to be the structural gene encoding for phospholipase A activity in 
Escherichia coli (OMPLA; EC 3.1.1.32) for more than two decades (de Geus et al., 1983). 
OMPLA of E. coli is a 31-kDa protein encoded by the pldA gene, and is composed of 269 amino 
acid residues preceded by a 20 amino acid signal sequence which directs the protein across the 
inner membrane. The gene is under the control of a constitutive promoter, resulting in the 
presence of 500 copies of the 31 kDa enzyme in the outer membrane of normal growing cells (de 
Geus et al., 1983; Homma et al., 1984). Furthermore, it has been shown that the OMPLA protein 
is well conserved among Enterobacteriaceae, including pathogenic species, and in non-
enterobacterial Gram-negative bacteria (Brok et al., 1994). The protein sequences of the PLA 
protein in E. coli, Salmonella typhimurium, Klebsiella pneumoniae, and Proteus vulgaris were 
compared. The sequence analysis of pldA genes revealed a high degree of similarity with 79% of 
the amino acid residues being identical in PLAs from all four species. The pldA genes encoding 
the PLA enzymes were also cloned in E. coli and they expressed enzymatically active gene 
products (Brok et al., 1994). Moreover, in a following study, Brok et al. (1998) screened data 
bases of whole genome sequencing projects and revealed the presence of proteins similar to 
OMPLA in Helicobacter pylori, Campylobacter coli, C. jejuni, Yersinia pestis, Neisseria 
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meningitidis, and N. gonorrhoeae. A comparison of OMPLA amino acid sequences of Gram-
negative bacteria also revealed that 30 amino acid residues are completely conserved, indicating 
an important physiological role of this enzyme (Brok et al., 1998). In a following study, Snijder 
et al., (2001) indicated that the key elements of calcium-binding and activation are conserved in 
Gram -ve bacteria, suggesting that the architecture of all OMPLA enzymes is most likely the 
same, and that their activity is calcium and dimerisation-dependent. Several conserved residues 
form a complete and highly specific consensus sequence motif, YTQ-Xn-G-X2-H-X-SNG 
(Snijder et al., 2001). This Ca+2 binding motif has been also reported for the protein product of 
the pldA gene in Y. pseudotuberculosis (Karlyshev et al., 2001). Furthermore, this pldA gene has 
been shown to be a virulence determinant in this pathogen, as a pldA mutant strain with a reduced 
PLA activity, was attenuated in vivo as compared to the wild type strain (Kadyshev et al., 2001). 
Grant et al. (1997) identified a pldA gene in Campylobacter coli upstream of an operon encoding 
an enterochelin transport system. The C. coli pldA gene product is a 35 kDa protein with 
significant similarity to the Escherichia coli OMPLA, and is considered to be a major hemolytic 
factor. A pldA gene was also reported for Campylobacter jejuni, encoding a putative 
phospholipase A protein with significant similarity to phospholipase A of C. coli (Brock et al., 
1998). More recently, the genome sequence of C. jejuni NCTC 11168 reported by Parkhill et al. 
(2000), revealed the presence of a pldA gene (Cj 1351) upstream of the ceuB and ceuC genes, 
similar to the position of the pldA gene in the C. coli genome. Furthermore, Ziprin et al. (2001), 
found that C. jejuni strains containing mutations in the ciaB and pldA genes are extremely poor 
colonisers, and were avirulent as a result of their impaired ability to colonise the chicken caecum. 
These strains could not establish themselves in the caeca even after massive doses were given 
both orally and intraperitoneally. 
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In this study a pldA homologue in C. concisus clinical isolates was amplified and 
characterised. The aims of the experimental procedures performed in this chapter were to 
• 
• 
• 
• 
Confirm the presence of a chomologous pldA gene in all C. concisus 
RCH isolates by PCR amplification 
Determine the pldA gene sequence in C. concisus strains from both 
genomospecies and detect any possible differences in these gene 
sequences. 
Analyse the predicted amino acid sequence of the phospholipase A 
protein encoded by the pldA gene in C. concisus and find the conserved 
residues in this sequence, in addition to the specific consensus sequence 
motif (YTQ-Xn-G-X2-H-X-SNG), which has been detected in pldA gene 
sequences of many Gram negative bacteria (Snijder et al., 2001). 
Clone the amplified pldA gene and complement an E. coli pldA mutant 
strain by restoring its hemolytic phospholipase A activity. 
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6.2. Material and Methods 
6.2.1. Bacterial strains and culture conditions 
Campylobacter spp. strains used in PCR amplifications for pldA gene are listed in tables 2.1 and 
2.2. E. coli strains and plasmids used for DNA manipulation and for pldA gene cloning are listed 
in table 6.1. Bacterial cultures were grown as described in (2.3.4.). 
6.2.2. peR amplification of the pldA gene of C. concisus: 
Two oligonucleotide primers, forward primer F1pla and reverse primer R1pla (Table 6.2) were 
designed from the conserved region in the C. coli phospholipase A (pldA) gene (Grant et at., 
1997; Brock et at., 1998), and used to amplify a 460 bp internal fragment of the homologous 
gene in C. concisus using a 56°C annealing temperature as described in 2.7.3.2. Genomic DNA 
prepared by the method of Maniatis et af. (1982) from eight C. concisus RCH clinical isolates, 
two type strains, ATCC 51561 and ATCC 51562, and the control C. coli strain 351 were used as 
templates in this reaction. Due to the extracellular DNase activity found in C. concisus strains as 
indicated by Matsheka et al., (2002), the PCR amplification of the 460 bp internal fragment of 
pldA gene was repeated more than three times to obtain a clear PCR product from C. concisus 
genomic DNA. 
Primers to amplify other regions of the pldA gene of C. concisus were also designed based on the 
nucleotide sequence of the 460 bp PCR product and later on other sequenced PCR products 
(Table 6.2). Forward primer F3pla and reverse primer Rcon (Table 6.2) were designed and used 
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to amplify a 950 bp PCR product of the pldA gene sequence of C. eoneisus including both the 
start and stop codons of this gene. 
6.2.3 .. Sequence analysis of the pldA gene of C. concisus 
The complete sequence of the pldA gene was determined by the primer walking 
sequencing technique. DNA sequencing was performed using the ABI PRISM BigDye 
Terminator Cycle Sequencing Ready Reaction Kit (Applied Biosystems) as described in 
2.7.4. The sequencing of each PCR product was repeated at least two times in each 
direction to confirm the accuracy of the results. Furthermore, the 460 bp PCR product of 
the internal fragment of the pldA gene of C. eoneisus strains ATCC 51561, ATCC 51562 
and C. coli strain 351 was amplified as described in 6.2.1. and was then sequenced as 
described in 2.7.4. 
6.2.4. Bioinformatics 
All sequence interpretation tools including BLAST (sequence similarity search), MOTIF (motif 
similarity search) and CLUST AL W (multiple sequence alignment) were obtained from the 
Australian National Genomic Information Service (ANGIS) within WebANGIS and BioManager 
(www.angis.org.au). Boxshade (version 3.21), which was used to shade identical and similar 
amino acid residues in aligned sequences, was accessed from the European Molecular Biology 
network (www.ch.embnet.org). The PSI-BLAST multiple sequence alignment were used to 
perform multiple alignments for the predicted amino acid sequence for the pldA gene of C. 
coneisus. Translation and analysis of nucleotide sequences was performed using the ExPASy site 
(SWISS-2DPAGE; VIRTUAL). Clone Manager by Scientific & Educational Software (2000) 
Was used to draw all vectors. The 3D protein structure for the PLA molecule of C. eoncisus was 
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constructed using the 3-D JIGSAW Protein comparative modeling server. The X-ray 
crystallography information of the E. coli OMPLA molecule, the PBD code 1ilz (n156a active 
site mutant ph 6.1), lqd5 (native ompla), and 1fw2 (native monomer Ca2+ bound) were used as a 
reference model. RasTop 1.3 by Philippe Valadon (2000) and RasMol molecular graphics 
programs were used for the visualisation of proteins molecules and to create the 3-Dimensional 
representation of PLA protein molecule. 
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Table 6.1. E. coli strains and Plasmid vectors used in this study 
Bacterial Genotype Souce 
strain/Plasmid 
e. coli 
ToplOF' F' {lacfITnlO (TetR)}mcrA D(mrr-hsdRMS- Invitrogen, 
mo'BC) f801acZDM15 DlacX74 recAl, 
araD139 D (ara-leu)7697 galK rpsL (StrR) 
Australia 
endAl nupG 
XLi-Blue recAl, endAl, gyrA96, thi-l,hsdR17, supE44, Stratagen, USA 
relAl, lac (plproAB, lacf!Zl1M15, TnlO), Td 
PC 2254 (K12 F) leu; thi; trp; his; pdxA; pyrA; lacy; galK; xyl; NCCB, The 
ara· mtl . fhuA . tsx· rpsL . recB2l . recC22· Netherlands " " , , , 
sbcB15; sup; lambda-
PC 4269 (CE1347) leu; thi; trp; his; pdxA; pyrA; lacy; galK; xyl; NCCB, The 
(pldA mutant) ara· mtl . fhuA . tsx· rpsL . recB2l . recC22· Netherlands ' , 'J , , , 
sbcB15; sup; lambda;del (pldA: : Km) 
PC 2899 (CE1302) fabB; supD; rpoB NCCB, The 
(fabB temperature- Netherlands 
sensitive mutant) 
Plasmids 
pCR@2.1 3.9 kb PCR cloning plasmid, AmpR KmR Invitrogen, 
Australia 
lacZ U, 3' T-overhang 
pGEM-7zf 2.99 kb, lacZ, AmpR, f1 ori Promega, USA 
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Table 6.2. PCR primers for the pldA gene sequence of C. concisus 
I Primer 
Flpla 
F3pla 
Rlpla 
Rcon2 
R460 
Rpld 
Nucleotide Sequence 
5 '-CCTCACCCTTTAGAGAAACAA-3 , 
5 '-TTGCGATGATTTTGAACAAGC-3 , 
5'-GCTTCCTCCATAGCCATT -3' 
5 '-GAAATCAAAAATCCCGTAGAAAGTCTTTG-3 , 
5 '-CTCATCTCCTTTGCCATTGC-3 , 
5 '-TGATACGAATAACCCCTAT-3 , 
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6.2.5. Cloning of the C. concisus pldA gene 
6.2.5.1. TA cloning of the pldA gene into plasmid pCR2.1 
The cloning of the pldA gene PCR product (950 bp) was performed using the original TA cloning 
kit according to the manufacturer's instructions. PCR product was purified using the Wizard 
PCR Purification Kit. Purified PCR product (200 ng of DNA) was then ligated to 50 ng of 
pCR2.1 in the presence of 4 units of T4 DNA ligase and ligase buffer. The ligation mixture was 
incubated in a 16°C water bath overnight and was then used to transform E. coli TOP10F 
competent cells as described in 2.7.5.5. One hundred millilitres of this culture were spread gently 
onto X-GAL plates containing 50 f,lg/ml ampicillin. The resulting recombinant plasmid 
containing the C. concisus pldA gene was named pCRpldA. 
6.2.5.2. Complementation of E. coli mutant strain PC 4269 with pCRpldA 
Competent cells of E. coli mutant strain PC 4269 were prepared according to the method 
described in 2.7.5.3.1. The cells were transformed with the plasmids pCR2.1 and pCRpldA by 
electroporation as described in 2.7.5.4. The cells were incubated for 1 h at 370C and then plated 
onto LA containing 50 f,lg/ml ampicillin and 50 f,lg/ml kanamycin as the E. coli pldA mutant is 
resistant to kanamycin. After incubation few white colonies were selected and then incubated on 
LA plates containing 100 f,lglml ampicillin to confirm the uptake of the pCR2.1 plasmid. 
Plasmid DNA from selected clones was prepared as described in 2.7.1.1. Primers to amplify a 
selected region of the C. coneisus pldA gene were used with the plasmid DNA to confirm the 
presence of the pldA gene insert in the plasmid DNA. Restriction digests with EeoRI and EeoRV 
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were also performed on the pCRpldA plasmid DNA to indicate the direction of the pldA gene 
insert as described in 2.7.5.1. 
6.2.5.3. Complementation of the E. coli mutant PC 4269 with pGEM7z pldA 
The pldA gene insert was cut from pCR pldA by double digestion with BamHIIXbaI. The 
resulted fragments were then ligated with pGEM7z plasmid DNA, which was previously digested 
with BamHIIXbaI as described in 2.7.5.1. Competent cells of XL1Blue E. coli were prepared as 
described in 2.7.5.3.1. and transformed with the plasmid pGEM7z pldA by electroporation as 
described in 2.7.5.4. The cells were incubated for 1 h at 370C and plated onto LA containing 100 
[!g/ml ampicillin. After incubation white colonies were selected, numbered and replica-plated on 
LA plates containing 50 [!g!ml kanamycin and on LA plates containing 100 [!g!ml ampicillin. 
Colonies susceptible to kanamycin were selected after they were proved to have been carrying 
the pGEM7z pldA plasmid and not the pCR2.1 plasmid. Plasmids pGEM7z and pGEM7z pldA 
were then used to transform E. coli pldA mutant strain PC 4269, by electroporation as described 
in 2.7.5.4. The cells were incubated for 1 h at 370C and plated onto LA containing 100 [!g/ml 
ampicillin and 50 [!g/ml kanamycin as the E. coli pldA mutant is resistant to kanamycin. Selected 
colonies were then grown in LB medium containing 50 !!g!ml kanamycin, 100 [!g!ml ampicillin, 
and 40 [!g!ml IPTG to induce production of the recombinant PLA protein. The colonies were 
also tested for hemolytic activity on sheep blood agar plates containing 50 [!g/ml kanamycin, and 
100 [!g!ml ampicillin. Restriction digests with EcoRI and also with BamHIIXbaI were performed 
on the pGEM7z pldA plasmid DNA to indicate the direction of the pldA gene insert as described 
in 2.7.5.1. The controls plasmid pGEM7z without insert was also digested with EcaRI and with 
BamHI/XbaI for comparison. 
207 
6.2.6. Detection of recombinant hemolytic phospholipase A activity 
6.2.6.1. by hemolysin assays 
Contact and liquid hemolysin assays (2.4.3 and 2.4.4 respectively, p. 88) were used to detect and 
quantify hemolytic activity of the E. coli parental strain PC 2254, E. coli pldA mutant strain PC 
4269, PC 4269 carrying pCRpldA, PC 4269 with pGEM7z pldA, PC 4269 E. coli pldA mutant 
strain with pGEM7z without insert. 
6.2.6.2. by phospholipase A2 detection kit 
The secretory phospholipase A2 detection kit was used to detect and quantify phospholipase A 
activity of E. coli parental strain PC 2254, E. coli pldA mutant strain PC 4269, PC 4269 carrying 
pCRpldA, PC 4269 with pGEM7z pldA, PC 4269 E. coli pldA mutant strain with pGEM7z 
without insert according to the manufacturer's instructions as stated in 5.2.6. 
6.2.6.3. by the in vivo phospholipase assay 
The in vivo phospholipase A assay is based on the method of de Geus et al. (1983). Cells of E. 
coli PC 2254, E. coli pldA mutant strain PC 4269 with pGEM7z pldA, PC 4269 E. coli pldA 
mutant strain with pGEM7z without insert, and E. coli pldA mutant strain PC 4269, were streaked 
across Muller-Hinton agar plates (MH) and incubated aerobically overnight. The bacterial 
growth on MH plates was then overlaid with 4ml of 1 % PI broth agar (Maniatis et al., 1982), 
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containing 0.05% Triton X-lOO, 200!!g/ml rifampin, 10 mM CaCh, and approximately 107 cells 
of the E. coli fabB temperature-sensitive mutant CE1302 (Table 6.2). The plates were dried for 
15 min at 370C and then incubated aerobically at 40°C overnight. The plates were then assessed 
for the growth of the E. coli fabB indicator strain in the soft agar above the growth of the E. coli 
streaked strains. 
6.2.6.4. by protein gel overlay method 
Native protein gel electrophoresis was performed on whole celllysates from clone PC 4269 with 
pGEM7z pldA (pIal), whole celllysates from PC 4269 E. coli pldA mutant strain with pGEM7z 
without insert and whole celllysates from E. coli pldA mutant strain PC 4269 carrying pCRpldA. 
Outer membrane proteins from C. concisus ATCC 51561, ATCC51562, crude hemolytic extract 
(CHE) from RCH3, and hemolytic extract (H) from RCH3 were also tested by this method. All 
samples were prepared as described in 2.6.1. using SDS free solutions. The native gel was placed 
in a square plate after electrophoresis and was then covered (overlaid) with 2% agarose gel 
containing 10% washed sheep erythrocytes. The gel overlay was placed in a humid plastic 
container and incubated overnight at 37OC. An identical SDS-PAGE gel stained with Coomassie 
blue stain was also performed for comparison. 
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6.2.6.5. by immunoblot analysis 
Immunoblots for whole cell lysates from E. coli parental strain PC 2254, E. coli pldA mutant 
strain PC 4269, PC 4269 E. coli pldA mutant strain with pGEM7z without insert, PC 4269 with 
pGEM7z pldA (pIal), PC 4269 carrying pCRpldA, and whole cell lysates from C. concisus 
RCH3 were prepared as described in 2.6.1.8. The blot was incubated with antiserum raised in 
mice injected with a suspension of whole bacterial cells from C. concisus RCH 3 as described in 
2.6.2. The antiserum was adsorbed overnight with E. coli antigens as described in 2.6.2.3 before 
it was used for western blotting. 
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6.3 Results 
6.3.1. peR amplification of the phospholipase A gene (pldA) of C. concisus 
PCR amplification of genomic DNA from two reference strains of C. concisus and other selected 
clinical isolates using primers Fpla and Rpla yielded a 460 bp PCR product which was similarly 
amplified from C. coli 351 genomic DNA (Figure 6.1 A) (Istivan et aI., 2004). The nucleotide 
sequence of this product was used to design other primers to amplify other regions of the pldA 
gene (Figure 6.1. B) including F3pla and Rcon which amplified a 950 bp PCR product including 
start and stop codons of the pldA gene in C. concisus (Figure 6.1 B lane 2). 
6.3.2. DNA sequence of the pldA gene in C. concisus 
A nucleotide sequence of (1408 bp) including the pldA gene sequence and flanking regions 
outside this gene in the C. concisus genome was composed using the sequencing results of the 
pldA gene PCR products (Appendix 1). The pldA gene sequence in C. concisus strain RCH 3 was 
submitted to the gene databases (EMBL/GenBank/DDBJ) and was given the accession number 
AJ786391 (Appendix 2). 
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Figure 6.1. PCR amplification of genomic DNA from C. concisus strains 
(A) 460 bp PCR product amplified using primers binding to for the conserved region of the pldA 
gene of C. coli. Lane 1, pBR322 DNAlAluI low molecular weight standard; lane 2, C. concisus 
RCH 3; lane 3, C. concisus strain ATCC 51561; lane 4, C. concisus strain ATCC 51562; lane 5, 
C. coli strain 351. 
(B) PCR products amplified from genomic DNA of C. concisus strain RCH3 usmg pnmers 
designed from the sequenced segments of pldA gene. Primers mixtures are F3pla/R460 in lane 
1, F3pla/Rcon2 in lane 2, F3plalRpld lane 3, Flpla/R460 in lane 4, Flpla/Rcon2 in lane 5, and 
FlplalRpld in lane 6. Lambda IPstI DNA molecular weight marker, in lane 7. 
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6.3.3. Analysis of the pldA gene of C. concisus 
The predicted amino acid sequence (297 amino acids) for this gene product (Figure 6.2) was 
given the protein ID "CAH10186.1" (EMBL/GenBank/DDBJ) representing an outer membrane 
protein phospholipase A (EC number 3.1.1.32). Translation and analysis of the nucleotide 
sequence using the ExPASy site (SWISS-2DPAGE; VIRTUAL) predicted that the molecular 
weight for the 297 aa PLA protein is 35076.3 Da. The theoretical pI for this protein was 
calculated as 6.32. The total number of negatively charged residues (Asp + GIu) is 34, and the 
total number of positively charged residues (Arg + Lys) is 32. The instability index (ll) was 
computed to be 34.06, which classifies the protein as stable. 
6.3.4. Comparison of the pldA gene sequence of C. concisus with the pldA 
gene sequences of other Gram negative bacteria 
The sequenced pldA gene product (CAH10186) showed 97% identities (98% similarity) 
(291/297) with the amino acid sequence for phospholipase A in Campylobacter coli (032349). 
However this predicted protein sequence has only 76% identity (86% similarity) to phospholipase 
A (EC 3.1.1.32) of Campylobacter jejuni (Q9PMU8). The C. concisus phospholipase A amino 
acid sequence has 39% identity (58% similarity) with Wolinella succinogenes PLDA 
(Q7MAU5), 37% identity with PLAl Pasteurella multocida (Q9CL22). It has a 34% identity 
with phospholipase A sequences of Escherichia coli (Q8CVJ6), Yersinia pestis, Y 
pseudotuberculosis (Q9S1D7) and with phospholipase Ai precursor (P37442) of Salmonella 
typhimurium and S. typhi. 
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300 atgcaaatttataaaaaactagccttgcaaaattctcctaaacaa 
M Q I Y K K L A L Q N S P K Q 
345 gatttaaaagaaaataatgcttctttactttcaagcataaagcac 
o L KEN N A S L L S S I K H 
390 gaaacacaaaatacccaaaaaacacctagcacaaaagaggatttt 
E T Q N T Q K T P S T KED F 
435 tcgcgcattgctttggcaaattatttaggagaaaattcaagtttt 
SRI A L ANY L G ENS S F 
480 aatccccttggaatcagctcatataagatgaattatttcctacct 
N P L G I S S Y K M N Y F L P 
525 tttgcttatagttttggctcattaggcggggaaaatagaaaaact 
FAY S F G S L G G E N R K T 
570 gaaatgaaatttcaactcagtattaaaaaaagattatttgaagat 
E M K F Q L S I K K R L FED 
615 ttgttaggattaggtgaaaaatattatgtaggctacactcaaaca 
L L G L G E K Y Y V G Y T Q T 
660 tcttggtggcaaaactataaacattcctcaccctttagagaaaca 
S W W Q N Y K H S S P F R E T 
705 aattatcaacctgaattttttgtagatattcctttgcattttgaa 
N Y Q P E F F V 0 I P L H F E 
750 gattataaatttcttaataatctaagagtaggaattttgcatgaa 
o Y K F L N N L R V G I L H E 
795 agcaatggcaaaggagatgagaatttagaatcacgctcttggaat 
S N G K G 0 E N L E S R S W N 
840 agaatttatgcttcaagcgtgtttttatatcagcgttttttattt 
R I Y ASS V FLY Q R F L F 
885 attcctagaatttggtatagaattcctgaaaacagcaaagatgat 
I P R I W Y RIP ENS K 0 0 
930 gataatcctgaaatcacacattatatgggaaattttgatatcaat 
o N P ElT H Y M G N F 0 I N 
975 atagggtatttaggaaatgattattttataaatctcatgctaaga 
I G Y L G N 0 Y FIN L MLR 
1020 aataatcttgattttcatgacaataaaggcgctgtgcaagtggat 
N N L 0 F H 0 N K G A V Q v 0 
1065 ataggatatgatatttttgataatggaatttattggtatttacaa 
I G Y 0 I F 0 N G I Y W Y L Q 
1110 tacttcaatggctatggagaaagccttatagattacaacaaacgc 
Y F N G Y G E S LID Y N K R 
1155 ttacaaagactttctacgggatttttgatttcatattaa 
L Q R L S T G F LIS Y * 
Figure 6.2. pldA gene nucleotide sequence and the translated amino acid sequence for 
the gene product (phospholipase A) in Campylobacter concisus. Performed using ORF 
Finder site from PubMed http://www.ncbi.nlm.nih.gov/entrez/query 
214 
6.3.4.1. Comparison of pldA gene sequences of C. concisus and C. coli 
strains 
PCR products (460 bp) of the pldA gene of C. concisus ATCC 51561, ATCC 51562 and 
C. coli strain 351 (Figure 6.1 A) were sequenced. The sequenced internal fragment of 
the pldA gene from C. coli strain 351 was then aligned to the published pldA gene 
sequence of C. coli (Accession number: CAA71915) and to the pldA gene sequence of 
C. concisus RCH3 using the Clustal W alignment tool. The resulting alignment 
confirmed a high degree of similarity between the pldA gene sequences of C. concisus 
and of C. coli. Similarly 460 bp PCR products of the pldA gene sequence from C. 
concisus reference strains ATCC 51561 (a genomospecies B strain) and ATTC 51562 (a 
genomospecies A strain) were sequenced and the sequences were compared to find any 
possible differences in the nucleotide sequence of the pldA gene in C. concisus strains 
from both genomospecies. Both sequences showed 99.8% similarity between them, 
confirming that the C. concisus pldA gene sequence is highly conserved in this species 
and in other closely related species as previously indicated (Figure 6.3). 
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6.3.5. The 3-dimensional (3D) protein structure of phospholipase A 
molecule in C. concisus 
A 3D protein structure for the PLA molecule of C. concisus constructed using the 3-D 
JIGSAW Protein comparative modeling server is illustrated in figure (6.4 A). A 3D 
protein structure for PLDA of C. coli constructed by SWISS-MODEL, Automated 
protein modelling server is illustrated in figure (6.4 B). The 3D protein structure of E. 
coli OMPLA produced by NiceProt is illustrated in figure (6.4 C). A comparison 
between the three models in figure 6.4 indicates that the ~JbarrÉl structure in the 
phospholipase A of C. concisus has a significant resemblance to the structure of PLA 
protein molecules of other Gram negative bacteria. 
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6.3.6. Cloning of the pldA gene in the pCru.1 plasmid 
Three selected colonies for E. coli pldA mutant PC 4269 carrying pCRpldA prepared as 
described in (6.2.4.1. and 6.2.4.2.) were named pCRpldA I, pCRpldA Il and pCRpldA Ill. The 
plasmid DNA for the selected clones pCRpldA I, pCRpldA II and pCRpldA Ill, was partially 
digested with EcoRI and EcoRY. The result indicated that clones pCRpldA II and pCRpldA III 
do not have the pldA gene insert in them as only one DNA fragment with similar size to the 
empty plasmid was detected in the ethidium bromide stained gel (Figure 6.5). Therefore only 
clone pCRpldA I was tested for complementation of pldA gene activity. A PCR amplification 
for an internal fragment of the C. concisus pldA gene confirmed the presence of the gene in 
clone pCRpldA I as a similar size PCR product was detected from this clone as from genomic 
DNA of C. concisus. No PCR product was amplified from DNA of pCR2.1 cloning vector 
(Figure 6.6). However, when hemolytic activity for pCRpldA I was tested using the contact 
hemolysin assay (2.4.3), no significant increase in hemolytic activity ratio was detected for 
PC4269 carrying pCRpldA I as compared to the non-hemolytic PC4269 carrying pCR2.1 
without pldA gene insert, and to the hemolytic E. coli parental strain PC 2254. 
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Figure 6.5. Molecular cloning of the 950 bp fragment of genomic C. concisus DNA 
including the 894 bp pldA gene sequence into plasmid vector pCR2.1 as indicated by 
diagram CA). 
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Figure 6.5. 
(B), RE analysis for three selected clones to confirm the presence and direction of the pldA 
gene insert in plasmid pCR 2.1. Lanes 1-3, EeaRI digestion of pCRpldAI, pCRpldAII, and 
pCRpldAIII. Lanes 4-6, EcoRV digestion for the selected clones I, ll, III respectively. The 
arrows indicate the size of the digestion products for clone I in lanes 1 and 4. 
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Kb 
11.5 
4.7 
2.8 
2.1 
1.7 
1.0 
0.8 
0.5 
580 bp PCR product 
Figure 6.6. PCR amplification using plasmid DNA from pCRpldAIl and pCRpldAI2 
with primers F3pla and R460 to amplify part of the pldA gene of C. concisus. Lanes 1 
and 2, PCR products from two selected clones; lane 3, no product from plasmid pCR 2.1 
without the pldA gene insert; lane 4, similar size PCR product using C. concisus RCH3 
genomic DNA as a template. 
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6.3.7. Cloning of the pldA gene in plasmid pGEM7z 
Plasmid DNA from selected clones (named as pIa 1 and pIa 2) for PC4269 carrying pGEM7z 
pldA was digested with EcoRI and also with BamHI and XbaI to indicate the direction of the 
pldA gene insert. RE analysis on the resulting recombinant molecules for plasmids pIa 1 and 
pIa 2 indicated the presence of the pldA gene in the correct direction for expression (Figure 
6.7 B). 
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Figure 6.7. (A) Diagram for the pGEM7z plasmid vector containingpldA gene. 
(B) RE analysis (EcoRI digestion) for plasmid DNA from clones pIal in lane 1, pla2 in lane 
2, and empty pGEM7z plasmid in lane 3. M, molecular weight standard (lambda DNA 
digested with PstI. The arrows indicate the different sizes of the digestion products. 
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6.3.8. Complementation of the E. coli pldA mutant with the C. concisus pldA 
gene 
6.3.8.1. Detection of hemolytic and phospholipase A activities using 
different assays 
Hemolytic activity was detected on blood agar plates when selected colonies for E. coli PC 4269 
carrying pGEM7z pldA (clones pIal and pla2) were grown on sheep blood agar as compared to 
the non-hemolytic E. coli PC4269. A significant increase in hemolysis rate was also detected 
from E. coli PC4269 carrying pGEM7z pldA clones pIal and pla2 when bacterial cells and cell 
extracts were tested for hemolytic activity by the contact and the liquid hemolysin assays 
respectively (Figure 6.8). Phospholipase Az activity levels, detected by the PLAz detection kit, 
were significantly higher in PC 4269 carrying the clones pIal and pla2 when compared to the 
PLA levels of the E. coli mutant PC 4269. The units of PLA activity measured in cellular 
extracts from the PC 4269 carrying the pGEM7z pldA clones pIal and pla2 were even higher 
than the units measured from cellular extracts of the hemolytic E. coli parental strain. No 
significant differences in PLA activity and hemolysis levels were found in cellular extracts of PC 
4269 carrying pCRpldA I as compared to the E. coli non-hemolytic mutant strain (Figure 6.9). 
Negligible amount of PLA activity was detected from a strong hemolytic phospholipase C extract 
of Clostridium perfringens which was used as a control in this test (Figure 6.9). 
The in VIVO phospholipase A assay described in 6.2.5.3. was used to indicate the 
complementation of PLA activity in the E. coli pldA mutant strain carrying the pGEM7z plasmid 
with the C. concisus pldA gene insert. Growth of the E. coli fabB indicator strain in the soft agar 
over the streaks of E. coli pldA mutant strain carrying the plasmid pGEM7z pldA and over the E. 
coli parental strain PC2254 was noticed. No growth of the temperature-sensitiv fabB mutant 
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indicator strain was noticed over the streaks of the E. coli pldA mutant PC 4269 and over E. coli 
pldA mutant PC 4269 carrying the pGEM7z without the C. concisus pldA gene insert. 
6.3.8.2. Detection of hemolytic protein bands in the native gel overlay 
The native protein gel overlay was checked for the presence of any hemolytic zones after 
incubation as described in (6.2.6.4.). Clear hemolytic zones located near the bottom edge of the 
native protein gel were noticed around C. concisus OMPs indicating that the hemolytic protein 
bands have low molecular weights (Figure 6.10. A). However in the HE samples, hemolytic 
zones were mostly on the top edge of the gel indicating that the proteins in these samples did not 
migrate towards the other end of the gel as compared to the SDS-PAGE identical gel (Figure 6.10 
B). This could be a result of the nature of the native gel. A hemolytic zone was also detected for 
celllysates from PC 4269 carrying the pGEM7z pldA (clone pIal) at a similar distance from the 
bottom edge of the gel to that detected for hemolytic zones from C. concisus OMPs (Figure 6.10; 
lane 5). No hemolytic zones were detected for the E. coli pldA mutant PC 4269 and for PC 4269 
carrying the pCRpldA (Figure 6.10, lanes 6&7). 
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Figure 6.9. Diagram for phospholipase A and hemolytic activities in E. coli cellular extracts, 
using the secretory PLA2 detection kit and liquid hemolysin assay, respectively. Tested 
samples were cellular extracts from the parental E. coli strain PC 2254, pldA mutant E. coli 
strain PC 4269, pldA mutant E. coli strain PC 4269 with an empty pGEM7z plasmid vector, 
hemolytic clones pIal and pla2, clone pCRpldA I, and phospholipase C hemolytic extract 
(PLC) from Clostridium perfringens. All samples were tested in duplicate, using both assays. 
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6.3.9. Immunoblot analysis for pIa hemolytic clones 
A western blot for whole cell lysates of C. concisus RCH 3, E. coli parental strain PC 2254, E. 
coli mutant PC 4269, PC 4269 carrying empty plasmid pGEM7z and PC 4269 carrying the 
pGEM7z pldA (pIal clone) was incubated with C. concisus antiserum (6.2.5.4.). After 
incubation and visualization of the membrane, immune bands were visible for the cell lysates 
from C. concisus RCH3 but not for any of the cell lysates of clone pCRpldA E. coli, parental 
strain PC 2254, pldA mutant E. coli strain PC 4269, pldA mutant E. coli strain PC 4269 with an 
empty pGEM7z plasmid vector (Figure 6.11; lanes 2, 3, 4, 5). Two immunoreactive bands (35 
kDa and 67 kDa) were also visible in the cell lysates of PC 4269 carrying the pGEM7z pldA 
(hemolytic clone pIal), which were similar in molecular weight size to the predicted molecular 
weight of the PLA molecule of C. concisus, (Figure 6.11, lanes 6 and 7 respectively). This 
indicates that the complemented phospholipase A hemolytic activity in the E. coli pldA mutant 
with pGEM7z with pldA gene (pIa clone) was restored by a protein molecule which is a product 
of the cloned pldA gene of C. concisus. 
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6.11. 
6.4. Discussion 
The genome of C. concisus strains showed nucleotide sequence similarity with the pldA gene of 
C. coli. The existence of this sequence similarity indicated that a similar gene encoding a 
hemolytic phospholipase A enzyme exists in C. concisus strains assigned to both PCR groups 
(genomospecies). Furthermore, the sequencing results for pldA gene PCR products from C. 
concisus ATCC 51561 (genomospecies B), C. concisus ATCC 51562 (genomospecies A) and C. 
coli 351, showed that the nucleotide sequence of the pldA gene is highly conserved in both C. 
concisus genomospecies and also in the sequenced C. coli strains 351 (this project) and C. coli 
UA585 (Grant et al., 1997). This is not unexpected, as the pldA gene is also highly conserved in 
other Gram negative bacteria, such as the pldA gene of Yersinia pseudotuberculosis which has 
100% identity to the corresponding sequence of Y. pestis the causative agent of human plague 
(Karlyshev et al., 2001). 
The NCBI BLASTP analysis of the amino acid sequence of the C. concius PLA protein indicated 
that it has more than 50% similarity to amino acid sequences for phospholipase A in other Gram 
negative bacteria including C. jejuni, Pasteurella multocida, Wolinella succinogenes, Vibio 
parahaemolyticus, Photobacterium profundum, Klebsiella pneumonifie, Yersinia Pestis, Y. 
pseudotuberculosis, Salmonella typhi, S. typhimurium, E. coli, Shigella flexneri and Pantoea 
agglomerans (sib-blast.unil.ch). Furthermore the 3D structure for the C. concisus PLA molecule 
(Figure 6.4 A) indicated that it has a ~JbarrÉl structure similar to the 12J~JstrandÉd architecture 
proposed for E. coli OMPLA (Figure 6.4 C), and of other ~JbarrÉl outer membrane proteins 
(OMPs) that have 8-22 strands (Brock et al., 1994). 
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It has been indicated that the two key elements of this model (calcium-binding and activation) are 
conserved in Gram negative bacteria, suggesting that the architecture of all OMPLA enzymes is 
most likely the same, and that their activity is calcium and dimerisation-dependent. The ~JbarrÉl 
of OMPLA has a hydrophobic outer surface with which the protein is embedded in the outer 
membrane with the active site of the enzyme located at the hydrophilic/hydrophobic boundary of 
the outer leaflet of the outer membrane (Dekker, 2000; Snijder et al., 2001). Several of the 
conserved residues form a complete and highly specific consensus sequence motif YTQ-Xn-G-
X2-H-X-SNG (Snijder et al., 2001). This consensus sequence motif has also been found in the 
amino acid sequence of the C. concisus PLA, in addition to the absolutely conserved Ser 152 
(Figure 6.3). These results are in accordance with sequence similarity previously reported for 
several OMPLAs (Snijder et al., 2001; Kingma et al., 2002). The phospholipase A sequences 
alignment and analysis also indicated the conservation of histidine 142 and serine 144 (Figure 
6.3). These amino acids were previously identified as essential residues in the active site of 
OMPLA by chemical modification and by site-directed mutagenesis, in addition to one calcium-
binding site (Figure 6.3) which has been identified in the structure of monomeric OMPLA 
(Figure 6.12; Snijder and Dijkstral, 2000; Dekker, 2000; Kingma et al., 2002). 
When the C. concisus pldA gene PCR product was cloned in plasmid vector pCR2.1 (Figure 6.5) 
and then introduced into the E. coli pldA mutant, no complementation was noticed for hemolytic 
phospholipase A activity. This lack of expression could be resulted from the cloning process 
which possibly caused a deletion that affected the active site (ribosomal binding site) of the gene 
or it could be caused by the lack of post-translational activation. Cloning of the C. concisus pldA 
gene in plasmid pGEM7z was therefore performed. Hemolytic phospholipase A activity was 
restored in E. coli pldA mutant strain PC 4269 carrying the pGEM7ZpldA plasmid (clone pIal) 
which expressed even higher rates of hemolysis and phospholipase A activities when compared 
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with the parental E. coli strain PC 2254. The complementation of hemolytic phospholipase 
activity in the non-hemolytic E. coli pldA gene mutant indicated that the cloning process was 
successful in restoring hemolytic phospholipase activity due to the expression and transportation 
of the PLA protein molecule in the host bacterial cell (Figures 6.8; 6.9; and 6.10). Furthermore, 
the strong hemolytic reaction and negligible PLA activity detected from a Clostridium 
perfringens phospholipase C extract indicated the accuracy of both phospholipase A and 
hemolysin assays. 
The in vivo phospholipase A assay also indicated the complementation of PLA activity in the E. 
coli pldA mutant PC4269 carrying the pGEM7ZpldA plasmid. The growth of the E. coli Jab 
mutant strain CE 1302 over the streaks of E. coli strains which produced phospholipase A 
enzyme and not over the strains lacking PLA activity confirmed the full production of 
phospholipase A in the transformed E. coli pldA mutant (de Geus et al., 1983; Grant et al., 1997). 
This in vivo phospholipase A assay was also was successful when applied on C. concisus and C. 
coli strains used in this study, however the growth of C. concisus strains was weaker on the MH 
agar due to the fastidious nature of these strains (data not shown). 
The native protein gel-blood overlay method (Figure 6.10) was a clear indication for the presence 
of a stable and active hemolytic protein product in the outer membrane extracts of C. concisus 
strains ATCC 51561 and ATCC 51562 (Figure 6.10 A lanes 1 & 2 respectively). A hemolytic 
band was also detected in a similar position for cellular extracts from the pIa clone as compared 
with cellular extracts for the non-hemolytic, pldA mutant E. coli host strain and with the non-
hemolytic clone pCRpldA (Figure 6.10 A, lanes 5-7) indicating the expression of the recombinant 
hemolytic phospholipase A protein from C. concisus. However, the hemolytic bands for crude 
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hemolytic extract (CHE) and hemolytic extract (HE) from RCH 3 were located in a different 
position from those of the OMPs and cellular extracts (i.e. in the top end of the native gel). This 
could be explained by the fact that CHE and HE were normal hemolytic extracts samples in PBS 
prepared by the extraction method explained in 5.2.2. as compared to the celllysates and OMP 
samples prepared by the standard method for protein gels (2.6.1.1 & 2.6.1.2). It is therefore 
likely that the protein molecules in the CHE & the HE samples did not migrate in the native gel 
and stayed in the top part of the gel where they were originally loaded (Figure 6.10 A, lanes 3 & 
4). The expression of the recombinant PLA protein was also confirmed by the presence of two 
immune bands, with molecular weights of around 35 kDa and 67 kDa in the cell lysates of the 
hemolytic E. coli pldA mutant PC4269 carrying the pGEM7ZpldA (clone pIa 1) (Figure 6.11, 
lane 6). The western blot was incubated with antiserum raised against whole cells of C. concisus 
RCH3 and adsorbed with E. coli antigens, therefore no immune bands were detected for any 
cellular proteins of E. coli parental or mutant strains (Figure 6.11, lanes 2-5). It can be suggested 
that the smaller immune band in the pIa clone (around 35 kDa) could be the recombinant PLA 
monomer while the 67 kDa immune band could be the PLA dimer as similar sized immune bands 
were also present in the cellular extracts of C. concisus RCH3 clinical strain. Similar results for 
monomer and dimer immune bands have been reported for E. coli OMPLA on SDS-PAGE 
western blots since 1997 (Ubarretxena-Belandia et al., 1998; Dekker et aI., 1999; Kingma et al., 
2002; Kingma and Egmond, 2002b). The outer membrane phospholipase A of E. coli is known 
to be present in a dormant state in the cell envelope as a monomer. Consequently, activation of 
the enzyme by various processes that cause cell lysis such as temperature shock, sonication and 
other chemical treatments, can induce dimerisation concurrent with the appearance of enzymatic 
activity (Dekker et al., 1997). A similar result is expected for the western blot of C. concisus cell 
lysates (Figure 6.11, lane 7), and for the two light immune bands in the cell lysates of the 
hemolytic clone pIal (Figure 6.11, lane 6). The presence of monomeric and dimeric OMPLA 
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(Figure 6.12) in SDS-PAGE by calcium induced cross-linking'with various Ca+2 concentrations, 
EDTA, IPTG, and by other dimerisation-favouring conditions has also been reported for E. coli, 
(Ubarretxena-Belandia et al., 1998; Dekker et aI., 1999; Kingma et al., 2002; Kingma and 
Egmond, 2002b). 
The sequencing and cloning results of the C. concisus pldA gene indicated that the nucleotide 
sequence of this gene in C. concisus clinical isolates resembles the pldA gene sequence encoding 
outer-membrane phospholipase A in other pathogenic campylobacters such as C. coli and C. 
jejuni. Moreover, cloning of this gene in an E. coli pldA mutant resulted in the complementation 
of both hemolytic and phospholipase A activities indicating the complete expression of hemolytic 
PLA activity by the cloned pldA gene sequence of C. concisus. 
The pldA gene in Gram negative bacteria is considered as a highly conserved structural gene 
encoding for phospholipase A which has been implicated as a virulence factor in pathogenic 
bacteria (Dekker, 2000; Snijder and Dijkstra 2000). A C. coli pldA mutant was shown to have a 
reduced hemolytic activity when compared with the wild type strain, while a C. jejuni pldA 
mutant was reported to have an impaired ability for cecal colonisation in chicken suggesting a 
role for pldA as a virulence determinant in campylobacters (Grant et al., 1997; Ziprin et al., 
2001). Similar research with a H. pylori pldA mutant suggested that the H. pylori pldA 
phospholipase has a role in colonisation of the gastric mucosa and possibly tissue damage after 
colonisation (Dorell et al., 1999). Moreover the pldA gene has been related to colonisation and 
persistence of H. pylori strains isolated from different geographic locations (Xerry and Owen, 
2001). Karlyshev et al. (2001), indicated that a PldA mutant strain of Y. pseudotuberculosis 
exhibited reduced phospholipase activity compared to the wild type strain. Furthermore, in vivo 
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attenuation of the mutant was confirmed suggesting that PldA is an essential virulence factor in 
the murine yersiniosis model of infection (Karlyshev et ai., 2001). A recent study on plaB gene 
which is known to encode for a major cell-associated phospholipase A activity in Legionella 
pneumophila, reported that a plaB mutant in L. pneumophila showed a reduced hemolytic activity 
and almost a complete loss in cell-associated lipolytic activity (Flieger et ai., 2004). 
The C. concisus pldA gene showed a significant similarity to the C. coli pldA gene, which has 
been considered a virulence factor in this pathogen (Grant et ai., 1997). Hence, the presence of 
this gene in C. concisus strains isolated from gastroenteritis patients indicates a possible 
pathogenic role for this gene and its encoded PLA protein in gastroenteritis. 
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Figure 6.12. Diagrams for Ca-binding sites in monomeric and dimeric molecules of E. coli 
OMPLA by Kingma et al., (2002). 
(A). The structure of monomeric OMPLA (I), with calcium ion bound between a carboxylate 
oxygen atom of Asp 149 in loop 3 and a carboxylate oxygen atom of Asp 184 in loop 4 (T I ). 
(B). Crystal structure of inhibited, dimeric OMPLA with one calcium ion per monomer bound at 
the dimer interface (1). The calcium ion is coordinated by the hydroxyl group of Ser 152 and the 
Ser 106 carbonyl oxygen atom of one monomer, the Arg 147 carbonyl oxygen atom of the other 
monomer, and three water molecules (I1). 
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Chapter Seven 
General Discussion 
Campylobacter spp. is one of the most common causes of community acquired bacterial 
diarrhoea in children both in Australia and throughout the world. Campylobacters have one 
of the highest incidences of infections of all the notifiable diseases in Australia, with a peak in 
children aged 0-35 months (Tenkate et al., 2001). The clinical manifestation of 
campylobacter infections depends on many variables including the infecting strain, the 
expression of virulence factors, and the host's immune status. C. jejuni and C. coli are most 
frequent causes of gastroenteritis and are established pathogens resulting in common 
symptoms of bloody diarrhoea together with dyspepsia and mild fever (Taylor and Hiratsuka, 
1990). However, atypical campylobacters such as C. concisus, C. upsaliensis, C. sputorum, 
C. lari, and C. jejuni subsp. doylei have also been associated with gastroenteritis; yet, the 
prevalence of these campylobacters appears to be significantly under-reported due to 
inappropriate isolation and identification methods. 
C. concisus is a fastidious hydrogen-requiring bacterium which has been linked to oral cavity 
infections by Tanner et al. (1981), and is currently known to be associated with gingivitis and 
periodontitis (Kamma et al., 1994; Kamma et al., 2001). C. concisus has been isolated from 
non-oral sources sin~É 1989 (Vandamme et al., 1989) and was also considered as a potential 
aetiological agent of enteritis in children (On, 1994; Russell, 1995; Lindblom, 1995). Some 
patient subgroups, mainly children under 24 months of age, the elderly and 
immunocompromised patients are known to be most susceptible to C. concisus enteric 
infections. Recently, C. concisus was also detected in the synovial fluid of patients with 
Campylobacter-associated reactive arthritis (Cox et al., 2003). Yet, little is known about this 
bacterium regarding its mode of transmission, reservoir and its true potential as a pathogen, 
due to the lack of any established typing procedure and other virulence related studies 
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(Engberg et al., 2000; Lastovica et al., 2000; and Maher et ai., 2003). The first isolation and 
identification of C. concisus in Australia was reported from· gastroenteritis cases in children 
under the age of two years at the Royal Children's Hospital (RCH) in Melbourne, between 
June, 1993 and June 1995, after modifying the protocol for detection and isolation of 
Campylobacter species (Russell, 1995). 
In this study 19 C. concisus strains isolated at the Royal Children's Hospital (RCH) and two 
C. concisus type strains ATCC 51561 and ATCC 51562 were identified by molecular 
methods and were analysed for the presence of possible virulence factors. The identification 
of these C. concisus isolates was confirmed by both biochemical and molecular methods. The 
detection of the 0.5 kb C. concisus species-specific PCR product in all C. concisus strains 
used in this study, following the method described by Matsheka et al. (2001), confirmed the 
identity of these strains, while no 0.5 kb PCR product was detected for isolates representing 
other Campylobacter spp. including the closely related species C. mucosalis. The C. concisus 
clinical strains were classified into two molecular groups (genomospecies) which was 
achieved by modifying the method of Bastyns et al. (1995) for PCR amplification of the 23S 
rDNA region. Using combinations of either primer pair MUC1-CON1 or primer pair MUC1-
CON2 respectively, the majority of the isolates(71 %), including the type strain ATCC 51562, 
were grouped as genomospecies A, while only 5 isolates and the type strain ATCC 51561 
(29%) were grouped as genomospecies B (Istivan et ai., 2004). However, in a similar study 
recently conducted on C. concisus clinical strains in Denmark, only 33.3% of the clinical 
isolates were found to be from genomospecies A, while the majority of the strains (66.7%) 
were from genomospecies B (Engberg et aI., 2005). DNA:DNA hybridisation studies 
previously conducted on C. consisus clinical isolates by Vandamme et al. (1989) also 
indicated that the reference strains ATCC 51561 (CCUG 20034) included in this study and 
the type strain (CCUG 13144) included in the study conducted by the Danish group were 
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from different DNA subgroups. Therefore, confirming the PCR typing results and suggesting 
that there is a true difference in geographical distribution of C. concisus strains related to 
gastroenteritis cases. Furthermore, the typing of C. concisus clinical strains into two distinct 
molecular groups (genomospecies) using PCR amplification in this study, confirmed previous 
findings by immunodiffusion analysis and numerical analysis of AFLP profiles for C. 
concisus strains (Matsheka et. al., 2002; On & Harrington, 2000). 
The outer membrane proteins (OMPs) of Gram-negative bacteria are the interface between the 
pathogen and the host and could play an important role in pathogenesis. In this study six 
different OMP protein profile patterns were detected using SDS-PAGE analysis, yet no 
correlation between the OMP profile groups, and the antibiotic resistant patterns of C. 
concisus against cephalothin or nalidixic acid could be established. The OMP protein profiles 
of C. concisus RCH clinical isolates and of C. concisus type strains were heterogenic in 
general, but they were easily distinguishable from the profile of the C. mucosalis reference 
strain. These results highlighted the heterogeneity and complex nature of these C. concisus 
strains isolated from cases of gastroenteritis at the Royal Children's Hospital in Melbourne 
(Russell et a!., 1998). Similarly, Aabenhus et al., (2002b) identified and differentiated C. 
concisus isolates from immunocompromised patients with diarrhoea, into two main groups 
depending on the protein profile patterns of whole celllysates, with 85% of the isolates found 
to be from the same group. Moreover, heterogeneity of OMP protein profiles has been 
recently reported in Pasteurella l11ultocida isolate, yet, no correlation was found between the 
OMP-type and disease status, or between OMP-type and geographic origin (Davies et al., 
2004). Therefore further molecular typing and identification studies should be conducted on 
C. concisus strains isolated from different clinical samples, including oral cavity infections, 
gastroenteritis conditions and arthritis conditions. Furthermore, clinical strains from different 
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geographic locations should similarly be analysed to detect the differences in distribution 
factors between different genomospecies. 
The characterisation of hemolytic activity in C. concisus clinical isolates was conducted in 
this study to find possible virulence factors that could highlight the pathogenic role of these 
bacteria in gastroenteritis. Only two studies on the potential pathogenicity of C. concisus 
species have been conducted on isolates from children with gastroenteritis. Adhesion and 
invasion assays performed on four C. concisus isolates showed that three strains were 
potentially associative strains causing disruption to the human Hep 2 cell line (Russell et al., 
1998). The second study was conducted on two C. concisus isolates, which were originally 
misidentified as C. mucosa lis (Figura et al., 1993). One isolate was found to induce 
intracytoplasmic vacuole formation on Intestine 407 cells similar to that caused by H. pylori, 
while both isolates induced a cytotonic-like effect as an elongation of Chinese hamster ovary 
(CHO) cells, which did not change after prolonged incubation (Musmanno et al., 1998). 
Many C. concisus strains used in this study were found to be hemolytic on blood agar plates, 
with some strains being more hemolytic than others on certain types of blood agar plates. 
Therefore, hemolytic activity in C. concisus clinical strains and strains of other 
Campylobacter spp. was tested by more than one of the hemolysis assays using series of 
different blood erythro"cytes, from mammalian and non-mammalian origins, to determine the 
interaction of the hemolysin(s) with the different membrane composition of those 
erythrocytes. Variable levels of hemolysis were detected from all tested strains on different 
types of blood erythrocytes, with human and rabbit erythrocytes producing higher hemolytic 
rates for all Campylobacter spp. tested strains as compared with sheep, horse, and chicken 
erythrocytes. The species specificity of red blood cells hemolysis and the difference in the 
hemolytic activity levels for strains of different Campylobacter spp. on erythrocytes from 
different mammalian species has been previously reported for C. jejuni (Hossain et al., 1993), 
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and H. pylori (Drazek et al., 1995). Hemolytic activity was detected in all the 19 C. concisus 
RCH isolates and the two reference strains ATCC 51561 and ATCC 51562 by using both the 
contact hemolysin assay and the liquid hemolysin assay. This was not unexpected as Pickett 
et al. (1992), demonstrated that several C. jejuni strains which did not appear hemolytic when 
plated on blood agar media, were hemolytic when tested by the contact hemolysin assay and 
that hemolysin production was strain dependent. Moreover, various levels of secreted 
hemolytic activity were constantly detected in culture filtrates (F) from C. concisus strain 
RCH 12 on blood agar plates and by the liquid hemolysin assay, indicating the possible 
presence of a secreted hemolysin with a molecular mass smaller than 10,000 kDa. It is 
possible that this type of hemolytic activity is a consequence of the action of one of the 
hemolytic cytotoxins possibly produced by C. concisus, as has been suggested for similar 
hemolytic activity in C. jejuni (Pickett, 2000). 
Hemolysins of Gram-negative bacteria are membrane-damaging toxins which destroy or 
derange known constituents of biological membranes leading to membrane dysfunction and 
physical disruption. Therefore they have been implicated as virulence factors in several 
bacterial species, which appear to benefit the pathogen by increasing the availability of iron. 
Hemolysins can increase the level of available iron in the host via lysis of erythrocytes and 
subsequent release of heme from hemoglobin (Stoebner and Payne, 1988). Iron limitation has 
a detectable effect on hemolytic activity of C. concisus strains when comparable amounts of 
C. concisus cells grown under varying iron limitation conditions were assayed for hemolysis. 
Other researchers have shown similar effects for iron restriction on hemolysin production in 
Vibrio cholerae (Stoebner & Payne, 1988), and c. jejuni (Hossain et aI., 1993). Therefore the 
presence of iron-regulated hemolysin(s) in C. concisus suggests a potential role for this 
hernolysin(s) as a virulence factor in the disease caused by these bacteria. 
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C. concisus strains show the presence of a heat-stable, calcium-dependent, membrane-bound 
hemolysin with phospholipase Az enzymatic activity (Istival). et ai., 1998). Similarly cell-
associated hemolytic activities reported to be produced by C. coli and C. jejuni strains were 
also related to pathogenicity (Wassenaar, 1997; Pickett, 2000). It was also concluded that the 
molecular weight of the phopholipase A hemolysin molecule is between 30-100 kDa as the 
filtrates of the 30 kDa MWCO filters were non-hemolytic and lacked phospholipase Az 
activity. This was confirmed by SDS-PAGE analysis and immunoblotting as a 35 kDa 
protein band was present in all OMP, CRE and in hemolytic extracts with phospholipase Az 
activity which could be considered as a potential component of the hemolytic phospholipase 
A protein molecule. When phospholipase inhibitors were used in this study, C. concisus 
hemolytic activity could only be inhibited by the lipid substrate phosphatidylcholine. 
Reactivity in this case implies the high degree of similarity between the active sites in the 
phospholipase Az in C. concisus and other bacterial PLAs which prefers phosphatidylcholine 
to phosphatidylethanolamine as a substrate (Matoba et al., 2002). Phosphatidylcholine is one 
of the main lipid components in the membranes of human and some other mammalian 
erythrocytes which explains the strong hemolytic effect of C. concisus hemolytic extract on 
human and rabbit erythrocytes (Istivan et aI., 1998). Calcium-dependent, outer-membrane 
phospholipase A activity in C. coli has also been reported to be more hemolytic on certain 
types of erythrocytes (Grant et al., 1997). Further studies to detect and purify other secreted 
hemolysins and cyt5toxins similar to those detected in other pathogenic Campylobacter spp. 
are needed to find other possible virulence factors in C. concisus. 
Phospholipase activity has been linked to pathogenesis in bacteria and recent studies indicated 
that many bacterial outer membrane or secreted phospholipases are hemolytic and could be 
responsible for tissue damage during infection (Songer, 1997). In this study, C. concisus 
crude hemolytic extracts showed a stable vaculation effect on eRO cell lines while the more 
244 
concentrated hemolytic extract had a strong cytolytic (damaging) effect on CHO cell lines. 
This intracytoplasmic vacuole formation effect, similar to that caused by cytotoxic 
Helieobaeter pylori was also detected when C. concisus bacterial cells were incubated with 
Intestine 407 cells, while performing adhesion tests (Musmanno et al., 1998). Hemolysins of 
Serratia marcescens and Haemophilus ducreyi have been reported to cause a damaging effect 
on human epithelial cells (Hertle et al., 1999; Wood et al., 1999), while phospholipase A in 
Legionella species has been reported to cause destruction of lung surfaces and epithelial cells 
(Flieger et al., 2000). Moreover, the phospholipases Ab Az and C of H. pylori were linked to 
the degradation of the phospholipid components of the mucosal barrier and phospholipase A 
of H. pylori is thought to have a role in colonisation (Dorell et al., 1999; Tannaes et al., 2001; 
Xerry and Owen, 2001). Further studies are required to determine whether this hemolysin 
isolated from C. cone is us produces a vacuolation effect on human epithelial cells similar to 
that produced by VacA toxin of H. pylori or VcVac from V. eholerae (Massari et al., 1998; 
Coelho et al., 2000) and also to detect any possible cytotoxic effects on different tissue culture 
cell lines. 
Interestingly, C. concisus clinical isolates RCH 3, RCH 6 and RCH 7 which were previously 
reported to be highly invasive by Russell -and Ward (1998), were found to have strong 
hemolytic phospholipase A activity in this study (Istivan et al., 2004). This supports the 
theory that hemolytic phospholipase A activity is an important virulence factor in C. cOl1cisus, 
and indicating that these strains could represent more virulent isolates than other C. concisus 
RCH strains. The variable rates for hemolytic and phospholipase A activity in different 
groups could be driven by the variation in virulence capabilities of these genomospecies. 
However, the clinical histories for the 19 RCH isolates and the small number of studied cases 
could not clearly indicate any difference in the severity of the symptoms of gastroenteritis in 
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infected children. Further analysis is required to identify and relate the clinical isolates with 
pathogenesis. 
Since hemolytic phospholipase A2 activity with cytolytic effect is considered as a virulence 
factor in pathogenic bacteria (Songer, 1997) and in strains of the closely related 
Campylobacter spp. of C. jejuni and C. coli (Brok et. al., 1998), the presence of similar 
activity in both genomospecies of C. concisus clinical isolates, supports the possible virulence 
role of this phospholipase/hemolysin in the pathogenicity of C. concisus. Protein studies are 
needed to further purify the membrane bound phospholipase A from different C. concisus 
isolates and to detect its specific biochemical properties. Furthermore C. concisus strains 
should also be examined for the possible presence of secreted phospholipase activities. 
The sequencing and analysis of the C. concisus pldA gene in this study indicated that the 
nucleotide sequence of this gene in C. concisus clinical isolates resembles the pldA gene 
sequence encoding outer-membrane phospholipase A in other pathogenic campylobacters 
such as C. coli and C. jejuni. The analysis of the translated amino acid sequence for 
phospholipase A in C. concisus indicated that the pldA gene encodes for a 35 kDa protein 
with 97% similarity to the 35 kDa phospholipase A protein found in C. coli (Grant et al., 
1997). When the nucleotide sequences of the flanking regions of the pldA gene were analysed 
in this study, it revealed that the pldA gene in C. concisus is located upstream of the ceuB 
gene. A similar structure of the pldA gene upstream of the ceuB and the ceuC genes has been 
reported in the C. coli and the C. jejuni genome, associated with the enterochelin transport 
system (Grant et al., 1997; Brock et aI., 1998; Parkhill et al., 2000). The pldA gene sequence 
in C. concisus shows a significant similarity to the pldA gene of C. coli, which is considered 
as a virulence factor in this pathogen (Grant et al., 1997). Therefore, the presence of this gene 
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in C. concisus clinical isolates indicates the possible pathogenic role for this gene in C. 
concisus. However further sequencing studies are needed to analyse both the ceuB and ceuC 
genes in different C. concisus strains belonging to both genomospecies and also from 
different geographic origins to detect any similarity between these genes and other pathogenic 
campylobacters. C. concisus clinical strains should also be screened for the presence of 
lipopolysaccharides (LPS), flagellin, and other known virulence related genes in closely 
related pathogenic campylobacters. 
BLASTP analysis of the amino acid sequence of the translated C. concius pldA gene indicated 
that it is more than 50% similar to phospholipase A proteins in other Gram negative bacteria. 
Furthermore, it indicated the presence of conserved residues and the complete and highly 
specific consensus sequence motif, (YTQ-Xn-G-Xz-H-X-SNG) in the amino acid sequence of 
the C. concisus PLA, in addition to the absolutely conserved Ser 152. These results are in 
accordance with sequence similarity previously reported for several outer membrane 
phospholipase A proteins (Snijder et al., 2001; Kingma et ai., 2002). Furthermore the 3D 
structure for the C. concisus phospholipase A molecule indicated that it has a I)-barrel 
structure similar to the 12-I)-stranded architecture proposed for E. coli OMPLA, and of other 
I)-barrel outer membrane proteins (OMPs) that have 8-22 strands (Brock et al., 1994). 
Moreover, cloning of this gene in E. coli pldA mutants resulted in the complementation of 
both hemolytic and phospholipase A activities in the recombinant strains indicating the 
complete expression of hemolytic PLA activity by the cloned pldA gene sequence of C. 
conclsus. 
Further molecular studies are required to construct C. concisus pldA gene mutant strains from 
different clinical samples (oral and gut strains). The attenuated strains should be examined 
for the ability to produce vacuolation and cytolytic effects on tissue culture cell lines and in 
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vivo on suitable animal models. The studies of the pathological effects of the hemolytic 
phospholipase A in C. concisus will highlight its role as a virulence factor similar to those 
found in other Gram negative pathogens. Furthermore, C. concisus strains isolated from 
healthy individuals should also be screened for the presence of possible virulence factors and 
typed using molecular methods to see if they belong to the same molecular groups as the 
clinical strains, in addition to the geographic distribution patterns of these isolates. It is 
recommended that all cases of diarrhoea in young children be appropriately investigated to 
determine the role of those campylobacters in neonatal gastroenteritis. The detection of 
possible virulence factors in C. concisus gastroenteritis-related strains in this study, in 
addition to the recent findings for its possible relation to other infections such as in cases of 
Campylobacter-associated reactive arthritis, indicates the importance of this opportunistic 
pathogen in patients with low or impaired immunity such as young children, the elderly, and 
immunocompromised patients. 
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The nucleotide sequence of the pldA gene of Campylobacter concisus including flanking regions on both sides of the gene (in Bold) 
with the possible translated amino acid sequences in three frameshifts. The predicted open readiJJg frame (ORF) for the PLA 
amino acid sequence is indicated font) on frameshift 3. Sequence data analysis was achieved by the Bioinformatics 
software Sci Ed Central for windows, (2000). 
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Appendix 2 
EMBL Nucleotide Sequence Database 
Accession#: AJ786391 
Status: not confidential 
Description: Campylobacter concisus pldA gene for phospholipase A 
ID AJ786391 standard; genomic DNA; PRO; 894 BP. 
XX 
AC AJ786391; 
XX 
SV AJ786391.1 
XX 
DT 30-JUL-2004 (ReI. 80, Created) 
DT 30-JUL-2004 (ReI. 80, Last updated, Version 0) 
XX 
DE Campylobacter concisus pldA gene for phospholipase A 
XX 
KW phospholipase A; pldA gene. 
XX 
OS Campylobacter concisus 
OC Bacteria; Proteobacteria; Epsilonproteobacteria; Campylobacterales; 
OC Campylobacteraceae; Campylobacter. 
XX 
RN [1] 
RP 1-894 
RA Istivan T.S.; 
RT 
RL Submitted (30-JUl'1-2004) to the EMBLlGenBanklDDBI databases. 
RL Istivan T.S., Biotechnology and Environmental Biology, RMIT University, 
RL Bundoora West Campus, PO Box 71, Bundoora, Victoria, 3083, AUSTRALIA. 
XX 
RN [2] 
RA Istivan T.S.; 
RT "Molecular characterisation of Campylobacter concisus, as a potential agent 
RT for gastroenteritis in children"; 
RL Unpublished. 
Appendix 2 I 
xx 
FH Key 
FH 
Fl' source 
FT 
FT 
FT 
FT 
FT 
FT 
FT CDS 
FT 
FT 
FT 
FT 
FT 
FT 
FT 
Location/Qualifiers 
1..894 
/ coun try=" Australia: Melbourn e" 
/db _ xref= "taxon: 199" 
/mol_type="genomic DNA" 
/organism="Campylobacter concisus" 
/isolation_source="stool of 12 months old male with 
gastroenteritis" 
1..894 
/evidence=EXPERIMENTAL 
/transl_ table= 11 
/gene="pldA" 
/product="phospholipase A" 
/EC_number="3.1.1.32" 
/function="outer membrane protein" 
/protein _id="CAH10186.1" 
FT /trans)ation="MQIYKKLALQNSPKQDLKENNASLLSSIKHETQNTQKTPSTKEDF 
FT SRIALANYLGENSSFNPLGISSYKMNYFLPFA YSFGSLGGENRKTEMKFQLSIKKRLFE 
FT DLLGLGEKYYVGYTQTSWWQNYKHSSPFRETNYQPEFFVDIPLHFEDYKFLNNLRVGIL 
FT HESNGKGDENLESRSWNRIYASSVFL YQRFLFIPRIWYRIPENSKDDDNPEITHYMGNF 
FT DINIGYLGNDYFINLMLRNNLDFHDNKGAVQVDIGYDIFDNGIYWYLQYFNGYGESLID 
FT YNKRLQRLSTGFLISY" 
Appendix 2 II 
Identification table for CLOs by phenotypic characteristics for clinical strains 
isolated between 199-1995, by Russell (1995). 
Organism Species Organism Species 
Number Number. 
1 C. jejuni subsp. doylei 21 C. concisus 
2 C. concisus 22 C. concisus 
3 C. concisus 23 C. concisus 
4 C. concisus 24 Unable to identify 
5 Unable to identify 25 Unable to identify 
6 C. sputorum subsp. sputorum 26 C. concisus 
7 C. upsaliensis 27 C. lari 
8 Unable to identify 28 Unable to identify 
9 Unable to identify 29 C. concisus 
10 C. concisus 30 C. concisus 
11 C. concisus 31 C. concisus 
12 C. sputorum 32 C. concisus 
13 Unable to identify 33 C. concisus 
14 Unable to identify 34 C. concisus 
15 C. concisus 35 C. concisus 
16 C. concisus 36 Unable to identify 
17 C. concisus 37 C. upsaliensis 
18 C. concisus 38 C. upsaliensis 
19 C. concisus 39 Unable to identify 
20 C. concisus 
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HAEMOLYSINS OF CAMPYLOBACTER 
CONC/SUS 
T.S. Istivan I, P.B. "Vard2, A. Lee I, P.J. Coloe I, S.C. Smith I 
I Dept of Applied Biology and Biotechnology, RMIT University, GPO Box 2476V, lIt/e/bot{/"/[e. 
Victoria 3001, Australia; 2i1tlicrobiology Dept, Royal Children's Hospital, Flemingtoll Road, 
Parkllil/e, Victoria 3052, Australia 
INTRODUCTION 
Call1pylobacter spp. are recognized as the major cause of acute bacterial gastroenteritis in 
humans. Hydrogen-requiring Cafllpy/obl{Crer concisus is commonly found in the oral cavity 
and is a conU110n isolate from children with diarrhoea. However, as yet no pathogenic role for 
C. concisus has been established in either periodontal disease or gastroenteritis in children. 
H]-requiring Campylobacter Spp.7 have been isolated from children with infectious 
dianhoea at similar frequency to C. jejl/ni, a major food-borne pathogen. In children with 
clinical diatThoea, where a bacterial pathogen is identified, 30-40 % of the isolates observed 
at the Royal Children's Hospital (RCH), Melbourne since 1993 were caused by C. jejtllli and 
'20-30 % caused by the H2-requiring Call1pylobacter spp. (of which 56.4 % are C. cOlleislls).7 
The importance of C. concislls as an agent of dialThoea in humans has been underesti-
mated. Phenotyping tests, immunotyping5 and polymerase chain reaction analyses, I show 
clinical disease-associated C. cOllcisus to have considerable genomic heterogeneity and 
represent a diverse group requiring further analyses. However, there is little information on 
the mechanism of pathogenicity of this bacterium. There is increasing evidence that 
Campylobacter spp. produce one or more toxins, including haemolysins. 11 The aim of this 
study was to determine and characterize the haemolysin activity of C. coneisus strains. 
METHODS & RESULTS 
Strains 
Identification was Ca/Tied out by standard methods on 21 C. concistls strains including 
ATCC 51561 and ATCC 51562 type strains, 10 one C. jejuHi ATCC 81116 strain, one C. hyoilei 
strain ATCC 51729 and one C. l11ucosalis ATCC 43462 strain. 
SOS-PAGE 
Outer membrane proteins were prepared ustng 1 % Sarkosyl, treated in SDS gel loading 
buffer and separated on a 12 % SOS-polyacrylamide gel and stained with Coomassie blue . .! 
The protein profiles of the clinical isolaces of C. COI1CiSlIS showed some variability in the 
major outer membranes compared to the two type strains of C. cOllcistts type strains. In 
addition, these protein profiles were considerably different from the C. II/ucosalis type strain. 
In all, 5 protein profiles were observed (Fig I). 
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Fig 1: Protein profiles of OMP frol11 C. C(}/lciSIIS stmins. lanes 1-12: C. CO/lcisus isolates 3 to 14. 
respectively; lane 13: C. (,(}Ilci.m.\" ATCC 51562; lane 14: C. COIICiSClS ATCC 51561; lane 15: 
C. I/l((cnsalis ATCC 43462. 
23S rDNA peR analysis 
The C. cOllcislIs-specific PCR assay was performed as described by Bastyns et al. I using 
DNA prepared after rapid boiling of cells of Call1fJylobacfer spp. (I x 10c, cfu). The expected 
size band of 306 bp was observed in all C. cOl1cis/./s isolates but not in C. l11((cosalis. The 
primers MUC I-CON 1 resulted in PCR amplification of seventeen of the C. cOllcisLlS isolates 
(group A) whilst the primers MUC l-CON2 resulted in PCR amplification of two of the 
C. cOllcislIS isoJates along with the C. cOllcisus ATCC strains 51561 and 51562 (group B) 
(Fig 2). 
Blood agar assay for bacterial haemolysin 
All C. cOllcisus isolates were tested for haemolytic activity on blood agar plates against 
other Campylobacfer spp. including C. jejwli ATCC 81116 and C. mucosa/is ATCC 43462. 
Call1pylobacter cells were grown in brucella broth (BB) microaerophilically for 3 days at 
3rC and aliquots of 0.1 mlof 1 x 106 cfu/ml were placed inlO 5 mm wells formed in blood 
agar plates. Bacteria were incubated for 3 days and screened for the presence of ~JhaÉmolótic 
zones around the wells. 
Haemolytic activity of the 19 C. cOl/cis/ls isolates was assayed on both chicken blood and 
rabbit blood agar plates at 3S oC (and at 42°C - data not shown) with 7 haemolytic isolates 
(only group A) observed. Incubation of the isolates on chicken blood agar plates containing 
10 pg/ml nalidixic acid enhanced the haemolytic activity of these isolates including 5 isolates 
previollsly non-haemolytic on both blood agars (both group A and B, data not shown). Only 
C. cOl1cisus ATCC strain 51562 showed haemolytic activity on chicken blood agar compared 
with C. mucosa/is strain 43462. 
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Fig 2: PCR analysis of the 23S rON A genes of C. C(mcis!ls isolates 3, 5, 6, II and 15, C. I/l!Ico,wiis 
ATCC 43462 (ilia, /lib and lIIe) using the C. cOllcisus specific primers. lane a: primers 
[vlUCI-CONI; lane b: primers MUCI-CON2; lane c: primers MUCI-CONI/CON2. 
Contact haemolysin assay 
Cells of Campylobacter spp. were washed and 106 cfu, were resuspended in PBS, mixed 
with an equal volume of I % washed erythrocytes and centrifuged at 2 000 x g for 5 min. The 
cell-erythrocyte pellet was incubated for 18-24 hours at 3rC microaerophilically prior to 
resLlspension in cold PBS and centrifugation of unlysed erythrocytes at 2 000 x g for 5 min 
at 4°C. The absorbance of the sllpernatant was determined at 550 nm. 
Using the contact microplate technique only three isolates showed weak or no haemolytic 
activity on human, sheep, chicken or rabbit erythrocytes. Figs 3 ancl 4 shows the results of 
C. COI1CiSLlS isolates 3-12 Llsing different erythrocytes. 
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Fig 3: Contact haemolysin assay ror c. COllcij'us isolates 3 to 12 compared with C. cOllcisllS ATCC 
strains 51561 and 51562 and other CWllpyiobacrer spp. using human and shcep Éróthrocót~s, 
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Molecular typing of the isolates by PCR analysis showed all the hospital isolates to be C. 
COI1CiSLlS (17 isolates produced PCR product using the MUC I-CON I primers whilst 2 
produced PCR product with the MUC I-CON2 primers as observed with the C. concisus type 
strains. 
Only a few strains including type strain ATCC 51562 produced haemolytic activity based 
upon the blood agar plates. The more sensitive contact haemolysin assay, however, showed 
that all C. COI1CiSLlS isolates were haemolytically active including the type strains ATCC 51561 
and 51562. The haemolysin(s) displayed a similar broad spectrum of activity against 
differenterythrocytes with maximum activity against human and rabbit erythrocytes and 
minimum activity against chicken erythrocytes as previously observed with C. jejuni. 
The relationship of haemolytic pattern to phenotypic and molecular typing schemes was 
evaluated. Strains with protein profiles similar to type strain ATCC 51561 showed weak 
haemolytic activity. Strains with protein profiles similar to type strain ATCC 51562 showed 
stronger haemolytic activity. C. concisus strains 3, 6 and 7 which are highly invasiveR were 
also strongly haemolytic. The haemolysin in these assays is shown to be membrane-bound, 
thermolabile and pronase-sensitive (data not shown) similar to membrane-bound haemolysins 
in C. jejuni 6 ancl C. coli. 2 The presence of iron-regulated haemolysin suggests a potential role 
as a virulence factor in disease. 
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Effect of iron-restriction on haemolytic activity 
Using 12.5 pg/ml EDDA or 12.5 pg/m I Dcsferral in Bmcc1la broth, C. cOl1ci.I"lIS isolate 3 
showed increased haemolylic aClIvily. which decreased at higher cancentrations (> 25 pg/ml 
af EDDA or Desferral) (Fig 5). 
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DISCUSSION 
SDS-PAGE pratein profiles of the whale-cell protein ancl aliter membranes (data nat 
shawn), has shawn several distinct pallerns far the C. cOllcislIS slrains fral11 RCH, Melbaurne. 
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INTRODUCTION 
Characterization of a haemolytic phospholipase A2 
activity in clinical isolates of Campyfobacter 
conc/sus 
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A membrane-bound, haemolytic phospholipase A2 (PLA2) activity was detected in clinical strains of 
Campylobacter concisus isolated from children with gastroenteritis. The clinical strains were 
assigned into two molecular groups (genomospecies) based on PCR amplification of their 23S 
rDNA. This calcium-dependent, heat-stable, haemolytic PLA2 activity was detected in strains from 
both genomospecies. A crude haemolysin extract (CHE) was initially prepared from cellular outer-
membrane proteins of these isolates and was further fractJonated by ultrafiltration. The haemolytic 
aClivity of the extracted fraction (R30) was retained by ultrafiltration uSing a 30 kDa molecular mass 
cut-off filter, and was designated haemolysin extract (HE). Both CHE and HE had PLA2 activity and 
caused stable vacuolating and cytolytic effects on Chinese hamster ovary cells in tissue culture. 
Primers for the conserved region of pldA gene (phospholipase A gene) from Campylobacter coli 
amplified a gene region of 460 bp in all tested isolates, confirming the presence of a homologous 
PLA gene sequence in C. concisus. The detection of haemolytic PLA2 activity in C. concisus 
indicates the presence of a potential virulence factor in this species and supports the hypothesis that 
C. concisus is a possible opportunistic pathogen. 
Cmnpylobacter species are one of the most common causes of 
human gastlOcntcIitis worldvvidc. Campylobacter jejuni and 
Campylo/Jacter coli are the species most commonly involved 
(Leach, 1997). However, recent studies have suggested that 
Campylobacter species other than C. jejltni and C. coli, such as 
Campylobacter cOllcisus, Campylobacter curvus, Campylo-
bactcr gracilis, Campylobacter upfaliensis and C. je;ul1i subsp. 
doylei (Musmanno et al., 1998; Maher et aI., 2003), may 
account for a proportion of cases of acute gastroenteritis in 
which no aetiological agent was identified. 
(Vandamme et aI., 1989; On, 1994; Russell, 1995) following 
the application of improved isolation methods (le Roux & 
Lastovica, 1998). Although C. concisus had been linked to 
gingivitis and periodontitis (Moore et aI., 1987; Kamma et 
aI., 1994), its pathogenic role in oral cavity infections could 
not be established. 
C. concisus straim were isolated from children with diarrhoea 
in different countries (Russell, 1995; Lindblom et al., 1995; 
le Roux & Lastovica, 1998), and are known to be most 
common in some patient subgroups, mainly children under 
24 months of age and immunocompromised patients 
(Engberg et al., 2000; Lastovica & le Roux, 2000; Aabenhus 
et aI., 2002). 
In the early 1990s, there was an increase in the numbers of 
the hydrogen-requiring C. COl1ciSIJS isolated from human 
oral cayities and from faeces of patients with enteritis 
tPresent address: Department of Microbiology/Austin Repatnatlon 
Medical Centre, Austin Campus, Melbourne, Australia. 
Abbreviations: CHE, crude haemolytiC extract; CHO, Chinese hamster 
ovary; HE, haemolytiC extract; LPS, Ilpopolysacchandes; OMP, outer-
membrane protein; OMPLA, outer-membrane phospholipase A; PC, 
phosphatldylchollne; PL, phospholipase. 
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C. cOllcisus is fastidious and characterized by low biochemical 
activity, which makes it hard to identify using conventional 
phenotypic techniques (Matsheka et aI., 2001). Furthermore, 
molecular typing methods such as DNA-DNA hybridization 
(Vandamme et al., 1989), PFGE (Matsheka et al., 2002), PCR 
(Bastyns etnl., 1995; Istivan etai., 1998) and protein profiling 
(Aabenhus et al., 2002) have shown it to comprise at least two 
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molecular groups (genomospecies), which are phenotypi-
cally indistinguishable, but genetically divergent (Matsheka 
et aI., 2002). 
Russell & Ward (1998) investigated C. conC1S11S isolated at the 
Royal Children's Hospital, Melbourne and showed that some 
isolates have the ability to adhere and invade HEp2 cells, at a 
rate 4-100-fold higher than the controls of pathogenic and 
invasive C. jejuni and C. coli strains. Musmanno et al. (1998) 
found that a C. cOllcisus strain isolated from stool samples in 
children with enteritis produced a cytotoxic-like effect on 
Chinese hamster ovary (CHO) cells similar to that shown by 
C. jejuni subsp. doylei, and induced intracytoplasmic vacuole 
formation similar to that caused by cytotoxic Helicobacter 
pylori, indicating the presence of different virulence factors in 
C. concisus clinical isolates and emphasizing the importance 
ofinvestigating the presence of virulence determinants in this 
organism. 
Phospholipases (PLs) constitute a very diverse subgroup of 
lipolytic enzymes that have the ability to hydrolyse one or 
more ester linkages in phospholipids with a phosphodiester-
ase as well as an acyl hydrolase activity. Phospholipases are 
diverse in the site of action on the phospholipid molecule, 
and their classification as phospholipases AI' A2, C and D is 
based on the site of cleavage of the attacked phospholipid 
(Waite, 1996). 
As phospholipids and proteins represent the major chemical 
constituents of the host cell envelope, enzymes capable of 
hydrolysing these chemical classes, such as phospholipases, 
are likely to be involved in the membrane disruption 
processes that occur during host -cell invasion. Conse-
quently, a wide variety of bacteria have evolved enzymes 
capable of hydrolysing phospholipids, which are key com-
ponents of all eukaryotic bilayer membranes (Waite, 1996; 
Songer, 1997). An example is the PLA of Gram-negative 
bacteria, which is an integral membrane protein located in 
the outer membrane and is recognized as a virulence factor 
for a number of bacterial species (Merino et al., 1999; Dekker, 
2000; Matoba et al., 2002). 
Studies indicate that many bact®"ial outer-membrane or 
secreted phospholipases are haemolytic and could be re-
sponsible for tissue damage during infection (Songer, 1997). 
Such enzymes include PLA in pathogens such as H. pylori 
(Dorrell et al., 1999; Tannaes et al., 2001; Xerry & Owen, 
2001 ), Legionella species (Flieger etal., 2000), C. coli (Grant et 
aI., 1997), Yersillia enterocolitica (Schmiel et al., 1998) and 
PLA I in Aeromonas species (Merino et al., 1999). 
We have previously reported (Istivan et al., 1998) a haemo-
lytic activity associated with lysis (haemolysis) of human and 
animal erythrocytes from 19 clinical strains of C. concisus, 
isolated from the faeces of children with gastroenteritis 
(Russell, 1995), and from the two reference strains ATCC 
51561 and ATCC 51562. The prevalence of this f3-hael11olytic 
activity in ageing bacterial cultures suggested that it could be 
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a cell-associated or membrane-bound haeI1101ysin(s), as has 
been previously detected in C. jejul1i and C. coli (Wassenaar, 
1997). 
In the present study, we report the extraction and initial 
characterization of a PLA2 membrane-bound haemolysin 
from C. cOl1cisus clinical strains, which were classified into 
two major molecular groups (genomospecies) based on their 
PCR product using primers designed to amplify the 23S 
rDNA region (Bastyns et (/1., 1995; Istivan et aI., 1998). In 
addition to haemolytic action on mammalian erythrocytes, 
the haemolytic extract causes vacuolation and cytolysis of 
CHO cells. We also report the presence of sequence similarity 
between the PLA gene pldA ofC. coli (Grant etal., 1997) and a 
gene sequence present in all clinical isolates of C. col1cisus 
tested. The detection of PLA2 activity in C. concisus strains 
suggests a possible pathogenic role for these bacteria in 
gastroenteritis and gingivitis. 
METHODS 
Bacterial strains and growth conditions. Nineteen C. cOllcisus 
clinical isolates (RCH 3-RCH 21) were used in this study. Data on 
c1imcal histories for patients related to the isolates are in (Table 1). 
C. col1cisus strains were isolated from children with mild or severe 
diarrhoea at the ROyal Children's Hospital, Melbourne, Australia, and 
were identified using standard phenotypic and bIOchemical tests 
(Russel1, 1995). Two C. cOl1cisus reference strains, ATCC 51561, ATCC 
51562, and the type strain ATCC 43264T of the closely related species 
CampyloiJactel 11lucosahs (Vandamme et al., 1989) were also used in this 
study. Haemolysin-positive C. coli strain 351 (a kind gift from N. Stern, 
USDA, GA, USA), C. cob NCTC 11366, C. jejlll1l strain 81116 and a 
C. jcjulli isolate (RCH 2) from a child's blood culture (Russel1 & Ward, 
1998) were also used in this study (Table O. All Campylobacter strains 
were grown on Columbia blood agar base (Oxoid) wpplemented with 
5-7 % (v/v) defibrinated horse blood, incubated at 37 QC for 2-4 days in 
anaerobic jars without anaerobic catalyst and flushed with a gas mixture 
consisting of 6 % O2 , 8 % CO2 , 6 % H2 and 80 % balance of nitrogen. 
The cell pellet WaS collected and washed with PBS for the contact 
haÉmoló~in assay, 01' with 10 mM Tris/HCI, pH 7'4,for the quantitative 
PLAz detection assay. Bacterial suspensIOns were prepared at 
109 c.f.u. ml-1 in PBS or Tris/HCI and, used when required. Stock 
culturÉ~ were preserved in tryptone milk (1 % tryptone and 10 % 
skimmed milk, w/v) at -70 QC. 
Molecular characterization of C. concisus by peR amplification. 
C. cOllcis1ts isolates were identified by PCR amphfication of the 23S 
rDl\'A following the method descnbed by Bastyns et al. (1995). This 
method was modified by using the two reverse primers (CONI and 
CON2) independently rather than a~ a m1Xture, and was used to group 
the clinical isolates. Segments of the 235 rDNA were amplified using the 
following pnmer pairs: mi.xture A, forWard primer ]',,!UC1 (5'-ATG 
AGTAGCGATAATIGGG-3') and reve!Se primel CONI (5'-CAGTAT 
CGGCAATTCGCT-3'); mixture B, forward primer MUC1 and reverse 
primer CON2 (5'-GACAGTATCAAGGATTTACG-3') and mixture C 
with all thlee primÉr~K RCH clinical isolates were grouped accOlding to 
their PCR product with either of the reverse primer sets A or B, 
compared wllh the reference strains ATCC 51561 and ATCC 51562 
(Istivan et al., 1998). 
All strains WCl e subjected to a second PCR identIfication protocol as 
described by Matsheka et al. (200 I) ba~Éd on the DNA sequence of the 
1·6 kb BglIJ-XbaI fragment of C. COI1ClSUS. Forward (5' -AGCAGCATC 
TATATCACGTT-3') and reverse primers (S'-CCCGTTTGATAGGC 
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Table 1. Campylobacter spp. strains used in this study 
Age is shown in years, y, or months, m. D, Diarrhoea; G, gastroenteritis; V, vomiting (days of 
symptoms). 
Strain no. Source and clinical conditioll Classification Other strain 
designation 
ATCC 51561 Faeces, 24 y, female C. conClsusB* CCUG 20034 
ATCC 51562 Faeces, 7 m, male, D C. conClsusA CCUG 20700 
ATCC43264T M ucosa of porcine intestine C. 111ucosahs CCUG 10771T 
RCH 1 Faeces, human C. coli NCTC 11366 
RCH2 Blood, hWl1an C. jejwli RCH, Australia 
RCH3 Faeces, 1 y, male, D & V, (3) C. concislIsA RCH, Australia 
RCH4 Faeces, 1 y, female, D & V, (5) C. concisusA RCH, Australia 
RCH5 Faeces,S m, female, D, (5) C. concisusA RCH, Austraha 
RCH6 Faeces, 2 y, male, D, (3) C. concisusB RCH, Australia 
RCH7 Faeces, 16 m, male, G & V, (7) C. concisusA RCH, Australia 
RCH8 Faeces, 5 m, female, D & V, (2) c. concisusA RCH, Australia 
RCH9 Faeces, 2 y, male, D & fever, (7) C. cOllcisusA RCH, AustJalia 
RCH 10 Faeces, 3 m, male, D, (6) C. COllCiSlIS A RCH, Australia 
RCH 11 Faeces, 2 y, male, D, (4) C. cOllcislISB RCH, Australia 
RCH 12 Faeces, 30 m, male, D, (20) c. concisllsA RCH, Australia 
RCH 13 Faeces, I y, male, D, (2) c. concisusA RCH, Australia 
RCH 14 Faeces, 2 y, female, Gt, (5) C. concisus B RCH, Australia 
RCH 15 Faeces,S m, female, G & V, (9) C. conrisusA RCH, Australia 
RCH 16 Faeces, 7 m, male, D & V, (2) c. conclsusB RCH, Australia 
RCH 17 Faeces, 13 m, male, D, (3) C. cOHcislIS A RCH, Austlalia 
RCH 18 Faeces, 2 m, female, D & V, (7) C. COIlCiSlIS A RCH, Australia 
RCH 19 Faeces, 2 y, female, D & V, (5) C. COl1C1SlISA RCH, Australia 
RCH 20 Faeces, 10 m, female, D & V, (14) C. col1cisusA RCH, Australia 
RCH 21 Faeces, 16 m, male, D, (2) c. concisusB RCH, Australia 
81116 Faeces, human C. jejulll UK, 1983 
351 Chicken isolate C. coli USA 
'Indicated as molecular group (genomospecies) A or B. 
t More than one pathogcn was detected. 
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GATAG-3') were used to amplify the 0·5 kb ORF3 region in C. roncisus 
strains (Matsheka et aI., 200I). C. ;ejllni 81116, C. coli 351 and C. 
mucosalis ATCC 43264T strains wcre used as controls. In both PCR 
protocols, boiled bacterial-cell extractions were used as a DNA template 
for PCR. All PCR amplifications were ~arriÉd out in triplicate to ensure 
the accur ac)" of this method. 
Extraction of the membrane-bound haemolysin from bacterial 
cells. Cell ;uspensions of 1010 cJ.u. ml- I of six C. COI1CiSIlS clinical 
isolates (RCH 3, RCH 5, RCH 6, RCH 7, RCH 11, RCH 15) and the two 
reference strains, ATCC 51561 and ATCC 51562, were sonicated. The 
sonicated cell. were centrifuged at 15000 gfm 15 min at 4 cc. The cell 
debris was separated [JOm the supernatant and tested for haemolytic 
activity using the contact haemolysin assay. To extract the membrane-
bound haemolysin, cell debris from the previous preparation was 
incubated for 16-20 h at 37°C in PBS with 0'05 % (v/v) Tween 20 
and 1 mglysozyme ml- I (Boehringer Mannheim). After incubation, the 
cell deblis was separated by centrifugation at 6000 g for IS min at 4 cC, 
and the supernatant was filtered through 0·22 I-lm filtcrs, before assay for 
haemolytic and PLA2 activities. This fi'action, designated crude hae-
molyslll extlact (CHE), was then subJected to ultrafiltration, bypassing 
through 100 and 30 kDa molecular mass cut-offYM filters (Amicon). 
http://Jmm,sgmJournals.org 
Retentates (RIOO, R30) and filtrates (FIOO, F30) from each ultrafiltra-
tion process were tested for haemolytic activity using the liquid 
haemolysin assay. R30 was designated haemolysin extract (HE) after 
testing for haemolytic actiVIty. Protein concentrations in CHE, HE and 
bacterial cells were estimated using the modified Lowry method 
(Markwell et al., 1987). All samples of the HE were tested for thc 
presence of lipopolysaccharides (Ll'S) uSll1g the method described by 
Spiro (J 966). 
Haemolysin assays. The contact haemolysin assay was used to detect 
the haemolytic activity of C. COIIC1SUS bactenal cells or cell pellets. 
Bacterial cell pellets were washed with stenlc PBS and then resuspendcd 
in PBS to 1 X 109 c.f.u. ml-I. Equal volumes of the bactenal suspension 
and of2 % (v/v) erythrocyte suspenslOn were mi.xed III a sterile tube. The 
mixture was then centnfuged at 1000 g for 5 mill to pellet the bacterial 
cells Oil top of blood erythrocytes. The tubes were then Illcubated at 
37 QC under microaerophilic conditions for 18 h. A comparative nega-
tive control of sterile PBS and blood erythrocytes was also lllcubated 
under similar conditions. After incubatlOn, the tubes were centrifuged 
at 1000 g for 5 min to pellet non-lysed cells and the OD550 of the 
supernatants was measured. A positive control for complete haemolysis 
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(100 %) was performed by replacing the same volume of bacterial 
suspension with distilled water in the test. 
The liquid haemolysin assay was used to test for the haemolytic activity 
ofHEs (with or without treatment with various agents). HEs (100 jJl) 
were mixed ,,~th an equal volume of 2 % (v/v) blood erythrocytes and 
incubated aerobically at 37°C for 2-6 h, and then centrifuged at 1000 g 
for 5 min to pellet non-lysed cells and the OD550 for the supernatants 
was measured. Negative controls of erythrocyte suspension mIXed with 
equal volumes of PBS buffer with or without treatment with various 
agents were also incubJted as indicated. Positive controls were 
performed by mixing equal volumes of 2 % (v/v) lysed erythrocytes 
with PBS contairnng a similar concentration of the added compound. 
Rabbit erythrocytes, 2 % (v/v) in PBS, were used in the haemolysin 
assays unless stated elsewhere. Both the contact and liquid haemolysin 
assays used in this study to quantIty the haemolytic activity we,'e 
repeated at least three times, using different samples for each bacterial 
strain. Moreover, each sample was tested in duplicate, and the mean of 
the OD550 readings is repmted. 
PLA2 assay. Quantitative PLA2 activity of CHEs and R30 HE in Tris/ 
HCl, pH 7·3, from C. concisus reference strams ATCC 51561 and 51562 
and clinical isolates RCH 3, RCH 6, RCH 15 was detected using the 
secretory PLA2 Correlate-Enzyme kit (Assay Designs), which also 
included a PLAz positive control, following the manufacturer's instruc-
tions. CHEsamples fi'om C.jejlllli 81116, C. coli NCTC 11366 and C. colt 
351 were also tested in this assay. All samples were tested for haemolytic 
activity, and lecithinase activity on egg-yolk agar plates; protein content 
was estimated by the modified Lowry method (Markwell et al., 1987) 
before samples were tested using the kit. A strongly haemolytic crude 
extract of Clostridium perfnngens with PLC but no PLA activity (a gift 
from Xenia Gastos, RJl.lIT University, Melbourne) was used to confirm 
the sensitivity of the PLA2 detection kit. 
Proteolytic treatment. Bacterial cells cultivated for 48 h were washed 
and resuspended to S X 109 c.f.u. in PBS and the protein content 
estimated (Markwell et al., 1987). Pronase solution (IO mgml-1; 
Boehringer Mannheim) was added to the cell suspemions at a ratio of 
3: 1 (w/w) cell protein/Pronase and the reaction mixture was incubated 
at 37°C for 30 min. Pronase activity was then stopped by heating the 
reaction mixture for 30 min at 65 QC, and the Pronase-treated cells were 
washed in PBS to remove residual Pronase prior to assay for haemolytic 
activity. Controls used were' bactenal cell suspensions without Pronase 
treatment; suspensions without P1 onase treatment heated at 65°C fOI 
30 mini and the negative and positive haemolysis controls. HE 
(containing 0·6 mg protein ml-1) was also treated ",'ith Pronase at a 
ratio of 3: 1 (w/w) HE/Pronase hefore testing for haemolytic activity 
and immunoblotting to characterize the nature of the haemolysin. 
J 
Preparation of outer-membrane proteins (OMPs), SOS-PAGE 
and immunoblot analysis. OMP plOfiles on SDS-PAGE were 
analysed to find a possible way of differentiating C. concisus isolates. 
OMPs were prepared from all C. COllciSIlS strains and the C. mucosalls 
type strain using 1 % (w/v) Sarkosyl according to the method of Filip et 
al. (1973). Fiftymicrograms of protein from each sample wereloaded on 
SDS-PAGE gels and protein profiles were visualized after electrophor-
esis by Coomassie blue stain. For Western blotting, CHE, Pronase-
treated CHE, HE and OMPs from C. concisus ATCC 51561 and from 
RCH 3 were solubilized in SDS-J'i-mercaptoethanol loading buffer, 
separated on a 12·5 % polyacrylamide SDS gel (Laemmli, J 970) and 
transferred electrophoretically onto nitrocellulose membrane using a 
Trans-Blot appalatus (Bio-Rad Laboratories) as described by Towbin 
et al. (1979). 
Polyclonal antiserum against whole bacterial cells of C. COI1CiSIlS RCH 6 
was rai5ed in female BALB/cmice by injecting 5 X 107 formalin-neated 
bacterial cells in PBS intraperitoneally; two booster injections were 
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given within 3 weeks before llljecting 106 Sp2 myeloma cells intrapel-
itoneally into the mice. The ascites flUld was drained from the injected 
mice from abdominal swellings after 2 weeks. The collected tluid was 
centrifuged at 6000 g for 10 min and the supernatant was used for 
1mmunoblottlllg. 
Evaluation of the effect of physical and chemical factors on 
haemolytic activity. Bacterial cell suspensions in PBS and HE from C. 
conCISUS Isolate RCH 3 were heated for 5, 10, 15, 20 and 30 min at 
different temperatures (45,60,75 and 100°C) cooled on ice for 5 min 
and then used in the contact or liquid haemolysin assay to test for heat 
stability. 
Calcium chloride and magnesium chloride were added separately to C. 
conCISUS cell suspensions or to CHE in final concentrations of 1,10,20, 
40, 50, 100, 200 and 500 j.LM, while ferrous chloride was added at final 
concentrations of 1, 10, 20, 40 Jnd 50 J.lM. The mixtures were incubated 
for 30 min at room temperature before cl)1:hrocytes were added to the 
haemolysin assay mixture. The effect of the calcium chelator EGTA on 
haemolytic actiVIty was also tested by adding it to the assay at a final 
concentration of 1 mM with or without the presence ofCaCI2 under the 
same conditions. Negative controls of 2 % erythrocyte suspension in 
PBS incubated with similar concentrations ofCaCl2, MgCIz, FeCl2 and 
EGTA in PBS were also tested in each a,say to investigate the effect of 
these divalent cation concentrations on blood el)1:hrocytes. 
Inhibition of haemolysis with lipid substrates. Phospholipase 
inhibitors and protein kinase inhibitors resembling major classes of 
lipids found in biological membranes were tested in the liquid 
haemolysin assay to determine the nature of the C. COIlCISUS haemolysin. 
HE from RCH 3 was incubated for 30 min at room temperature w,th 
20-60 J-lg ml- 1 final concentrations of each of the following compounds 
(pnor to the addition of erythroC)1:es to the assay mi.'Cture): stauro-
sporine (a protein kinase inllibitor), sphingomyelin, phosphatidylgly-
cerol, phosphatidylcholine (a PLA inhibitor), p-nitrophenyl phosphoryl 
cholme (a PLC inhibitor) and phosphatidylcthanolamine. All com-
pounds were obtained from Sigma. Inhibition of haemolytic activity 
was determined by comparison of results from samples with and 
without inlubitor. Negative controls contained 2 % el)1:hroC)'te 
suspension in PBS incubated ,vith the same concentratIOns of 
inhibitors. 
Preparation of CHO cell cultures for evaluation of cytotoxiC 
activity. The C)'totoxic activity of HE (R30) and CHE wa' tested on 
CHO cells. Cells were routinely cultured in 25cm2 tissue culture flasks 
containing 10-12 ml Dulbecco's modified Eagle's medium (DMEM) 
supplemented with 10 % (v/v) newborn calf serum (Trace Biosciences). 
The cultures were incubated at 37°C with 5 % CO2 , When used for 
cytotoxicity, confluent cells were washed with sterile PBS and harve5ted 
from culture flasks using trypsin/EDTA. The pellet was resuspended in 
J·O mIDMEMwithout;eruIl1.AnaliquotofO·1 mlofl X 105 CHOcells 
(estimated usmg a Neubauer counting chamber) was added to each well 
of a 96-well culture plate. Samples (100 J-Ll) of serial1:Vl>0fold dilutions of 
CHE or HE (extracted from five different C. concIsus strdll1s) were then 
added separately to each well and incubated as above. The cells were 
tested for C)1:otoxic effect (vlsible rounding or cell damage) at 16,24,48 
and 72 h. Filtrates fi'om 30 kDa molecular mass cut-off filters (F30) wele 
also tested on CHO celll fm C)'totoxic activity. CHE, HE and F30 
Samples were also tested for haemolytic actIVity before they were used in 
the c)'totoxicity assay. 
PCR amplification of pldA gene sequences from C. concisus. Two 
oligonucJeotlde primers, forward primer Fpla (5' -CCTCACCCTTTA 
GAGAAI\CAA-3') and reverse primer Rpla (3' -GCTTCCTCCATAGC 
CATT-5'), wele designed from the conserved region III the C. colI 
phospholipase A (pldA) gene (Grant ct al., 1997; Brok et al., 1998) and 
used to amphfy a 460 bp internal fragment of the homologous gene 
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from C collcislIS. Genomic DNA prepa! ed by the method of Maniatis 
et al. (1982) from C. collcisHS RCH dinicallsolates, the two reference 
stJains ATCC 51561 and ATCC 51562 and the control C. coli strain 351 
were used as templates 111 this reaction. Due to the extracellular DNase 
activity found in C. C0l1CiSH5 strains reported by Matsheka et al. (2002), 
the PCR amplification of the 460 bp internal fragment of pldA gene was 
repeated more than three times to obtain a clear PCR plO duct from 
C. COl1CiSU5 genomic DNA. 
RESUL TS AND DISCUSSION 
Molecular typing of C. concisus isolates 
The detection of a 0·5 kb C. col1cislIS species-specific PCR 
product (Matsheka et al., 2001) in all RCH clinical isolates 
used in this study confirmed the strains to be C. concisus. No 
0·5 kb PCR product was detected for isolates representing 
other Campylobacter species (data not shown). 
By modifying the method for PCR amplification of the 23S 
rDNA region (Bastyns et aI., 1995) and using combinations 
of either MUCI-CONl or MUCI-CON2, we were able to 
classify clinical C. c011cisU5 isolates from gastroenteritis cases 
in children into two genomospecies, where the majority of 
the isolates, 14 out of 19 (74%), and the reference strain 
ATCC 51562, were grouped in genomospecies A, while only 
five isolates (26 %) and the reference strainATCC 51561 were 
grouped in genomospecies B. Interestingly, the sequences of 
the two reverse primers, CON 1 and CON2, are significantly 
different, yet yield a similar-sized PCR fragment (306 bp), 
indicating a significant genomic difference between the two 
PCR groups. PCR molecular grouping and clinical histories 
for RCH isolates are summarized in Table l. 
Molecular Identification and typing of C. concisus isolates has 
shown this species to be a complex species, that represents a 
taxonomic 'continuum', comprising several genomospecies 
(Matsheka et al., 2002). Our results support the complex 
nature of C. concisus by demonstrating two molecular groups 
(genomospecies) within the Australian isolates involved in 
clinical cases of diarrhoea, with the majority of cases 
belonging to genomospecies A. However, the significance 
of these two genomospecies and their relatedness to patho-
genesis is yet to be established. 
J 
Phospholipase A2 aclivlty In Campylobaeter cone/sus 
Five different protein profiles were detected using SDS-
PAGE analysis of OMP extracts for C. concisus strains, 
compared with the protein profile for the C. Inl/cosalis 
reference strain (Fig. 1, lane 2). The majority of PCR group 
B strains showed an identical protein pattern (Fig. 1, lanes 8, 
13, 18 and 23) except for the reference strain ATCC 51561 
and strain RCB 14, which appear to be missing major 
polypeptide bands in the 43 kDa region (Fig. 1, lanes 3 and 
16). However, PCR group A (genomospecies A) isolates 
demonstrated more diversity in their SDS-PAGE protein 
profile (Fig. 1, lanes 4-7, 9-12,14,15,17,19-22). 
Recently, C. cOl1cisflS isolates from immunocompromised 
patients with diarrhoea were differentiated into two groups 
depending on protein profiles ofwhole-celllysates, with 85 % 
of the isolates found to be from the same group (Aabenhus et 
aI., 2002). Immunodiffusion analysis (Vandamme et aI., 
1989) and numerical analysis of AFLP profiles (On & 
Harrington, 2000) have also indicated the presence of two 
distinct gcnomospecies. 
However, we have not yet aligned our two molecular 
grouping patterns for the Australian isolates with patterns 
generated by other researchers. Therefore, it remains unclear 
whether the genotype of the majority of C. col1cisflS RCH 
strains assigned to PCR group A (genomospecies A) resem-
bles that of the majority of C. concisus strains isolated from 
immunocompromised patients (Aabenhus et al., 2002). 
Haemolytic activity of bacterial cells and 
haemolysin extract 
Different levels of haemolytic activity were detected in all C. 
concisus clinical isolates and reference strains using the 
contact haemolysin assay, even though clear haemolytic 
zones were not produced around colonies on blood agar 
cultures of some C. collcisus and other Campylobacter species 
isolates. The pellet of sonicated C. cOllcisU5 cells showed 
similar haemolytic activity to the intact cells. No haemolysis 
was detected when the supernatants, collected after sonica-
tion and centrifugation, were tested using the liquid assay, 
indicating a cell-bound haemolytic activity. 
The CBE showed lower haemolytic activity compared with 
101112 13141516 17181920212223 24 
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Fig. 1. SOS-PAGE of aMP profiles of C. con-
c/sus strains Visualized by Coomassle blue stain. 
Lanes: 1 and 24, low molecular mass protein 
markers; 2, aMPs for C. mucosalis ATCC 
43264T; 3, aMPs for C. conClSus ATCC 
51 561 ; 4, aMPs for C. concisus ATCC 51 562; 
5-23, OMPs for RCH C. conc/sus cltnical ISO-
lates. Arrows Indicate the six C. conc/sus strains 
aSSigned to genomospecies B, In lanes 3. 8, 13, 
16, 18 and 23. The other 15 C. conc/sus strams 
were aSSigned to genomospecles A. 
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FIOO filtrates and R30 retentates (HE), which completely 
haemolysed the erythrocytes after a short incubation period 
(1-3 h) when tested using the liquid haemolysin assay 
(lOO % haemolysis). A similar pattern was observed when 
HEs from seven other C. col1cisus isolates representing both 
genomospecies were examined (data not shown). 
The LPS test of the HE (Spiro, 1966) showed that all of the 
HE samples tested contained small amounts of LPS 
« 3 f,lgml- 1), compared with a positive control of LPS 
extracted from C. jejuni strain 81116 containing 500 f.1g 
LPS ml- 1• Furthermore, C. cOl1cislIS strains showed the 
presence of strong cell-associated haemolytic activity, with 
higher levels of haemolytic activity on human and rabbit 
erythrocytes when compared with C. jejll1li and C. coli tested 
strains (lstivan et al., 1998). 
Haemolytic activity in all C. cOl1cisus isolates was membrane-
bound. Sonication of cells did not release the hacmolysin 
from cell debris and treatment with lysozyme and detergent 
was needed for effective haemolysin extraction, indicating 
the presence of a membrane-bound haemolysin (Deshpande 
et al., 1997). Pronase-treated cell suspensions, CHEs and HEs 
showed negligible haemolytic activity in comparison with 
control untreated samples, when tested using the haemolysin 
assay, indicating that the haemolysin was proteinaceous in 
nature. 
Quantitative detection of PLA2 activity in HEs 
Varying levels ofPLA2 activity, ranging from 25-135 units in 
50 f.1l samples of CHE, were detected in C. concisu5 clinical 
isolates and reference strains, representing both genomos-
pecies, when the secretory PLAz Correlate-Enzyme kit was 
used. PLA2 activity for CHE from C. jejuni 81116, C. coli 
NCTC 11366 and C. coli 351 controls were 20, 26 and 55 U, 
respectively, in 50 f.1l samples (Fig. 2). Higher levels of PLAz 
activity were detected from HE (R30) of c. col1cisus strains, 
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Fig. 2. PLA2 activity In CHEs from C. conClsus strains representing 
genomospecies A and B and from other Campylobacter strains. PLA2 
activity was detected uSing a commerCial kit for detecting secretory 
PLA2 activity In clinical fluid samples. PLA activity in 50 III CHE 
samples protein was measured and plotted according to the standards 
prOVided In the kit. 
~~ -------------------
with a range of 90-160 U per 50 )J1 sample. In HE samples 
from strain RCH 3, 1-2 U of PLA2 activity (f,lg protein)-l 
was detected, while CHE samples from the same strain had 
only 0·5-1 U PLAz activity (f.1g protein)-l (Table 2). 
To show that the phospholipase activity in C. col1cislIS was not 
due to the presence of haemolytic PLC activity, CHE and HE 
samples and C. concislls bacterial cells were inoculated on egg 
yolk agar. No PLC (lecithinase) activity was detected on the 
medium compared with the control PLC sample from 
Clostridium perfringcl1s. Furthermore, no PLA2 activity was 
detected when an extract of PLC from Clostridium perfril1gcns 
was tested using the secretory PLA2 Correlate-Enzyme kit, 
confirming the specificity of the test kit. 
Table 2. PLA2 actiVity, haemolytic activity on 2 % rabbit erythrocytes and effect on CHO cells for different bacterial cell fractions of 
C. concisus RCH 3 strain J 
PLA2 activity was quantitatively detected as units per 50 ~tJ of sample (per jlg protem) by a commercial kit. 1\1', Not tested. 
Sample tested PLA2 activity [V (pg protcin)-i] Haemolysis (%)* Effect on CHO cells 
Intact bacterial cells :\1' 60" 1\1' 
Sonicated cell pellet 1\1' 75" 1\1' 
Supernatant from sonicated cells No actmty No haemolYSiS b No effect 
Cl ude haemolysin extract (CHE) 65 VII U (pgprotein-l)] 80b Vacuolation 
R30 haemolysin extract (HE) 120 V 12 V (pg protein-i)] 100b Cytolysis 
Diluted haemol),sin eA'tract (HE) 58 V 11·4 V (pg protein- 1)] 100b Vacuolation 
Pronase-treated haemolysin extlact :\1' No haemolysis I> No effect 
F 30 No activity No haemolysis/> No effect 
'Haemolysis rate was detected by contact haemolysll1 assay (a) or liquid haemolysin assay Cb) as a percentage of complete lysis of rabbit blood 
el ythrocytes. 
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Immunoblot analysis of OMPs and HEs 
A major immunoreactive band of around 34 kDa and a 
number of minor immunoreactive bands (39, 44, 67 kDa) 
from the OM Ps, CHEs and HEs (Fig. 3, lanes 1,2,3,4 and 6) 
were detected on the immunoblot using polyclonal anti-
whole-cell C. concisus serum in standard samples but were 
absent after Pronase treatment of HE (Fig. 3, lane 5). This 
indicated the proteinaceous nature of this HE. The 34 kDa 
major immunoreactive band was present in the HE sample 
as well as a less intense 39 kDa band, but no higher mole-
cular mass immunoreactive bands were detected in the HE 
sample. 
The 34 kDa protein band was present in all haemolytic 
extracts with PLA2 activity (data not shown) and could be 
considered a potential component of the haemolytic PLA 
protein molecule. This may account for the retentates (R30) 
retaining macromolecules with strong PLA2 activity and 
haemolytic effect when tested on erythrocytes, while the 
filtrates (F30) did not show any effect (Table 2). 
Protein molecules of approximately the ;ame molecular mass 
with PLA activity have been reported in other enteric 
bacteria, such as PLA in C. coli with a predicted molecular 
mass of 35 kDa (Grant et al., 1997), and in Serratia species, 
the predlCted molecular mass for PLA] is 33·4 kDa (Song 
et Ill., 1999), while the molecular mass for the outer-
membrane phospholipase A (OMPLA) monomer in Escher-
ichia coli is 31 kDa (de Geus et al., 1983; Brok et aI., 1998). It 
could be suggested that the molecular mass of the enzyme 
monomer in C. concisu5 is approximately 34 kDa, by com-
parison with the major immunoreactive band on the blot, 
while one of the other minor bands (67 kDa) may represent 
the dimeric state of the enzyme. 
Fig. 3. Immunoblot for C. concisus extracts. Lanes: 1, ATCC 51561 
OMPs; 2, ATCC 51 562 OMPs; 3, RCH 3 OMPs; 4, HE from RCH3; 5, 
Pronase-treated HE from RCH 3; and 6, CHE from RCH 6. The blot 
was Incubated With antiserum raised III mice injected with a suspen-
sion of whole bacterial cells from C. concisus RCH 6. The 34 and 
67 kDa bands Indicated are pOSSible bands for PLA monomers and 
dlmers, respectively. 
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Phospholipase AQ activity In Campylobacter conc/sus 
The effect of different chemical and physical 
treatments on haemolytic activity 
C. cOl1cisus haemolysin activity was not affected when cell 
suspensions were heated at 45, 60 and 75 QC for IQ, 20 and 
30 min, indicating thermal stability to 75 QC. The HE was 
more susceptible to heat treatment than were whole-cell 
suspensions, with a loss of 40 % of the total haemolysin 
activity after treatment at 75 QC for 10 min (data not shown). 
Haemolytic activity of cells and HE kept at -20 and -70 QC 
for several months showed no detectable change by both the 
contact and liquid assays, indicating that haemolysis was 
caused by a heat- and cold-stable factor. 
Calcium ions had a notable effect on the haemolytic activity 
when added to the haemolysin assay miA'1:ure in varying 
concentrations compared with controls. When C. concisus 
bacterial suspensions or HEs were tested in the presence of 
Ca2+, there was a 5-15 % increase in haemolytic activity 
upon the addition of 1-10 pM CaCh. However, higher 
concentrations (20-500 J..LM) caused a gradual decrease in 
the haemolytic activity of HE (Fig. 4). Removing Ca2+ from 
the environment, by the addition of 1 mM EGTA as a calcium 
chelator, completely blocked the haemolytic activity, which 
could not be restored by the addition of extra Ca2~ (IO-
100 J..LM) to the assay (Fig. 4). 
Ferrous ions also had a significant effect on haemolytic 
activity of C. concisus when tested using the contact haemo-
lysin assay, with 10 flM FeCh decreasing the activity to 40 % 
and 20 flM FeCl2 to 20 % of the total haemolysis. Concen-
trations of 40 J..LM FeClz or higher completely blocked the 
activity of this haemolysin (Fig. 4). 
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Fig. 4. Effect of divalent cations and the calcium chelator EGT A III the 
presence of CaCIQ on haemolytiC actiVity of C. conc/sus. Bacterial 
suspensions from C conc/sus stralll RCH 3 were tested using the 
contact haemolysln assay In the presence of M~RMM ~lM CaCIQ (+), 
l~ 100 f.lM FeCI2 (A), M~RMM tJM MgCI2 (:::I) and 1 -100 f.lm CaCI2 
With 1 mM EGT A (X). All samples were tested In triplicate. 
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The addition of Mg2~ had a weaker effect on haemolytic 
activity compared with the effect of CaH and Fec+ ions. 
Haemolytic activity was only reduced significantly when 
concentrations higher than 40 f.LM MgCh were added to the 
contact hacmolysin assay (Fig. 4). Moreover, the addition of 
Ca2-, MgH or FeH ions to the haemolysin assay did not 
seem to have any effect on erythrocytes, compared with 
negative controls containing similar concentrations of these 
diyalent cations. 
Calcium ions are required for the catalytic activity of 
cukaryotic and prokaryotic PLA (Weinberg, 1985; Songer, 
1997), such as the strictly calcium-dependent OMPLA in E. 
coli (Dekker, 2000). Recently, CaH was found to play a 
catalytic and regulatory role in the formation and stabiliza-
tion of the active dimeric state of OMPLA therefore 
preventing uncontrolled breakdown of the surrounding 
phospholipids in the outer membrane of the bacterial cell 
(Kingma & Egmond, 2002). It is likely that calcium also acts 
in a similar role in regulating the PLA2 activity of C. concisus. 
These results can best be explained by the presence of a heat-
stable, calcium-dependent protein with haemolytic and 
PLA2 activities in C. concisus similar to the haemolytic, 
calcium-dependent PLA in C. coli (Grant et al., 1997) and to 
the calcium-dependent OMPLA of E. coli, which harbours 
PLA] and A2 activities (Dekker, 2000). 
The ability to acquire iron is essential for the bacteria to grow 
and, consequently, iron deficiency is a major factor involved 
in the induction of virulence determinants in pathogenic 
bacteria (Pickett et al., 1992). Yields of bacterial enzymes and 
toxins in complex medium can be modulated by iron, such as 
lecithinase production in ClostridIUm pelfril1gens and the a-
haemolysin of Staphylococcus aureus, where the invasiveness 
of those pathogens is enhanced in strains that can release iron 
from host macromolecules (Weinberg, 1985). Ferric ions 
were found to a have a significant effect on grovvth, OMP 
composition and siderophore synthesis in C. jejuni (Field 
et al., 1986). 
In this study, C. concislls haemolytic activity was reduced 
when ferric ions were added to the haemolysin bioassay, with 
a sudden decrease in the haemolytic activity of cells observed. 
In a previous study, we reported th~t growing C. concisus cells 
in an iron-deficient medium (using EDDA as an iron 
chelator) caused a detectable increase in haemolysis rates 
when these cells, and culture filtrates, were tested in the 
contact and liquid haemolysin assays, respectively (Istivan 
et al., 1998). This was not unexpected, since a similar 
regulatory effect of calcium and iron on haemolytic activity 
was reported for C. jejuni and C. coli haemolysins (Hossain 
et al., 1993; Grant et al., 1997) and supports our theory 
that haemolytic activity is an important virulence factor in 
C. col1cisus. 
Haemolytic activity in the presence of lipid 
substrates and phospholipase inhibitors 
PC reduced haemolysis when used in the liquid haemolysin 
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assay with the HE. Concentrations of up to 60 Ilg PC ml- l 
caused 60 % reduction in haemolytic activity. Higher con-
centrations caused spontaneous lysis of the erythrocytes 
compared to PC-treated erythrocytes without HE, and 
therefore could not be tested for haemolysis. Other lipid 
substrates including NPPC, the PLC inhibitor, showed no or 
little effect on haemolysis (Fig. 5). 
Lipase and phospholipase inhibitors have been used to study 
the nature, mode of action and structure of different 
phospholipases such as OMPLA in E. coli (Ubarretxena-
Belandia et al., 1999). In this study, PLC inhibitor and 
protein kinase inhibitor lipid suhstrates failed to show any 
inhibitory effect, whilst the C. concisus HE could be inhibited 
by the lipid substrate Pc. Since the PLA inhibitors interact 
with a specific active site of the enzyme (Dekker, 2000), 
reactivity in this case implies a high degree of similarity 
between the active sites in the PLA2 in C. concisus and 
bacterial PLA2, which prefers PC to phosphatidylethanola-
mine as a substrate (Matoba et al., 2002). PC is one of the 
main lipid components in the membranes of human and 
other mammalian erythrocytes, which explains the strong 
haemolytic effect of C. concislIs haemolytic extract on human 
and rabbit erythrocytes (Istivan et al., 1998). Memhrane-
bound phospholipases (haemolysins) active against the 
membranes of erythrocytes are widespread among entero-
pathogens including the PLA in C. coli (Grant et al., 1997) 
and PLA2 of H. pylori (Donell et al., 1999), 
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Fig. 5. Effect of lipids staurosponne (0), sphmgomyelin (Ill), phos-
phatidylglycerol (A.), phosphatidylcholine (0), p-nlirophenylphosphor-
yl choline (cJ) and phosphatldylethanolamme (4111) on haemolylic actiVity 
of C. conC/sus, Llplds were added to HE from C. conC/sus strain RCH 3 
at final concentrations of 20, 40 and 60 fl9 ml- 1, HEs were Incubated 
with lipid substrates for 30 mln before addition to the liqUid haemo-
lYSin assay, 
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Effect of HEs on CHO cells 
Addition of 100 III diluted HE (containing 0·2 mg protein 
ml- 1) induced vacuolation of CHO cells after 16 h of 
incubation (Fig. 6a), while a similar volume of concentrated 
HE (containing 0·8 mg protein ml-1) caused a strong 
cytolytic effect after 16 h of incubation (Fig. 6b). CHE had 
a weaker effect on the CHO cells at 16 h (Fig. 6c), with 
vacuolation noticed after 36 h of incubation. Both the 
cytolytic and the vacuolating effects were stable after 72 h 
of incubation. The haemolysin filtrates (F30) showed no 
visible effect on the normal growth of CHO cells even after 
72 h of incubation (Fig. 6d). 
The effect of haemolytic concentrates (HE) on CHO cells 
indicates the strong cytolytic (damaging) effect of the 
membrane-bound phospholipase haemolysin. Both diluted 
HE and CHE caused a distinct, stable, vacuolation effect on 
cells, with similar effects shown by HEs from both PCR 
groups (genomospecies). All CHE and HE samples with 
vacuolating or cytolytic effect on CHO cells were haemolytic 
to erythrocytes when tested using the liquid haemolysin 
assay, while the F30 haemolysin filtrates had no cytotoxic 
effect on CHO cells and were not haemolytic to erythrocytes. 
PLA2 activity, haemolytic activity and effect on CHO cells for 
different bacterial cell fractions are summarized in Table 2. 
This intracytoplasmic vacuole-formation effect, similar to 
that caused by cytotoxic H. pylori, was also detected when C. 
concisus bacterial cells were incubated with Intestine 407 cells, 
while performing adhesion tests (Musmanno et al., 1998). 
HaemoIysins of Serratia marceSCeHS and Haemophilus ducreyi 
have also been found to have a damaging effect on human 
epithelial cells (Hertle et al., 1999; Wood et al., 1999). PLA in 
Legionella species has been reported to cause destruction of 
lung surfaces and epithelial cells (Flieger et al., 2000), and 
PLA of H. pylori is thought to have a role in colonization 
(Dorrell et al., 1999). Further studies are required to 
determine whether the haemolysin isolated from C. concisus 
http.!/jmmsgmjournals.org 
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produces a vacuolation effect on human epithelial cells similar 
to that produced by VacA toxin of H. pylori or VcVac from 
Vibrio cholerae (Massari et aI., 1998; Coelho et al., 2000). 
PCR analysis of PLA gene 
Genomic DNA from two reference strains of C. concislIs and 
other selected clinical isolates were tested by PCR using 
primers that amplified a 460 bp fragment of C. coli PLA 
(Grant et al., 1997). PCR amplification of this region yielded 
similar-sized PCR products from genomic C. col1cisus DNA 
extracted from clinical isolate RCH 3, ATCC 51561, ATCC 
51562 and C. coli USA 351 (Fig. 7, lanes 2, 3, 4 and 5, 
respectively) . 
bp 
908-
650-
521-
403-
2 3 4 5 
460 bp 
Fig. 7. PCR amplification of genomic DNA from C. concisus strains 
uSing prtmers for the conserved region of the pldA gene sequence of 
C. coli. The 460 bp PCR products were loaded on a 2 % (w/v) agarose 
gel for electrophoresis and then stained With ethidium bromide and 
Visualized on a UV trans-illummator. Lanes: 1, low molecular mass 
DNA standards; 2. PCR product from C. conc/sus RCH 3; 3, PCR 
product from C. conc/sus strain ATCC 51561; 4, PCR product from C. 
conc/sus sh aln ATCC 51562; 5. PCR product from the pld A pOSitive 
C. col/ strain 351 
Fig. 6. Phase-contrast photomicrographs of C. 
concisus HE-mduced vacuolation and cytolysis 
of CHO cells after 16 h. Confluent cells were 
cultured In DMEM supplemented With 0·1 ml 
PBS alone (d), or contalnmg diluted HE (a), 
concentrated HE (b) and CHE (c). After incuba-
tion at 37°C in a 5 % C02 atmosphere for 16 h, 
cells were examined by phase-contrast mlcro-
scopy. In (a), the vacuolating effect of diluted HE 
IS Visible, (b) demonstrates the cytolytic effect of 
concentrated HE, (c) demonstrates the weak 
effect of CHE and (d) shows normal CHO cells. 
Original magnification, x200. 
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The genome of C. conci5u5 strains demonstrate nucleotide 
sequence similarity to a 460 bp region of the pldA gene of 
C. coli PLA haemolysin. The existence of this sequence 
similarity suggests that a similar gene sequence for a 
haemolytic PLA enzyme exists in C. collci5U5 strains assigned 
to both peR groups (genomospecies). A pldA mutant of 
C. coli was previously shown to have marked reduction in 
haemolytic activity when compared with the wild-type 
strain, suggesting a role for pldA as a virulence determinant 
in campylobacters (Grant et al., 1997), while a C. jejul1i pldA 
mutant was reported to have an impaired ability for caecal 
colonization in chicken (Ziprin et al., 2001). Similar research 
with a H. pylori pldA mutant has been reported, suggesting 
that the H. pylori pldA phospholipase has a role in coloniza-
tion of the gastric mucosa and possible tissue damage after 
colonization (Dorrell et al., 1999). Moreover, pldA gene has 
been related to colonization and persistence of H. pylori 
strains isolated from different geographical locations (Xerry 
& Owen, 2001). 
Since haemolytic PLA2 actJVlty with a cytolytic effect is 
considered as a virulence factor in pathogenic bacteria 
(Songer, 1997) and is present in strains of the closely related 
species C. jejul1i and C. coli (Brok et al., 1998), the presence of 
similar activity in both genomospecies of C. concisus clinical 
isolates supports the possible virulence role of this phospho-
Jipase/haemolysin in the pathogenicity of C. col1cisU5. Studies 
have been undertaken by our team to analyse the pldA gene in 
C. col1cisus as a potential virulence factor associated with 
tissue destruction that may be related to intestinal inflam-
mation as a consequence of infection by C. concisus. Further 
molecular studies are needed to analyse the relatedness of 
C. col1cislls isolates assigned to the two genomospecies and 
their role in gastroenteritis and gingivitis. 
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